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Protein tyrosine phosphorylation is essential for the development and survival of 
eukaryotic organisms due to its role in regulating many cellular processes, including 
proliferation, differentiation, and migration (1). The frequency and duration of tyrosine 
phosphorylation of proteins is maintained by the antagonistic activities of protein-
tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs) (2). Both inactivating 
and activating mutations of either PTKs or PTPs have been demonstrated to lead to 
aberrant tyrosine phosphorylation, which results in a plethora of developmental 
defects and diseases (3), highlighting the importance of balanced phospho-tyrosine 
signalling.
In humans, the PTP superfamily consists of 125 PTPs: 116 dephosphorylate 
phospho-tyrosine through a mechanism involving a conserved cysteine amino acid (4, 
5), whereas the other 9 genes encode PTPs that dephosphorylate phospho-tyrosine 
through a distinct catalytic mechanism involving either aspartic acid or histidine (6, 7). 
The 116 cysteine-based PTPs are divided into three subgroups based on their structure 
and function: the classical PTPs, dual-specificity PTPs, and the low molecular weight 
PTPs. The classical PTPs are further subdivided into receptor and non-receptor PTPs. 
Each classical PTP has at least one catalytic domain containing the catalytic cysteine 
(in bold) within a conserved signature motif (I/V)HCXAGXXR(S/T)G (8). The catalytic 
PTP domain is associated with additional domains, such as Src homology 2 (SH2) con-
taining domains in the classical PTP SHP2, or a C2 domain in the tumour suppressor 
phosphatase and tensin homolog (PTEN). The associated domains vary for each PTP 
and contribute to the specificity, regulation, and activity of the individual PTP (5). 
Post-translational modifications (PTMs) of the PTP domain or the associated do-
mains also often regulate the localisation and activity of the PTP. Some PTPs are acti-
vated by phosphorylation. For example, tyrosine phosphorylation of RPTPα, a receptor 
PTP, enables interaction with substrates (9). PTP1B, a cytoplasmic PTP, is activated 
by phosphorylation following growth factor stimulation of the insulin receptor (12). 
Most classical PTPs are inhibited by oxidation of the catalytic cysteine (13), examples 
include PTP1B (14), SHP2 (15), RPTPα (16), and RPTPɛ (17), a mechanism which will 
be subsequently described below. Other PTMs are specific to PTPs because these PTPs 
contain the appropriate domains. For example, the plasma membrane localisation of 
PTEN is due to lysine SUMOylation in its C2 domain (18). In addition to PTMs, catalytic 
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activity of cytoplasmic and receptor PTPs can be regulated through the formation of 
homo- and hetero-dimers (19–21).
As previously mentioned, the catalytic pocket in the PTP domain of classical PTPs is 
highly conserved, and provides a general catalytic mechanism (22). The conserved ca-
talytic cysteine contains a sulphur atom, which is reactive due to being a thiolate anion 
with electrons to spare, allowing it to act as a nucleophile and mediate reactions with 
more positively charged atoms. As a result, the cysteine catalyses dephosphorylation 
through a two-step mechanism: first, the sulphur atom of the cysteine commences 
nucleophilic attack on the phosphorous atom (more positively charged than the 
sulphur atom) of the phospho-tyrosine residue of the substrate, creating a phospho-
cysteine intermediate; second, hydrolysis of this intermediate releases the inorganic 
phosphate and returns the cysteine to a free and active state (15, 23, 24). Several 
residues in and around the catalytic site of the PTP are required for correct substrate 
dephosphorylation: the arginine in the catalytic pocket is required for substrate bin-
ding and stabilizing the phospho-cysteine intermediate; and an aspartic acid residue 
in the conserved WPD loop acts as a general acid and protonates the phenolic oxygen 
group on the phospho-tyrosine, cleaving the phosphate off the tyrosine residue of 
the substrate. The same aspartic acid residue subsequently acts as a general base, in 
consort with a conserved glutamic acid residue, to promote hydrolysis of the phospho-
cysteine intermediate (24–26). 
Classical PTPs exclusively dephosphorylate phospho-tyrosine residues due to a 
deep catalytic pocket, preventing the shorter phospho-serine and phospho-threonine 
residues from reaching the catalytic cysteine (27). In addition, the residues surrounding 
the catalytic cysteine ensure a low dissociation constant (pKa) for the catalytic pocket, 
conferring catalytic activity to the cysteine in its thiolate anion form. The nature of 
the cysteine’s catalytic activity is such that it is also highly susceptible to oxidation 
by reactive oxygen species (ROS), which is why most PTPs are regulated by reversible 
oxidation-mediated inactivation.
ROS, such as hydrogen peroxide (H2O2), can reversibly oxidize the catalytic cystei-
nes of PTPs. Mild oxidation results in conversion of the sulphur atom to sulphenic acid, 
inactivating the PTP as the sulphur atom on the cysteine now no longer has electrons 
to attack the phosphorous atom of the phospho-tyrosine substrate with (28, 29). 
Although this state is reversible, highly oxidizing environments can oxidize the sulphur 
atom to sulphinic acid, or sulphonic acid, permanently inactivating the PTP (30, 31). 
The catalytic cysteine protects itself from irreversible oxidation by rapidly forming a 
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disulphide bond with another nearby cysteine (32, 33) or a sulphenyl-amide ring with 
a nearby nitrogen atom (14). Both states are stable, making them resistant to further 
oxidation, and are readily reduced back to the catalytically active form of the PTP by 
endogenous glutathione and thioredoxin systems (17, 34–36).
The numerous PTMs enable precise and context dependent regulation of phospho-
tyrosine signalling. Therefore, this establishes PTPs as fundamentally essential signal-
ling molecules. Functional analyses of PTPs in Drosophila, C. elegans, zebrafish, and 
mice over the last couple of decades has resulted in overwhelming evidence in support 
of this fact (reviewed in chapter 2).
RegeNeRAtioN
Extensive research over the last century has revealed that there are several forms 
of regeneration. Epimorphic regeneration is the complete replacement of lost tissue 
without scar formation. The process has been studied for well over a century (37), and 
its progress has fostered the field of regenerative medicine. Humans harbour the abi-
lity of epimorphic regeneration early in gestation, but unfortunately rapidly lose this 
ability with age (38). Adult humans are capable of another form of regeneration called 
compensatory growth, where lost tissue is replaced through hypertrophy (increase 
in cell size) or hyperplasia (increase in cell number) (39), but, as the name suggests, 
compensatory growth does not replace the original tissue that was lost. Examples of 
compensatory growth include when a kidney is removed and the remaining kidney 
grows to twice its normal size (40), or when lobes of the liver are removed and the 
remaining lobes grow in size to the original size of the liver. In these examples, a new 
kidney or new lobes of the liver are not formed, hence distinguishing compensatory 
growth from epimorphic regeneration. Compensatory growth has been observed in 
several more organs, including the thymus (41), the beta-cells of the pancreas (42), 
the heart (43), the spleen (44), and the cortex of the adrenal glands (45). The most 
recent practical advancements in the field of regenerative medicine have been 
delivered by leaps in tissue engineering, enabling the fabrication of tissue grafts for 
transplantation to replace the lost tissue and promoting integration of host vascu-
lature (46). Alternatively, wound healing or compensatory growth are promoted by 
injection of (induced pluripotent) stem cells or immune modulation (47). However, 
the possibility of re-activating the ability of epimorphic regeneration is what inspired 
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the field of regenerative medicine, and fundamental research studies organisms that 
retain a lifelong capacity for epimorphic regeneration with the aim of improving our 
understanding of this process, and in the hope of discovering the mechanism required 
to instigate the process in human adults. 
Several vertebrate animals, including salamanders, axolotls, and zebrafish, can fully 
regenerate organs and appendages (48). Zebrafish (Danio rerio) are the most studied 
and fully regenerate multiple organs after injury, including the heart, retina, pancreas, 
spinal cord, and caudal fin (49–51). In the last decade, major strides have been made in 
understanding zebrafish cardiac (52–55) and spinal cord (56–58) regeneration, which 
has been accompanied by advances in understanding bone (59–61) and blood vessel 
(62, 63) regeneration. 
The zebrafish caudal fin is, by far, the most studied for several reasons: it is easily 
accessible in embryos and adults, it occurs rapidly, it is easily observable, and loss of 
the caudal fin does not impair the animal (64). Following amputation of the zebrafish 
caudal fin, regeneration proceeds sequentially through three distinct phases: wound 
healing, blastema formation, and regenerative outgrowth. This process completes 
within two-three weeks in adults, and within 72-96 hours in embryos (65). In the first 
step, nearby cells migrate to cover the wound and form an apical epidermal cap (66). 
No proliferation occurs during this step. In the second step, the apical epidermal cap 
signals for the dedifferentiation of cells to form a blastema (49, 50). The fate of the 
dedifferentiated cells is lineage restricted, and hence the proliferative cells of the 
blastema demonstrate a multipotent potential (67). In the third step, the cells of the 
blastema proliferate and re-differentiate to replace the lost tissue of the zebrafish 
caudal fin. 
Many advances have been made in understanding the molecular mechanisms 
involved in regeneration. Immediately following amputation of the caudal fin of 
zebrafish embryos, termed the caudal fin-fold, a large increase in H2O2 is observed 
emanating from the wound margin and extending into the tissue (68). This production 
of H2O2 may be a crucial trigger for regeneration, as inhibiting the production of the 
H2O2 completely blocks regeneration (69, 70). The function of the H2O2 produced 
following caudal fin-fold amputation is not clear, but has been shown to recruit im-
mune cells to the wound margin (68, 71). ROS are recognized as crucial second mes-
senger molecules that, through the coordination of multiple intracellular signalling 
pathways, instigate appropriate cellular responses to stress (72–74). Furthermore, 
ROS have been demonstrated to regulate PTP activity in cancer (75), the migration of 
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cells (76), and insulin signalling and diabetes (77, 78). To date, many genes have been 
implicated in the regenerative process, including serine/threonine phosphatases (79, 
80), and most up-regulated transcripts have a role in metabolism or signalling (81). 
Multiple signalling pathways have been experimentally validated by creating genetic 
knock-out or overexpression mutants. Signalling pathways shown to be essential for 
regeneration include fibroblast growth factor (82, 83), sonic hedgehog (84, 85), bone 
morphogenetic protein (86, 87), Wnt (88, 89), Notch (90–92), and phosphoinositide 
3-kinase (PI3K) (93–95). 
The signalling pathways often have a role in multiple aspects of the regeneration 
process and this is also reflected by the fluctuation of gene expression during different 
phases of the regenerative process (80), demonstrating a need for precise spatio-
temporal regulation of multiple signalling pathways. The genes identified implicate 
almost every cellular process, such as mitosis, protein degradation, migration, and 
metabolic processes, highlighting the complexity of the molecular and cellular pro-
cesses required for regeneration, and adding to the challenge of understanding this 
extremely complex process.
sCoPe oF this thesis
The work described in this thesis aims to implicate PTPs as essential signalling mo-
lecules for the regeneration of the zebrafish embryo caudal fin-fold. The production 
of ROS immediately following zebrafish caudal fin-fold amputation likely stimulates 
many changes in protein activity and cell behaviour. We hypothesized that, due to the 
sensitivity of PTPs to oxidation, PTPs would become oxidized in response to caudal fin 
amputation. We further used pten and ptpn11 knock-out zebrafish to demonstrate the 
importance of PTP activity in the process of regeneration.
Amputation of the zebrafish caudal fin hence represents an opportunity to study 
PTP oxidation in vivo, under physiologically relevant conditions. PTP oxidation by ROS 
has been extensively established through the treatment of PTPs in cells or in vitro with 
exogenous H2O2. However, the difficulty of measuring intracellular ROS concentrations 
has hindered ascertaining if PTPs become oxidized in vivo by endogenous ROS levels. 
By combining chemical modifications of reduced and reversibly oxidized thiols, the 
use of an antibody specific for irreversibly oxidized PTPs, and state-of-the art mass 
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spectrometry, we investigate the oxidation of PTPs in zebrafish tissue directly following 
amputation.
In addition, zebrafish embryos are powerful tools for delineating the specific role 
of proteins through the ability to create knock-outs and re-introduce mutant proteins. 
Their transparency enables easy imaging, and drug screens are easy to perform 
because they are oviparous. We used genetic pten and ptpn11 knock-out zebrafish, 
deficient for Pten and Shp2 respectively, and by re-introducing mutant proteins that 
are catalytically inactive, unable to bind substrates, or have altered sensitivity to oxi-
dation, we demonstrate the role of Pten and Shp2 in the regenerative process. Using 
inhibitors of the signalling pathways Pten and Shp2 are involved in, we shed light on 
the signalling roles of Pten and Shp2 during zebrafish caudal fin-fold regeneration.
outliNe oF this thesis
Chapter 2 provides a review of the recent advances made to understand the role of 
PTPs in embryonic development. We provide an overview of developmental processes 
dependent on receptor and non-receptor PTPs in a variety of model organisms. We 
highlight the requirement for balanced phospho-tyrosine signalling and provide a few 
examples of diseases that result from mutations in PTPs.
Chapter 3 describes some of the methods used in the experiments within this the-
sis. We detail how the micro-injection of zebrafish embryos is performed to introduce 
mutant proteins. Moreover, we detail how the zebrafish embryonic caudal fin-fold 
amputations are performed, as well as how to prepare embryonic zebrafish tissue for 
detection of protein by immunoblotting. Additionally, we provide tips on crucial steps 
and alternatives.
Chapter 4 describes the importance of the tumour suppressor Pten in zebrafish 
caudal fin-fold regeneration. We show that pten knock-out zebrafish embryos do not 
regenerate their caudal fin-folds, and that regeneration is rescued by re-introducing 
wild-type Pten, but not catalytically inactive mutant Pten. Blastema formation occurs 
normally in the caudal fin-folds of Pten deficient zebrafish embryos, but proliferation 
during regenerative outgrowth is arrested. Zebrafish embryos deficient for Pten also 
display elevated Akt phosphorylation, and their regeneration is rescued when treated 
with the PI3K inhibitor LY294002.
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Chapter 5 unveils differential oxidation of PTPs following amputation of adult zebra-
fish caudal fins. Adult wild-type zebrafish caudal fins were lysed in reducing or alkyla-
ting buffers to enable detection of all PTPs or the oxidized PTPs following amputation 
of the caudal fin respectively. Using an antibody specific for the conserved oxidized 
catalytic site of PTPs and identification by liquid chromatography mass spectrometry, 
we identified 33 PTPs in the zebrafish caudal fin and 8 were reversibly oxidized 40 
minutes after caudal fin amputation. Zebrafish embryos deficient for functional Shp2, 
which is oxidized, do not regenerate, whilst zebrafish embryos deficient for RPTPα, 
which is not oxidized, regenerate normally.
Chapter 6 describes the importance of the PTP Shp2 in zebrafish caudal fin-fold 
regeneration, demonstrating that both catalytic activity and the SH2 domain of Shp2a 
are required for its function in caudal fin-fold regeneration. We show that ptpn11 
knock-out zebrafish embryos, lacking functional Shp2, do not regenerate their caudal 
fin-fold. Whereas expression of catalytically inactive Shp2a or a SH2 domain mutant of 
Shp2a did not rescue caudal fin-fold regeneration of ptpn11 knock-out zebrafish em-
bryos, expression of a C-terminal domain mutant of Shp2a did rescue caudal fin-fold 
regeneration. Compared to sibling zebrafish embryos expressing Shp2a, proliferation 
during regenerative outgrowth is arrested in ptpn11 knock-out zebrafish embryos, 
despite normal blastema formation. Interestingly, zebrafish embryos deficient for 
Shp2 display reduced mitogen activated protein kinase (MAPK) phosphorylation, and 
inhibition of MAPK in wild-type zebrafish embryos also inhibits regeneration and ar-
rests proliferation during regenerative outgrowth.
Chapter 7 covers structure and function analysis of Shp2a in zebrafish caudal fin-
fold regeneration. We further assessed the role of Shp2a by mutating the back-door 
cysteines of Shp2a, which have previously been proposed to have a role in protecting 
the catalytic cysteine from irreversible oxidation-mediated inactivation. We show that 
the back-door cysteine mutants of Shp2a have reduced catalytic activity in vitro and 
experience enhanced oxidation in response to ROS in cells. Surprisingly, expressing 
the back-door cysteine mutants of Shp2a in ptpn11 knock-out zebrafish embryos, 
lacking functional Shp2, rescued zebrafish caudal fin-fold regeneration. Considering 
the reduced catalytic activity of the back-door cysteine mutants of Shp2a, we also 
investigated the role the level of Shp2a catalytic activity has in its function in caudal 
fin-fold regeneration. Interestingly, expression of two known mutants of Shp2a with 
increased (D61G) or reduced (A462T) catalytic activity in ptpn11 knock-out zebrafish 
embryos rescued caudal fin-fold regeneration to a similar extent. Collectively, our 
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results suggest that the level of Shp2a catalytic activity does not affect the function of 
Shp2a in the regenerative outgrowth of the caudal fin-fold. 
Chapter 8 summarizes the discussions of Chapters 4-7, and proposes future 
research that will address the outstanding questions that results from the work des-
cribed in this thesis. Finally, we provide some perspectives on the field of regeneration 
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Protein-tyrosine phosphatases (PTPs) remove phosphate groups from tyrosine resi-
dues, and thereby propagate or inhibit signal transduction, and hence influence cel-
lular processes such as cell proliferation and differentiation. The importance of tightly 
controlled PTP activity is reflected by the numerous mechanisms employed by the 
cell to control PTP activity, including a variety of post-translational modifications, and 
restricted subcellular localization. This review highlights the strides made in the last 
decade and discusses the important role of PTPs in key aspects of embryonic deve-
lopment: the regulation of stem cell self-renewal and differentiation, gastrulation and 
somitogenesis during early embryonic development, osteogenesis, and angiogenesis. 
The tentative importance of PTPs in these processes is highlighted by the diseases that 




The Hubrecht Institute has a long history of signal transduction research and how 
signalling affects developmental biology and stem cells. More than a quarter of a 
century ago, den Hertog cloned genes encoding PTPs and ever since, the function of 
PTPs in development and disease has been studied at the Hubrecht Institute. Recent 
progress in our understanding of PTP function resulting from research at the Hubrecht 
and elsewhere will be discussed here. 
The phosphorylation and de-phosphorylation of proteins is an essential mecha-
nism by which cellular signalling is regulated. Proteins are phosphorylated on tyrosine 
residues by protein-tyrosine kinases (PTKs) and de-phosphorylated by protein-tyrosine 
phosphatases (PTPs). PTPs have demonstrated to be important regulators of fundamen-
tal cellular processes, including proliferation, differentiation, and cell-cell adhesion.
Since the purification of the first PTP, PTP1B, in 1988 (1), 125 PTPs have been iden-
tified in the human genome, constituting an enzyme superfamily divided into three 
groups: the classical PTPs, dual-specificity PTPs, and the low molecular weight PTPs 
(2, 3). The classical PTPs are further subdivided into receptor and non-receptor PTPs 
(table 1 and Fig. 1). Each PTP holds one or two catalytic domains with a conserved sig-
nature motif (I/V)HCXAGXXR(S/T)G containing the catalytic cysteine (in bold) essential 
for catalysing the removal of a phosphate group from a phospho-tyrosine residue. The 
domains associated with the catalytic domains of PTPs are diverse and contribute to 
their specificity, regulation, and activity (3). PTPs are often regulated by post-translati-
onal modifications, including phosphorylation and oxidation. For example, RPTPα and 
SHP2 are activated by phosphorylation of two serine residues and a tyrosine residue 
respectively (4). Most classical PTPs are inhibited by reversible oxidation of the cys-
teine residue in the catalytic site, and the unique micro-environment of the catalytic 
site determines the sensitivity of each PTP to oxidation-mediated inhibition (5). The 
activity of RPTPs is also regulated by dimerization, where activation or inactivation is 
determined by the exact orientation of the dimer. In addition, post-translational modi-
fications alter the status of the RPTP dimer, and thereby influence catalytic activity (4).
In the last decades, research has revealed an important role for PTPs in development. 
Moreover, mutations in PTPs, which lead to aberrant PTP activity, result in disease or 
contribute to disease progression. This review will focus on the recent advances in 
understanding the role of PTPs in stem cell self-renewal and differentiation, gastrulation 
and somitogenesis during early embryonic development, osteogenesis, and angiogene-
sis. Finally, disease phenotypes correlated with mutations in PTPs will be discussed.
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table. 1. list of classical protein-tyrosine phosphatases divided into receptor PtPs and non-re-
ceptor, cytoplasmic, PtPs. Human (Homo sapiens), Mouse (Mus musculus), and Zebrafish (Danio 
rerio) orthologues are listed.
GENE PROTEIN Gene PROTEIN gene Protein
PTPN1 PTP1B Ptpn1 PTP1B ptpn1 Ptp1b
ptpn2a Tc-ptpa
ptpn2b Tc-ptpb
PTPN3 PTPH1 Ptpn3 PTPH1 ptpn3 Ptp-h1
ptpn4a Meg1a
ptpn4b Meg1b
PTPN5 STEP Ptpn5 STEP ptpn5 Step
PTPN6 SHP1 Ptpn6 SHP1 ptpn6 Shp1





PTPN12 PTP-PEST Ptpn12 PTP-PEST ptpn12 Pest
PTPN13 PTP-BAS Ptpn13 PTP-BAS ptpn13 Ptp-bas
PTPN14 PTPD2/PEZ Ptpn14 PTPD2/PEZ ptpn14 Pez
PTPN18 PTP-HSCF Ptpn18 PTP-HSCF ptpn18 Ptp-hscf
PTPN20 PTPN20 Ptpn20 PTPN20 ptpn20 Ptpn20
PTPN21 PTP-D1 Ptpn21 PTP-D1 ptpn21 Ptp-d1
PTPN22 LYP Ptpn22 LYP ptpn22 Lyp
ptpn23a Hd-ptpa
ptpn23b Hd-ptpb
PTPRC CD45 Ptprc CD45 ptprc Cd45
PTPRM RPTPµ Ptprm RPTPµ ptprm Rptpµ
PTPRK RPTPκ Ptprk RPTPκ ptprk Rptpκ









PTPRB RPTPβ Ptprb RPTPβ ptprb Rptpβ
ptprja Dep-1a
ptprjb Dep-1b
PTPRH SAP1 Ptprh SAP1 ptprh Sap1
PTPRO RPTPO Ptpro RPTPO ptpro Rptpo
PTPRQ RPTPQ/PTPS31 Ptpro RPTPQ/PTPS31 ptprq Rptpq







PTPRR PC-PTP Ptprr PC-PTP ptprr Rptpr
ptprna Rptpna
ptprnb Rptpnb


















PTPN11 SHP2 Ptpn11 SHP2
PTP-MEG2Ptpn9PTP-MEG2PTPN9
RPTPʎPtpruRPTPʎPTPRU






























































Fig. 1. Family of classical protein-tyrosine phosphatases divided into receptor PtPs and non-
receptor, cytoplasmic, PtPs. PTPs are clustered based on their functional domains, indicated in 
the boxed legend (top right).
2. PtPs iN the RegulAtioN oF stem Cell selF-ReNewAl ANd 
diFFeReNtiAtioN
Stem cells are able to proliferate and maintain their pluripotent capacity by self-
renewal, and are at the origin of all cell types. In response to key stimuli, stem cells 
forfeit their pluripotency and differentiate into tissue specific cell lineages. PTPs are 
involved in the regulation of stem cell fate via various signalling pathways (reviewed 
in (6)). Here, we will discuss the importance of PTP regulation in stem cell fate and 
differentiation during development.
2.1 embryonic stem cells
Several PTPs have been found to be important in determining embryonic stem cell 
(ESC) fate. SHP2, a cytoplasmic PTP encoded by the PTPN11 gene and containing two 
SRC homology 2 (SH2) domains, is required in the initial stages of mouse and human 
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embryonic development for the differentiation of ESCs into the three germ layers (7, 
8). In mice, it has been reported that SHP2 promotes ESC differentiation into heman-
gioblasts, multipotent precursor cells that differentiate into cells of the hematopoietic 
cell lineage and endothelial cells (8). SHP2 has a crucial role in adipogenesis, as SHP2 
deficiency supresses differentiation of ESCs to adipocytes (9), and of pre-adipocytes to 
adipocytes (10).
Phosphatase and Tensin Homolog (PTEN) belongs to the PTP superfamily and is a 
dual specificity phosphatase with roles in cell motility, metabolism, and polarity (11). 
PTEN negatively regulates AKT, a major instigator of cellular processes such as prolife-
ration, migration, and cell survival. PTEN de-phosphorylation of phosphatidylinositol 
3,4,5-triphosphate (PIP3) to phosphatidylinositol 4,5-bisphosphate (PIP2) inhibits the 
phosphorylation cascade that activates AKT. Knockdown of PTEN in human ESCs results 
in increased proliferation, survival, and self-renewal. In addition, ESC differentiation 
into neuro-ectoderm, rather than cells of the other germ layers, increases (12). This 
indicates that PTEN is not solely important for ESC growth, but is also required for 
proper differentiation of ESCs into all three lineages.
Protein-tyrosine phosphatase 1B (PTP1B), encoded by the PTPN1 gene, has an im-
portant role in determining the mesendodermal fate of ESCs. Overexpression of PTP1B 
results in ESC differentiation towards a mesendodermal fate, whilst PTP1B knockdown 
leads to differentiation towards a neuro-ectodermal fate (13). 
2.2 hematopoietic stem cells
PTPs are important for the regulation of hematopoietic stem cells (HSCs). SHP2 is es-
sential for the maintenance of the HSC pool and differentiation into lineages of the 
hematopoietic system. Loss of Ptpn11 in the HSCs of mice leads to loss of almost all 
HSCs and progenitors of hematopoietic cell lineages, and mortality within 6 to 8 weeks 
post birth (14). Whilst knockdown of SHP2 in human CD34+ cells results in reduced 
proliferation and differentiation into hematopoietic cell lineages in vivo, gain-of-
function mutations in SHP2 result in aberrant differentiation and proliferation profiles 
of HSCs (15–18).
In contrast, T-cell PTP (TC-PTP), encoded by PTPN2 and so named because it was 
originally cloned from T-cells and is highly expressed in cells of the hematopoietic 
system, negatively regulates HSC self-renewal and differentiation. Knockout of Ptpn2 
or pharmacological inhibition of TC-PTP increases the number of stem and progenitor 
cells in mice (19). RPTPσ, encoded by PTPRS, also negatively regulates HSC self-renewal 
29
2
because transplanting Ptprs-/- bone marrow cells in mice increases HSC regeneration 
(20). 
2.3 Neuronal stem cells
In addition to ESCs and HSCs, SHP2 is vital to the proliferation and self-renewal of 
neuronal stem cells (NSCs), neuronal migration, and neurite outgrowth. SHP2 deficient 
NSCs have severely decreased neuron and oligodendrocyte differentiation, and mice 
suffer postnatal lethality (21, 22). In contrast, neurite outgrowth is negatively sup-
pressed by RPTPσ, since neurite outgrowth is enhanced in RPTPσ deficient neurons 
(23). 
2.4 mesenchymal stem cells
Leukocyte common antigen-related RPTP (LAR), RPTPQ, and SHP1, encoded by PTPRF, 
PTPRQ, and PTPN6 respectively, are all involved in differentiation of mesenchymal 
stem cells (MSCs) into adipocytes. Knockdown of LAR increases adipogenesis, whereas 
overexpression of LAR decreases adipogenic differentiation (24). Similarly, RPTPQ 
overexpression decreases MSC differentiation into adipocytes (25).  
Like LAR and RPTPQ, SHP1 negatively regulates MSC differentiation into adipocytes. 
SHP1 modulates Wnt/β-catenin signalling to express transcription factors needed for 
differentiation of MSCs into osteoblasts, shifting the balance between adipogenesis 
and osteogenesis in favour of MSC differentiation to an osteoblast fate (26). SHP1 
deficient mice therefore have increased adipogenic markers and decreased osteogenic 
markers, accompanied by an increase in adipose tissue and a reduction in bone mass.
3. Role oF PtPs iN gAstRulAtioN ANd somitogeNesis duRiNg 
eARly embRyoNiC develoPmeNt
During early embryonic development, gastrulation is the process where the single-
layered blastula is reorganized to form the three primary germ layers: endoderm, 
ectoderm, and mesoderm, that will eventually give rise to all organs. Gastrulation 
starts with emboly, the process where a layer of cells migrates and converges into the 
interior of the embryo forming an underlying layer. Following emboly, cells extend 
along one axis and converge (narrow) along a perpendicular axis in convergence and 
extension (C&E) movements. Epiboly, the thinning and spreading of cell layers, mostly 
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of ectoderm, that will finally cover the whole embryo, occurs in parallel (27). After 
gastrulation, the ectoderm will form the epidermis and nervous system, and the endo-
derm the epithelium of the digestive system, organs associated with this system, and 
the respiratory system. The mesodermal layer will give rise to somites on either side of 
the neural tube, which will eventually give rise to blood and blood vessels, the skele-
tomuscular system, connective tissue, and internal organs (28). A substantial number 
of PTPs have been identified as important regulators of development. The exact timing 
when each PTP acts, and on which signalling pathways, for normal development to 
occur still needs to be mapped. Here, we provide an overview of the recent research 
investigating the role of PTPs in early embryonic development.
3.1 Cytoplasmic PtPs
PTEN is undoubtedly important to normal development as Pten knockout mice suffer 
early embryonic lethality (29–31). Zebrafish contain two pten genes, ptena and ptenb, 
that are both highly homologous to human PTEN. Zebrafish deficient for both Ptena 
and Ptenb are embryonic lethal by 5-7 days post fertilization. Pten deficient zebrafish 
are characterized by smaller eyes that are set wider apart, a shortened body axis, an 
enlarged head, and heart oedema (32). Increased Akt phosphorylation, which enhan-
ces proliferation and cell survival, in Pten deficient zebrafish is the underlying cause 
of their phenotype, as treatment with a PI3K inhibitor can rescue the abnormalities. 
Further studies in mice demonstrated that PTEN is important for the formation of 
the anterior-posterior axis, by regulating migration of anterior visceral endoderm. 
Mouse embryos lacking PTEN in the epiblast demonstrate defects in migration of the 
embryonic layers, suggesting an important role for PTEN in migration of endoderm and 
mesoderm after gastrulation (33).
Overexpression of Ptp1b in zebrafish induces lethal defects in gastrulation and 
somitogenesis (34). Later studies in Drosophila emphasized the importance of correct 
tyrosine phosphorylation of proteins in early embryonic development. Lack of PTP61F, 
the Drosophila gene that encodes both the PTP1B and TC-PTP orthologues, results in 
reduced fecundity and life span. Reducing PTP61F expression by RNAi results in eye 
overgrowth and thickened and deformed veins in the wings, and overexpression of 
PTP61F impairs growth (35). PTP1B and TC-PTP regulate insulin receptor (IR) signal-
ling in non-redundant and distinct ways. Importantly, whereas loss of PTP1B results in 
enhanced MAPK signal transduction, loss of TC-PTP does not affect insulin stimulated 
MAPK signalling in mouse embryonic fibroblasts (36–38). Of note is that MAPK signal 
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transduction induced by other ligands, such as tumor necrosis factor (TNF), is enhan-
ced by loss of TC-PTP. In Drosophila, PTP61F acts as a negative regulator of MAPK 
signal transduction (39), suggesting a similar role as PTP1B. However, further research 
is needed to determine if the observed phenotype in Drosophila is due to aberrations 
in MAPK signalling, and hence that the defects can be ascribed to the orthologue of 
PTP1B, TC-PTP or both.
PTP-PEST, encoded by the PTPN12 gene, is a phosphatase containing PEST-
sequences, and is mostly expressed by cells of the hematopoietic system. Gastrulation 
occurs normally in PTP-PEST deficient mouse embryos, however after E9.5 several 
developmental defects such as growth retardation, a smaller cardiac region, caudal 
development arrest, and disrupted somite formation are observed. These mice also 
lack the formation of a fetal liver and reach embryonic lethality between E9.5 – E10.5. 
The precise role of PTP-PEST in embryonic development needs to be elucidated, but 
these results imply that PTP-PEST is more important in later embryonic development 
(40). As PTP1B appears to affect early embryonic development, and that PTP-PEST 
appears to affect later stages, there is evidence that specific PTPs may regulate distinct 
stages of embryonic development.
In early mouse development, SHP2 deficiency leads to embryonic lethality due 
to aberrant ERK signalling causing increased apoptosis in trophoblast stem cells (41). 
Similarly, Shp2 deficient zebrafish are embryonic lethal at 6-7 days post fertilization 
and display a reduced body axis, heart and eye oedema, and craniofacial defects (42).
3.2 Receptor PtPs
The C. elegans orthologue of the mammalian RPTP, LAR, has two isoforms, PTP-3A 
and PTP-3B, and loss-of-function results in mild, but lethal, gastrulation defects (43, 
44). Mutations in Syndecan-1 (SDN-1), a heparin sulphate proteoglycan with which 
members of the LAR family interact, lead to movement and egg-laying defects, and 
low levels of lethality. As mutations in both PTP-3B and SDN-1 result in severe defects 
during gastrulation and arrested embryogenesis during epiboly, PTP-3B and SDN-1 
likely have overlapping functions during early embryonic development (44). PTP-3B 
likely acts in Wnt signalling during embryonic development as knockdown of the 
Wnt ligand LIN-44 in PTP-3B mutants resulted in no synergistic phenotypes. Ongoing 




In early mouse embryogenesis, knockout of Ptprs and Ptprf leads to urogenital and 
craniofacial defects, such as smaller lower jaws, cleft palates, and no nasal capsules, 
resulting in a phenotype similar to Pierre-Robin Sequence (45, 46). This phenotype 
in RPTPσ and LAR deficient mice is thought to be due to decreased proliferation of 
mandibular cells and defective patterning of mandibular bone and cartilage, as a result 
of altered regulation of the BMP and Wnt signalling pathways (46).
In Drosophila a potential orthologue of the human stomach-associated SAP1 PTP, 
PTP52F, has an essential role in the transition from larva to pupa, as mutations lead to 
mortality at the post pupal stage (47).
In Zebrafish, Rptpα, Rptpɛ, Ptp-bas, and Ptpn20 are all essential for gastrulation. 
Knockdown of these four PTPs in zebrafish embryos induces phenotypes that correlate 
with defects in C&E movements and epiboly cell migration, formation of oedemas 
around the yolk and heart upon Rptpα knockdown, and a shortened body axis upon 
both Rptpα and Rptpɛ knockdown (6, 48). Rptpα and Rptpɛ, encoded by ptpra and 
ptpre respectively, act upstream of kinases Fyn and Yes, activating RhoA, which in turn 
activates Rock, ultimately resulting in cell polarization. In contrast, Ptpn20 and Ptp-
bas, encoded by ptpn20 and ptpn13 respectively, signal to reduce RhoA activity. This 
balance of positive and negative regulation of RhoA is essential for cell polarization, 
which in turn determines proper C&E movements and epiboly cell migration.
4. PtPs iN boNe FoRmAtioN
Osteoblasts and osteoclasts are important cells in the maintenance of bone matrix, 
and have opposing activities to constantly remodel bone. Osteoblasts form a speciali-
zed unit of connected cells, called the osteon, which synthesize essential cross-linked 
collagen and a calcium- and phosphate-based mineral, called hydroxyapatite, for the 
formation and mineralization of bone in a process known as osteogenesis (49). Os-
teoclasts, multi-nucleated cells formed through the fusion of monocyte-macrophage 
precursor cells, digest bone in the process known as bone resorption.  Differentiation 
of precursor cells into osteoclasts is regulated by receptor activator of nuclear factor 
kappa-B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) (50). When 
attached to bone, osteoclasts form adhesion structures called podosomes, which are 
densely packed into a ring referred to as the sealing zone. Osteoclasts then release 
acid and collagenase to demineralise and degrade the bone matrix. The podosome 
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core is composed of filamentous actin and its formation is regulated by a multi-protein 
branching machinery that consists of cortactin, Wiskott-Aldrich syndrome protein 
(WASP), WASP interacting protein (WIP), and the Arp2/3 complex. When integrins from 
osteoclasts bind to ligands in the bone, they recruit proteins involved in podosome dy-
namic and organization, such as PYK2 and SRC (50, 51). Knockout of Csk in mice leads 
to osteopetrosis, i.e. increased bone density, due to reduced bone resorption (52), 
underpinning the importance of well regulated SRC activity during bone formation.  
4.1 Cytoplasmic PtPs
In 1995, Ari Elson discovered a cytoplasmic form of PTPɛ encoded by the PTPRE gene 
(53), which is referred to as cyt-PTPɛ and plays an important role in osteogenesis. 
Lack of cyt-PTPɛ increases the trabecular bone mass of young adult female mice, as a 
consequence of reduced bone resorption. cyt-PTPɛ deficient mice show reduced num-
bers of osteoclasts in contact with bone, but no reduction in total osteoclast number, 
suggesting impaired functioning of osteoclasts (54, 55). In addition, podosomes have 
a perturbed internal structure, cellular organization, and reduced stablity, presuma-
bly because of dysregulated SRC, PYK2, RHO, and RAC activity, which are involved in 
integrin signalling pathways required for podosome formation. cyt-PTPɛ is activated 
by SRC following integrin signalling and maintains SRC activity via a positive feedback 
loop (56, 57). Since RPTPα is closely related tot PTPɛ, it has been suggested that RPTPα 
performs a similar role in osteoclast function. However, mice lacking RPTPα do not 
show any changes in bone mass, function of osteoclasts, or podosome organization 
and function (54).
PTP-PEST is associated with SRC, PYK2, proline-serine-threonine phosphatase-
interacting protein (PSTPIP), and WASP in podosomes. PTP-PEST dephosphorylates 
SRC at Y527, allowing SRC-mediated phosphorylation and activation of WASP and 
Cortactin, ultimately resulting in formation of the sealing zone (58, 59). PTP-PEST also 
regulates osteoclast function through dephosphorylation of PYK2, leading to PYK2 
inactivation and reduced osteclast activity, followed by re-organization of the sealing 
zone (60). Furthermore, monocyte-macrophage fusion, required for oseoclast forma-
tion, is dependent on delicate PTP-PEST controlled PYK2 phosphorylation; both PYK2 
hyperphosphorylation, as a result of PTP-PEST deficiency, and PYK2 inhibition lead to 
a fusion defect (61). PTP-PEST also has an important role in osteoblasts because PTP-
PEST increases differentiation of pre-osteoblasts to osteoblasts and has been shown 
to decrease osteoblast migration in vitro, by inactivating the GTPase Dynamin (62).
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SHP2 deficient mice suffer such severe impairment of osteogenesis that they 
develop osteopetrotic bones and develop cartilage abnormalities (63, 64). However, 
how SHP2 regulates osteogenesis in mice is under debate. Bauler et al. suggest that 
osteogenesis is impaired in SHP2 deficient mice as a result of a lack of AKT activation 
required for the proliferation and survival of osteoclast precursor cells (63). In contrast, 
Zhou et al. demonstrate that SHP2 deletion has little effect on the proliferation and 
survival of osteoclast precursor cells in the presence of M-CSF and RANKL, and instead 
propose that SHP2 is important in pre-osteoclast fusion by responding to RANKL signa-
ling (64). Whichever pathway SHP2 acts on, it is likely in response to, or in an effort to 
regulate, SRC activity.
4.2 Receptor PtPs
RPTPO, encoded by the PTPRO gene, is an osteoclast transmembrane PTP and mainly 
expressed in hematopoietic cells, such as B-lymphocytes, osteoclasts, and their pre-
cursor cells. RPTPO has been demonstrated to be important for the differentiation 
and activity of osteoclast-like cells derived from a lymphoblast cell line (65), and likely 
regulates osteoclast activity, migration, and survival through a SRC-dependent manner 
(66, 67). Overexpression of RPTPO maintains increased osteoclast activity as a result of 
reduced apoptosis, whereas knockdown, or overexpression of inactive RPTPO leads to 
increased apoptosis and reduced osteoclast actvity (67). Furthermore, overexpression 
of RPTPO in osteoclast-like cells decreases bone density and mass in young adult male 
mice due to increased bone resorption (68). This is in stark contrast to the effect of 
knocking-out the aforementioned cyt-Ptpɛ in female mice. Since overexpression of 
RPTPO or knockout of cyt-Ptpɛ results in the same phenotype in male or female mice 
respectively, it could be that sex-dependent hormone signalling in osteoclasts is affec-
ted by the activity of each PTP and that both converge on the same pathway. In parallel 
to activation of SRC, RPTPO also increases the bone resoprtion activity of osteoclasts 
independently of SRC by inactivating EPHA4, a negative regulator of osteoclast activity 
(69). 
5. PtPs iN ANgiogeNesis
Blood vessel formation is regulated by VEGF mediated signalling through the VEGF 
tyrosine kinase receptor family, consisting of VEGF receptor (VEGFR) 1, 2 and 3, of 
35
2
which VEGFR2 mediates the major actions. Stimulation with VEGF activates VEGFR2 
signalling that induces VE-Cadherin tyrosine phosphorylation (70). Hence, it comes 
as no surprise that PTPs have a critical role in angiogenesis. New blood vessels are 
formed by sprouting of endothelial tip cells from pre-existing blood vessels towards an 
angiogenic stimulus, such as VEGF. Tip cells contain filopodia that have many VEGFR2 
receptors to ‘sense’ the VEGF gradient and migrate towards the source of this gradient. 
The stalk cells that are positioned next to tip cells proliferate upon tip cell movement, 
causing the blood vessel to elongate. This vessel-branching model of tip cell migration 
and stalk cell proliferation is under the control of NOTCH signalling. The permeability 
and stability of blood vessels is regulated by intercellular junctions, and vascular endo-
thelial (VE)-Cadherin is the major determinant of blood vessel wall integrity, changing 
the activity or presence of VE-Cadherin at cell-cell contacts will affect the permeability 
and stability of the blood vessel walls. Loss of VE-Cadherin, therefore, does not lead 
to inhibition of angiogenesis, but to defects in vessel remodelling and cell-cell junction 
integrity (71).  
5.1 Cytoplasmic PtPs
PTP1B overexpression in endothelial cells inhibits VEGF mediated phosphorylation 
of VEGFR2 and reduces VE-Cadherin tyrosine phosphorylation, resulting in reduced 
proliferation and migration, stabilized cell-cell contacts between endothelial cells, 
and disrupted angiogenesis (72, 73). PTP1B knockout primary mouse endothelial 
cells display enhanced VEGF induced MAPK and VEGFR2 phosphorylation, and PTP1B 
deficient mice and leptin deficient obese mice (ob/ob mice), in which PTP1B is inhibi-
ted, demonstrate enhanced angiogenesis (73, 74). Hence, PTP1B negatively regulates 
angiogenesis, and recent research implicates PTP1B in a Calpain-dependent negative 
feedback mechanism of VEGF induced angiogenesis (75). Yet, it remains to be deter-
mined if PTP1B acts on VEGFR2 directly.
In contrast to PTP1B, PTP-PEST positively regulates angiogenesis by stimulating 
endothelial cell migration and vascular development. Loss of Ptpn12 in mice leads to 
a reduced number of endothelial cells in the aorta and yolk sac, fewer, but larger ves-
sels, and mortality between E9.5 and E10.5 (40). Moreover, when PTP-PEST deficiency 
is limited exclusively to endothelial cells, these cells show a decreased adhesion to 
collagen and fibronectin, and reduced migration, with the resulting perturbation in 
angiogenesis leading to embryonic lethality (76). PTP-PEST has been shown in vitro to 
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contribute to integrin-mediated adhesion and migration of endothelial cells, through 
the dephosphorylation of CAS, Paxillin, and PYK2. 
Zebrafish deficient for Ptena and Ptenb, alongside elevated phospho-Akt levels, 
have upregulated levels of Vegfaa, and subsequently demonstrate hyper-vasculariza-
tion (77). It is the lipid phosphatase activity of Pten, rather than the protein phosp-
hatase activity, and proper spatial expression of Pten that are essential for regulation 
of angiogenesis and the development of blood vessels in zebrafish. Pten mutated at 
lysine 13 to an arginine has enhanced plasma membrane localization in mammalian 
and zebrafish cells, and rescues the hyper-vascularization phenotype (78, 79). Howe-
ver, stalled intersegmental vessels are observed during development when this Pten 
mutant is expressed in wild-type zebrafish embryos, suggesting that sufficient, and not 
excess, membrane localized Pten is required for proper angiogenesis. In mice, PTEN is 
important for the regulation of stalk cell proliferation, and NOTCH induced PTEN ex-
pression results in cell cycle arrest, and hence proper formation of blood vessels (80). 
Overexpression of PTEN reduces endothelial cell proliferation and vascular density, 
and aberrant angiogenesis is observed when PTEN activity is reduced (81), suggesting 
a fine balance of PTEN activity is required for proper blood vessel formation. One of 
the limitations to understanding the exact role of PTEN in angiogenesis during normal 
embryonic development is that knowledge pertaining to angiogenesis has mostly been 
inferred from tumour angiogenesis. Tumours often exhibit enhanced angiogenesis 
but, also, PTEN is a tumour suppressor gene that is often mutated in tumours (82–84). 
It is therefore difficult to appreciate the role of PTEN in angiogenesis. Nevertheless, 
it is evident from studies to date that PTEN has a crucial role in angiogenesis and is a 
factor that ensures proper blood vessel development.
5.2 Receptor PtPs
Mice deficient for RPTPβ, also known as vascular endothelial PTP (VE-PTP) because 
it is exclusively expressed in endothelial cells, display severe vascular remodelling 
defects, and reach mortality by E10. The mice are not able to form a hierarchical 
branched vascular network, indicating that RPTPβ is not necessary at the initial stages 
of blood vessel formation, but for the maintenance of blood vessels. In addition, 
RPTPβ deficient mice have defects in heart formation (85, 86). RPTPβ, encoded by the 
PTPRB gene, maintains blood vessels by binding VE-Cadherin and ensuring optimal 
VE-Cadherin function, and thereby endothelial cell-cell adhesion. Furthermore, RPTPβ 
cooperates with integrins and RAS to induce endothelial cell spreading and migra-
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tion. In the presence of fibronectin, RPTPβ promotes the formation of filopodia and 
lamellipodia, and induces cell migration. These effects are abolished when SRC family 
kinases are inhibited, suggesting that integrin-induced activation of SRC family kinase 
signalling is important for RPTPβ induced endothelial cell spreading and migration 
(87). VEGF stimulation induces dissociation of RPTPβ from VE-Cadherin, and, due to 
the loss of endothelial cell-cell adhesion, results in increased cell layer permeability 
and diapedesis of leukocytes (88, 89). Although proximity ligation assays suggested 
a direct association of RPTPβ with VEGFR2 (90), the mechanism is proposed to be 
mediated by PYK2 activation of RPTPβ substrates. Substrate binding to RPTPβ would 
then induce a conformational change resulting in detachment of the extracellular 
domain of RPTPβ from VE-Cadherin (91). RPTPβ is also implicated in orchestrating 
vessel remodelling independent of VE-Cadherin via TIE-2, a receptor tyrosine kinase 
that functions downstream of vascular growth factor Angiopoietin. When RPTPβ is 
inhibited, TIE-2 dissociates and is activated, driving endothelial cell proliferation, and 
stabilizing endothelial cell-cell junctions (92, 93). Since TIE-2 also determines blood 
vessel size, its activity is restricted by RPTPβ to ensure proper blood vessel formation 
and size (92). Interestingly, the stimulation of VE-Cadherin by active RPTPβ and the 
activation of TIE-2 upon RPTPβ inhibition, is a feedback mechanism that ensures endo-
thelial cell-cell integrity: active RPTPβ inhibits TIE-2 and stimulates endothelial cell-cell 
adhesion via VE-Cadherin, whereas inactive RPTPβ cannot activate VE-Cadherin, but 
endothelial cell-cell adhesions are still stabilised by the now active TIE-2 (93). 
Density Enhanced PTP (DEP-1), also known as CD148, is a glycoprotein encoded 
by PTPRJ, and found at the cell surface. It is closely related to RPTPO, RPTPQ and 
RPTPβ, and consists of a single PTP domain and an extracellular domain consisting 
of fibronectin III repeats (Fig. 1). DEP-1 deficient mice have impaired VEGF induced 
formation of functional capillaries, and the capillaries that do form are shorter and 
less dense (94). This results in a phenotype, similar to PTP-PEST deficient mice, charac-
terized by impaired angiogenesis, enlarged vessel formation, disruption of branching 
and vascular remodelling, and embryonic lethality by E11.5 (95). DEP-1, encoded by 
the PTPRJ gene, functions to maintain endothelial cell permeability by activating SRC 
in response to VEGF, and SRC subsequently phosphorylates Cortactin and VE-Cadherin 
(94, 96, 97). Depletion of DEP-1 leads to a reduction of VEGF induced phosphoryla-
tion of VE-Cadherin, thus maintaining cell-cell junction integrity, and to decreased 
Cortactin phosphorylation, resulting in impaired vascular branching and invasion of 
endothelial cells. Interestingly, increasing DEP-1 activity, using a bivalent antibody, also 
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impairs endothelial cell proliferation and angiogenesis (98). And consistent with this, 
overexpression of DEP-1 inhibits proliferation, migration, and formation of capillary-
like structures of primary endothelial cells (99). In addition, DEP-1 overexpression 
promotes VEGF induced cell layer permeability in cultured human umbilical vein en-
dothelial cells (HUVECs) (97). Taken together, these studies confirm the importance of 
regulating DEP-1 activity for angiogenesis.
6. PtPs iN diseAse
Recent and ongoing research continues to highlight the importance of PTPs in deve-
lopment, and it is therefore not surprising that PTPs contribute to a plethora of human 
diseases and disorders (100, 101). For some PTPs it is still unclear what their role is 
in disease. PTPN22, for example, has been implicated in type 1 diabetes (T1DM) and 
breast cancer, but little follow up work has been done and mutations in PTPN22 are 
even predicted to be over-represented in breast cancer (102–105). PTPs are often con-
sidered the guardians of kinase driven phosphorylation cascades, and loss-of-function 
is fittingly associated with enhanced signal transduction, as observed in many cancers 
(106). However, there are numerous examples where PTP activity is not inhibiting, 
and is required to stimulate signal transduction and promote cellular responses. Of 21 
RPTPs, 20 are mutated in multiple cancers and RPTPs more often experience a gene 
amplification rather than a gene loss (107). However, as the most common mechanism 
of genetic modification of RPTPs is mutation, further research will have to be done to 
determine if these are activating or silencing mutations, or rather neutral mutations 
acquired during the tumorigenic process. Both too little or too much PTP activity may 
lead to disease, and the role of each PTP, whether it is limiting signalling or promoting 
signalling, may very well be context (i.e. cell type) dependent. For example, a gain-
of-function mutation in SHP2 is found in juvenile myelomonocytic leukemia (JMML) 
patients (108), but in hepatocellular carcinogenesis SHP2 acts as a tumour suppressor 
(109).
6.1 shP2 (PtPN11)
A large number of mutations, activating and inactivating, have been identified in SHP2 
in association with human disease (110). Mutations in SHP2 that increase or decrease 
its catalytic activity are associated with Noonan syndrome (NS) and Noonan syndrome 
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with multiple lentigenes (NS-ML, formerly LEOPARD syndrome), respectively. Individu-
als with NS and NS-ML have characteristic cranio-facial abnormalities, heart defects, 
short stature, and an increased risk of developing JMML. Interestingly, NS is caused 
by mutations in SHP2 that activate SHP2 catalytic activity (e.g. D61G), whereas NS-ML 
is caused by mutations in SHP2 that strongly reduce catalytic activity (e.g. A461T). 
Recently, it was demonstrated that the NS-ML SHP2 mutants Y279C, A461T, G464A, 
T468M, R498L, Q506P, and Q510E do indeed have impaired catalytic activity but also 
display structural properties typical of activating mutations, which could explain the 
similar symptoms presented by individuals with NS and NS-ML (111, 112). The SHP2 
mutant proteins from NS and NS-ML patients appear to have an increased tendency to 
adopt an open conformation and interact longer with scaffolding adaptors, prolonging 
substrate turnover, and thereby compensate for the reduced phosphatase activity (111, 
112). The exact mechanism by which mutated SHP2 induces NS and NS-ML is poorly 
understood, but aberrant ERK phosphorylation and signalling is a likely consequence 
of unbalanced SHP2 activity. Enhanced SHP2 activity is associated with systemic lupus 
erythematosus and, recently, Wang et al. (2016) demonstrated that inhibition of SHP2 
reduced the autoimmune response thought to underlie the disease. SHP2 inhibition 
normalized ERK/MAPK signalling and reduced proliferation of cultured human lupus 
T cells. In contrast, mutations in SHP2 that lead to a loss-of-function result in a mye-
loproliferative disorder, because of enhanced proliferation and decreased apoptosis 
of hematopoietic stem cells (18). This may be because of pro-inflammatory cytokines, 
secreted by monocytes recruited to the stem cell micro-environment of SHP2 deficient 
hematopoietic stem cells, having detrimental effects on the homeostasis of the hema-
topoietic stem cell population (114).
6.2 PtP1b (PtPN1) and RPtPσ (PtPRs)
Type 2 diabetes (T2DM) is associated with mutations in PTPN1 and PTPRS. Negative 
regulation of insulin receptor (IR) signalling by PTP1B is well established (reviewed 
by (115)), and Ptpn1 knockout mice fed a high fat diet are resistant to weight gain 
compared to control mice (116). PTP1B deficiency also increases insulin sensitivity 
and glucose uptake in insulin receptor substrate-2 (IRS-2) deficient mice, suggesting 
PTP1B inhibits IR signalling by acting on or downstream of IRS-2 (117). Indeed, PTP1B 
depletion improves insulin sensitivity and glucose tolerance, as well as decreasing the 
occurrence of diabetes development, in mice deficient for IR and IRS-1 (118). Howe-
ver, mice lacking PTP1B also display an accentuated pro-inflammatory response and 
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compromised macrophage viability (119), indicating care should be taken in ongoing 
clinical trials. Variations in the PTPRS gene are associated with T2DM development 
(120), and, similar to PTP1B, RPTPσ deficient mice have a reduced body mass and 
increased insulin sensitivity (121).
6.3 tC-PtP (PtPN2)
Development of T1DM is associated with mutations in PTPN2, which negatively 
regulates IR signalling in concurrence with PTP1B. Lack of TC-PTP leads to multiple 
cellular defects related to T1DM, including increased β-cell apoptosis, altered β-cell 
function, and decreased self-antigen tolerance due to increased T-cell receptor signal-
ling and dysregulation of FOXP3 T-regulatory cells (103, 104). Mutations in PTPN2 also 
influence susceptibility to Crohn’s disease (CD) (122–124). CD development is driven 
by epithelial barrier defects and a dysfunctional immune response, and TC-PTP plays 
a role in preserving the epithelial barrier function by regulating the inflammatory 
response (125, 126). In addition, TC-PTP deficiency leads to impaired autophagosome 
formation, resulting in defective bacterial clearance of intestinal cells and increased 
apoptosis in intestinal epithelial cells (127). Moreover, mutations in PTPN2 lead to 
aberrant T-cell dysfunction, and consequently increased intestinal inflammation and 
dysbiosis (microbial imbalance) (128). Both autophagy and T-cell dysfunctions are also 
found in CD patients, implicating TC-PTP. 
6.4 PteN (PteN)
Mutations in PTEN cause PTEN hamartoma tumour syndromes (PHTS), rare inherited 
syndromes characterized by hamartomas in tissues originating from all three germ 
layers. PHTS encompasses four distinct syndromes: Proteus syndrome, Proteus-like 
syndrome, Cowden syndrome, and Bannayan-Riley-Ruvalcaba syndrome, of which 
Cowden syndrome is the most prevalent (129). PHTS are consistent with mutant ze-
brafish lacking three of four pten alleles, that develop hemangiosarcomas (130). Not 
only the lipid phosphatase activity of PTEN, which suppresses Akt activity, but also the 
protein phosphatase activity of PTEN, important in cell cycle arrest and inhibition of 
cell invasion, has been shown to have a tumour suppressive function (131). Loss-of-
function mutations in PTEN, which lead to increased AKT activation, IR signalling, and 
thus insulin sensitivity, are also associated with an increase in adiposity and obesity 
(132). Constitutive AKT activation also corresponds with the development of autism 
spectrum disorders (ASDs), extensively reviewed in other publications (133–135). ASDs 
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are neurodevelopmental disorders characterized by communication deficits, impaired 
social interactions, and restricted and repetitive behaviour. PTEN is involved by influ-
encing different cellular processes, for example deletion of Pten in the hippocampal 
adult neural stem cells of mice results in an increased proliferation and differentiation 
of these stem cells, leading to depletion of the stem cell pool, and development of 
hypertrophied neurons. These mice display seizure activity, macrocephaly, and impair-
ments in social interactions (136).
7. CoNClusioN ANd FutuRe PeRsPeCtives
In conclusion, PTPs have diverse roles in various biological processes, as represented 
schematically in Fig. 2. This schematic is not comprehensive and future research on 
the role of PTPs in development will undoubtedly lead to the inclusion of more PTPs 
and more developmental processes. Nevertheless, it is evident that PTPs have crucial 
roles in various developmental processes and, as a result, also in disease. Because 
PTPs have a pivotal role in disease and because they regulate protein-tyrosine phosp-
horylation enzymatically, PTPs are now being considered as drug targets. The major 
concern regarding the development of PTP inhibitors is selectivity because the PTP 
catalytic site is highly conserved and it is therefore challenging to develop inhibitors 
that target the catalytic site of just one specific PTP. In addition, the catalytic site is 
positively charged, and heavily charged molecules that may target such a site do not 
easily cross the cell membrane. For this reason, and in the hope to gain specificity, at-
tempts are being made to develop inhibitors that do not target the conserved catalytic 
site directly, but instead less conserved allosteric sites. 
Various non-specific PTP1B inhibitors have been developed (137, 138), and one 
of the latest, anti-sense oligonucleotide ISIS-113715, looks promising as it increases 
insulin sensitivity and adiponectin concentrations in monkeys (139). In 2014 the lab 
of Nick Tonks tested a novel allosteric inhibitor of PTP1B, MSI-1436, which does not 
target the catalytic site but instead the C-terminus of PTP1B (140). MSI-1436 traps 
PTP1B in an inactive state, and its effectiveness was demonstrated in a mouse model 
of HER2 driven breast tumourigenesis, where it inhibited HER2 signalling and abroga-
ted metastasis.
In contrast to the large number of PTP1B inhibitors, there are only a few SHP2 
inhibitors. In recent years, SHP2 inhibitors have been developed that block prolife-
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ration of patient derived hematopoietic progenitor cells expressing the E67K or the 
D61Y mutation, and leukemic cells and mouse myeloid progenitor cells that carry the 
E76K mutation (141–143). Since D61G is the most common mutation in NS, it should 
be determined whether these compounds also work for NS patients with the D61G, 
and other SHP2 mutations. Recently, a highly potent and selective allosteric inhibitor 
for SHP2 (SHP099) has been developed which inhibits proliferation and differentiation 
in mouse tumours, and in human cancer cells in vitro driven by mutated receptor 
tyrosine kinases (144).
Taken together, the great strides made in the last decade in fundamental and 
translational research to understand the function and importance of PTPs, and to 
target them in an attempt to cure disease, have left a bright future for research and 
the well-being of patients alike. With more research to elucidate the function and 
regulation of PTPs, and development of drugs that target PTPs, PTP inhibitors may 



























Fig. 2. Protein-tyrosine phosphatases are involved in key aspects of development. Big circles 
represent developmental processes and small circles are individual PTPs. Lines indicate involve-
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Protein-tyrosine phosphatases (PTPs) are a large family of signal transduction regu-
lators that have an essential role in normal development and physiology. Aberrant 
activation or inactivation of PTPs is at the basis of many human diseases. The zebrafish, 
Danio rerio, is being used extensively to model major aspects of development and 
disease as well as the mechanism of regeneration of limbs and vital organs, and most 
classical PTPs have been identified in zebrafish. Zebrafish is an excellent model system 
for biomedical research because the genome is sequenced, zebrafish produce a large 
number of offspring, the eggs develop outside the mother and are transparent, facili-
tating intravital imaging, and transgenesis and (site-directed) mutagenesis are feasible. 
Together, these traits make zebrafish amenable for the analysis of gene and protein 
function. In this chapter we cover three manipulations of zebrafish embryos that we 
have used to study the effects of PTPs in development, regeneration and biochemistry. 
Micro-injection at the one-cell stage is at the basis of many zebrafish experiments 
and is described first. This is followed by a description for measuring regeneration 
of the zebrafish embryo caudal fin-fold, a powerful and robust physiological assay. 
Finally, the considerable but manageable troubleshooting of several complications 
associated with preparing zebrafish embryos for immunoblotting is explained. Overall, 
this chapter provides detailed protocols for manipulating zebrafish embryo samples 





Protein-tyrosine phosphatases (PTPs) are a large family of signal transduction regula-
tors, determining rate and duration of phosphotyrosine (pTyr) phosphorylation casca-
des [1]. Disruption of PTP activity leads to aberrant pTyr signalling and is at the basis of 
many human diseases [2]. Much is already known of the mechanisms PTPs employ to 
regulate signal transduction [3] and the regulation of their dephosphorylating activity 
[4-6]. Yet, a full appreciation of the importance of temporal and spatial control of PTP 
activity is best acquired in vivo. Model organisms used to acquire such insights include 
the invertebrates Drosophila [7] and C. elegans [8] and the vertebrates Danio rerio [9], 
mouse [10] and rat [11].
The zebrafish Danio rerio is being used extensively to model major aspects of 
development [12] and diseases including cancer [13,14], metabolic disease [15-17] 
and cardiovascular disease [18]. Zebrafish are even used to study the mechanism of 
regeneration of limbs and vital organs [19,20]. Evidently, zebrafish studies are a key 
aspect of translational research and are enabling advancements in human health [21]. 
Zebrafish are oviparous, provide up to 200 embryos per mating pair per week and de-
velop within 5 days, with most organs forming within 48 hours. Many existing genetic 
mutants are available from stock centres (Zebrafish International Resource Center in 
Eugene, USA, and European Zebrafish Resource Center in Karlsruhe, Germany) and 
mutagenesis is highly feasible using optimized transcription activator-like effector 
nucleases (TALENs) [22] or the combination of Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR) with the CRISPR associated protein (CAS) [23-25]. 
Transient over-expression or stable transgenesis can readily be achieved through 
micro-injection of synthetic messenger RNA (RNA) or plasmid DNA respectively at 
the one-cell stage [26]. In addition, mutagenesis-based gene inactivation is carried 
out using reagents such as N-ethyl-N-nitrosourea (ENU) to generate random single 
nucleotide mutations [27].
Zebrafish embryos are transparent, allowing for easy analysis of developmental 
progression and defects as well as disease phenotypes. Intravital imaging of fluorescent 
markers expressed in a tissue- or cell type-specific manner provides a powerful tool 
for studying developmental processes. This has been taken advantage of extensively 
to study angiogenesis [28], lymphangiogenesis [29], convergence and extension cell 
movements during development [30] and even to capture embryonic development 
in 3D [31,32]. Intravital imaging of fusion proteins facilitates the analysis of protein 
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localization, protein-protein interactions and function in a whole organism in vivo. In 
addition, several techniques are now being refined and will augment the advantages 
of zebrafish as an experimental system. These include proteomics analysis of zebrafish 
embryos using mass-spectrometry following selection by immunoprecipitation [33-
35], analysis of the plasma proteome following blood collection [36] and derivation of 
cell lines from single embryos [37]. 
Finally, the relative simplicity of adding compounds to either the water of the adults 
or the medium of the embryos, combined with the possibility for large sample number 
and rapid reproducibility has led to several bioactive compounds screens [18,38]. 
Notably, combining knock-outs or embryos with transient over-expression with timed 
drug treatments provides an unparalleled opportunity to pin-point the exact temporal 
role of proteins in vivo.
An important experimental consideration is that the zebrafish genome was duplica-
ted early in evolution [39,40]. Whilst some of the duplicated chromosomes were lost, 
the duplicated genes that remain may have complementary or diverging expression 
patterns and exhibit redundant or complementary functions. Therefore, gene duplica-
tions may complicate the creation of knock-out mutants by requiring two redundant 
genes to be targeted. The translational value is another essential consideration when 
choosing an experimental system and the reason the zebrafish is regularly used to 
model disease is in part due to 84% of human genes associated with a disease having 
a zebrafish counterpart [41].
All classical PTPs, except ptpn7, ptpn12 and ptpn14, have been identified in the 
zebrafish genome and 14 are duplicated [42]. Van Eekelen et al. 2010 also characterize 
expression duration and localization using in situ hybridization, identifying that some 
of the duplicated PTP pairs have divergent expression patterns, indicative of diverging 
functions. A good example of the complexity arisen from PTP duplication is that of 
ptpn11, encoding the Shp2 protein. Bonetti et al. 2014 demonstrate that zebrafish ptp-
n11a and ptpn11b encode highly homologous proteins, Shp2a and Shp2b respectively. 
Yet, whilst ptpn11a-/- mutants have severe developmental defects and are embryonic 
lethal, ptpn11b-/- mutants show no obvious developmental defects. This difference 
may suggest that Shp2a and Shp2b proteins are functionally distinct. Shp2b does have 
a function in development, because ptpn11a-/- ptpn11b-/- mutants exhibit a slightly 
more severe phenotype than ptpn11a-/- mutants. Furthermore, severe developmental 
defects displayed by ptpn11a-/- ptpn11b-/- double mutant embryos are rescued by tran-
sient over-expression of either Shp2a or Shp2b, demonstrating functional similarity 
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of Shp2a and Shp2b proteins. The expression patterns of ptpn11a and ptpn11b are 
distinct; ptpn11a is constitutively expressed at a high level throughout development, 
whereas ptpn11b expression is at a relatively low level during early development 
and increases steadily through later stages. Hence, we conclude that the difference 
in expression patterns of ptpn11a and ptpn11b, rather than an intrinsic difference in 
protein function of Shp2a and Shp2b is at the basis of the difference in function of 
ptpn11a and ptpn11b during development [43]. The accompanied complexity of gene 
duplication can be used to extensively delineate gene function and the advantages of 
zebrafish as an experimental system make it ideal for elucidating the intricate function 
and regulation of PTPs in vivo. Hence, zebrafish are often used to understand the role 
of PTPs in signalling in development [44-47] and, lately more, in disease [34].
2. mAteRiAls
All solutions are prepared in double-distilled, deionized MilliQ filtered water (resisti-
vity of 18MΩ cm at 25°C).
2.1 micro-injection
1. Brightfield/Nomarski optics stereo-microscope (e.g. Leica MZ9.5)
2. Micromanipulator (World Precision Instruments)
3. Pneumatic microinjector (Picopump PV830, World Precision Instruments)
4. Nitrogen (N2) gas
5. Glass capillaries: Outer diameter 1mm, Inner diameter 0.78mm, length 100mm 
(Harvard Apparatus)
6. 0.01mm micrometre slide (e.g. TS-M1 from www.labshops.com)
7. 10µl microloader pipette tips (Eppendorf)
8. 0.5% Phenol red (Sigma)
9. Thermomixer (Eppendorf)
10. E3 medium: 5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, 0.33mM MgSO4
11. 0.05% Methylene blue (Sigma)
12. Micropipette puller P97 (Sutter Instruments)
13. Putty or tape
14. Slanted lane mould (TU-1, Adaptive Science Tools)
15. Plastic 15cm plate (Corning)
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16. Plastic 10cm plate (Corning)
17. Ultra Pure agarose (Invitrogen)
18. 70% ethanol
19. Mineral Oil (Sigma)
2.2 Regeneration assay
1. Stereo-microscope (e.g. Leica MDG17)
2. Brightfield/Nomarski optics stereo-microscope with camera function (e.g. Leica 
M165FC with Leica DFC420C camera)
3. 0.4% MS222: 0.4% ethyl 3-aminobenzoate methanesulfonate salt (MS222), 1M 
Tris-HCl pH7.5
4. Stainless steel surgical blade (Swann-Morton no.11)
5. Plastic Pasteur pipette 
6. Glass Pasteur pipette
7. Plastic 10cm dish (Corning)
8. Plastic multi-well plates (Corning)
9. 10µl microloader pipette tips (Eppendorf)
10. E3 medium: 5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, 0.33mM MgSO4.
2.3 tissue lysis for protein extraction
1. 1.5ml tubes (Eppendorf)
2. Mini-pestle (to fit in the 1.5ml tubes)
3. 1ml syringe (BD Biosciences)
4. 0.2-0.8mm needles (BD Biosciences)
5. Sonicator (e.g. Diagenode Bioruptor Standard)
6. Degassed lysis buffer: 25mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) pH 7.4, 150mM NaCl, 0.25% deoxycholate, 1% triton X-100, 10mM MgCl2, 
1mM Ethylenediaminetetraacetic acid (EDTA), 10% glycerol
7. RIPA buffer: 25mM Tris-HCl pH7.6, 150mM NaCl, 1% NP-40, 1% sodium deoxycho-
late, 0.1% sodium dodecyl sulphate
8. Ginzburg fish Ringers buffer: 111.2mM NaCl, 3.35mM KCl, 2.38mM NaHCO3.
9. Liquid nitrogen (N2)
10. Thermomixer (Eppendorf)
11. Cold centrifuge (e.g. SciQuip 1-15PK)
12. Protease inhibitors Aprotinin, and Leupeptin (both 1mg/ml)
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13. Phosphatase inhibitors Sodium Fluoride (0.5M), beta-Glycerophosphate (1M), and 
Sodium Orthovanadate (200mM)
14. 70% ethanol
15. 2x Laemmli sample buffer: 2% β-mercaptoethanol, 20% glycerol, 0.125M Tris-HCl 
pH6.8, 4% sodium dodecyl sulphate, (a pinch) bromophenol blue
3. methods
The underlying principle of the protocols and notes that follow is that zebrafish em-
bryos are a living organism, useful for analysing phenotypes, but can also be considered 
a compact factory of cells malleable to existing molecular techniques. All procedures 
involving zebrafish described were approved by the local animal experiments com-
mittee and performed according to local guidelines and policies in compliance with 
national and European law. Zebrafish maintenance and breeding were performed 
following published protocols [48].
An absolute must for the genetic manipulation of zebrafish is the skill to micro-
inject at the one-cell stage. This will be covered first (section 3.1) and following this a 
plethora of manipulations are available. Here, a description for measuring regenera-
tion of the zebrafish embryo caudal fin-fold, a powerful and robust physiological assay, 
will be described (section 3.2). Also, the method of lysing zebrafish tissue for protein 
extraction to perform SDS-PAGE and immunoblotting will be detailed (section 3.3), 
which requires considerable but manageable troubleshooting due to the complicati-
ons that arise from obtaining a homogenous zebrafish cell lysate and lack of antibodies 
that recognize the zebrafish orthologue.
In section 3.1 we cover the use of micro-injection for introduction of alien genetic 
material into an organism, which began in 1971 when it was used to introduce DNA into 
xenopus oocytes [49]. Since then the technique has been adapted for micro-injection 
of zebrafish embryos at the one-cell stage and early mouse blastocysts for transge-
nesis [50,51] and cells in culture [52]. A detailed video protocol for micro-injection of 
zebrafish embryos can be found on Jove entitled “Microinjection of zebrafish embryos 
to analyse gene function” [53]. Needles for holding and injecting RNA or DNA are 
made using a glass capillary micropipette puller, which contains a heating filament 
that slowly melts the glass and as the two halves separate the tip is stretched to the 
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correct diameter. Each machine model will need to be calibrated according to the 
manufacturer’s instructions before use. 
RNA micro-injection leads to efficient, and usually high, expression within several 
hours and will be described below, though the reader can consider all uses of “RNA” 
interchangeable with “DNA”. The only significant factor when micro-injecting DNA is 
that accuracy needs to be high to ensure that the DNA ends up in the cell. For this 
reason, significant effort is made to align embryos properly in the micro-injection plate 
to improve accuracy of injecting directly into the cell. Micro-injection is a technique 
that develops and improves with experience. It is easy to learn but difficult to teach as 
a lot is based on a singular coordinated movement of fingers moving the needle into 
the embryo and feet ejecting the RNA or DNA, and this is a “comfortable” feeling once 
mastered. For example, it takes practice to be able to estimate just how much of the 
needle needs to be shortened once mounted; there is no way to measure this. Prac-
tice is essential, and once the technique is acquired the individual tends to improve 
without any further guidance.
In section 3.2 a zebrafish embryo caudal fin-fold regeneration assay is described. 
Some urodeles and teleosts are capable of epimorphic regeneration, perfect or 
near-perfect replacement of lost tissue, throughout their lifetime [54]. Zebrafish are 
capable of regenerating multiple tissues, including fins, the brain, retina, spinal cord 
and heart [19]. Zebrafish are therefore an excellent model to study and understand the 
mechanism of epimorphic regeneration. The results that emerge from such research 
may pave the way to enabling adult mammal organs to regenerate, most of which are 
currently limited to inflammation and formation of a collagen-rich connective tissue 
scar following injury [55]. Adult zebrafish caudal fin regeneration takes 10-12 days to 
complete. In comparison, embryo caudal fin-folds only take three days, making the 
embryonic regeneration assay an efficient and reproducible technique. A previously 
established zebrafish embryo caudal fin-fold regeneration model [56] was adapted to 
amputate at 2 days post fertilization and regeneration is then completed by three days 
post amputation (5 days post fertilization).
Importantly, as regeneration rate is higher in embryos, wound healing is also 
more rapid. For this reason, it is paramount that a picture of the amputated caudal 
fin-fold be taken as soon as possible to capture the wound margin as accurately as 
possible. Another consideration with a zebrafish embryo caudal fin-fold regeneration 
assay is that changes in regeneration rate could also be due to changes in rate of 
embryonic development. It’s ideal to compare amputated embryos with same stage 
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uncut embryos and, therefore a picture of an uncut embryo is taken at the same time 
as the embryo with the wound margin. This technique can easily be combined with 
micro-injection of RNA or DNA or drug treatments.
Section 3.3 describes tissue lysis of whole zebrafish embryos for extraction of 
protein. Zebrafish embryos, up to 6 days, can be considered tissue extracts for ap-
plying molecular techniques. Thus, the method remains the same regardless of age 
but becomes more laborious with older, more defined tissue. Preparation of zebrafish 
embryos for SDS-PAGE requires de-yolking, and then lysis buffer is applied before the 
sample is homogenized. A general method can be found on the ZFIN database [57] but 
we have developed our own lysis buffers and homogenization techniques for specific 
uses of the protein extract and this will be explained in detail below. 
Zebrafish embryos have a yolk sac, providing nutrients for growth until day 6 when 
the embryos can eat particle food [58]. This yolk sac contains a high concentration 
of vitellogenin, a phospholipo-glycoprotein composed of multiple subunits, the most 
predominant two at around 150kDa and 80kDa. Unfortunately, the yolk proteins in-
terfere with detection of specific proteins by immunoblotting, presumably due to the 
high expression levels of the yolk proteins. Particularly detection of specific proteins of 
similar sizes as the yolk proteins is problematic. This interference can be largely redu-
ced by de-yolking embryos using Ginzburg fish ringers solution [59]. After de-yolking, 
lysis buffer is applied. We use one of two lysis buffers, each has advantages and dis-
advantages. Whereas RIPA lysis buffer is fast and provides high yield, the presence of 
SDS may disrupt delicate protein-protein interactions. In comparison, degassed lysis 
buffer will yield less protein but the absence of SDS protects delicate protein-protein 
interactions, which is useful if intending to perform co-immunoprecipitation. Follo-
wing the choice of lysis buffer there are three options for homogenization. The least 
challenging, but also the least effective in terms of yield, is using a mini-pestle to crush 
the embryo in the 1.5ml tube containing lysis buffer. A higher yield can be obtained by 
using a syringe and needle to aspirate and push the tissue through a small (<0.4mm) 
needle opening (shearing). Complications arise with larger tissue (e.g. adult zebrafish 
fin clips and embryos approaching 5 days post fertilization) which may clog the needle. 
Though laborious, this complication can be resolved by first choosing an appropriately 
sized (>0.6mm) needle for the dense tissue extract and repeating homogenization with 
a smaller needle afterwards. The final alternative is to use a sonicator, which works 
well on embryos up to 4 days old but may take considerably longer on defined tissue 
such as adult zebrafish fin-clips. 
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Following successful lysis of zebrafish tissue, the lysate can be loaded onto an 
SDS-PAGE gel following a standard protocol. The only exception is that a protein con-
centration assay (e.g. Biorad Bradford assay) is not performed on zebrafish embryos 
because the sample is less pure than from cells and there is an abundance of yolk 
protein which will skew the estimation. Instead protein level is correlated with the 
number of embryos per unit volume of lysis buffer used. A standard protocol for im-
munoblotting can also be applied. A far greater problem is the sheer lack of antibodies 
that recognize the zebrafish protein homologues. It is not uncommon that when the 
zebrafish and mammalian homologues share a high percentage amino acid sequence 
similarity, the antibody raised against the mammalian homologue does not bind the 
zebrafish homologue. Even when the epitope sequence is conserved the antibody 
doesn’t necessarily work for the zebrafish homologue; sometimes the antibody will 
simply not bind anything but more often the problem is increased non-specific binding 
(including sequestration of the antibody by the yolk protein). This antibody issue may 
be partially circumvented by raising an antibody against the purified target zebrafish 
protein. Though, functionality of these antibodies is not necessarily guaranteed and 
should be tested thoroughly for validation. Also of note is that these antibodies 
don’t always have the same efficiency on endogenous proteins in zebrafish embryos. 
Hopefully, with time, a range of antibodies produced and validated by different labs 
will become available on the commercial market. Some are already available at the 
Zebrafish International Resource Centre (ZIRC).
3.1 micro-injection
1. Dissolve ultra-pure agarose in E3 medium with 0.01% methylene blue to prepare a 
2% agarose solution.
2. Pour 2% agarose into a plastic 10cm dish and gradually apply the plastic lane mould 






Fig. 1. Example of a micro-injection plate made of 2% agarose (A) and higher magnification sho-
wing the grooves with the bevelled edge (arrow heads) on the bottom side (b).
3. Remove the mould and pour E3 medium with 0.01% methylene blue to cover the 
surface. Store at 4°C (see Note 2).
4. Prepare RNA by diluting as required in a mixture of MilliQ water and 0.5% phenol 
red (see Note 3).
5. Heat RNA for 5-10mins at 65°C and 1150rpm in a thermomixer (see Note 4). Keep 
RNA on ice.
6. Switch on pneumatic microinjector and open the N2 gas valve. The “regulator” 
pressure should not exceed 30psi.
7. Wipe base of stereo-microscope with 70% ethanol and adjust lamp brightness as 
desired. 
8. Place needle under stereo-microscope and use the micrometre slide to determine 
the point at which the needle tip width is equal to 20µm. Use tweezers to remove 
the excess of the needle that extends beyond this point.
9. Use microloader pipette tips to transfer 1-2µl of RNA into the cut needle.
10. Position micromanipulator and mount needle half way up the shaft of the pressure 
dispenser.
11. Position needle tip in a small dish of mineral oil and check pneumatic microinjector 
is set to “gated”.
12. In “gated” mode apply pressure to the foot pump for 1-2sec. to eject some RNA 
solution (see Note 5). 
13. Switch pneumatic microinjector to “timed,” switch the “range” to “100ms” and the 
“period” to maximum “2.0” so that duration of ejection is 200ms. Now, a single 
push of the foot pump will eject a single drop of RNA.
62
3
14. Press down on foot pump to eject a single drop of RNA into the mineral oil. Use the 
micrometre slide to measure size of droplet (see Note 6). 
15. Adjust droplet size to 1nl by first reducing the duration of ejection. Lower the 
“period” slightly and repeat step 15. If droplet size is still too small when duration 
of ejection is 70ms (“period” is “0.70”), use the tweezers to remove more of the 
needle tip and repeat adjustment with “period” (see Note 7). Once a droplet of 1nl 
is obtained rest the needle in mineral oil.
16. Collect fresh fertilized embryos in a plastic 10cm dish with E3 medium. From this 
point on you have ~30mins before the single cell of the embryo divides. Work fast 
(see Note 8).
17. Transfer embryos to the lanes in the microinjection plate using a plastic Pasteur 
pipette (see Note 9). 
18. Under the stereo-microscope the single cell of the embryo will be clearly visible. 
Position embryo such that the cell is at the top (see Note 10).
19. Use micromanipulator to adjust needle position and penetrate through the cho-
rion and into the cell of the embryo. Almost simultaneously, press the foot pump 
to eject some RNA into the cell and withdraw the needle (see Note 11).
20. Move to the next embryo and repeat the micro-injection until the desired number 
of embryos has been micro-injected. 
21. When finished use a plastic Pasteur pipette and E3 medium with 0.01% methylene 
blue to rinse the embryos into a plastic 10cm dish with fresh E3 medium with 
0.01% methylene blue. Incubate at 28.5°C (see Note 12).
22. Discard needle in sharps bin and remaining embryos in designated waste bin. Close 
the N2 gas valve, switch pneumatic microinjector to “gated” again and use foot 
pump to eject remaining N2 gas. Switch off pneumatic microinjector and stereo-
microscope light.
If injecting RNA encoding a fluorescent protein, a standard fluorescence microscope 
with appropriate filter can be used to visually assess success rate. It is common for 
protein expression to vary between embryos (Fig. 2) as each embryo is micro-injected 
in a slightly different position and embryos have varying rates of protein synthesis, 
depending on health and developmental stage. Practice micro-injections using mRNA 
encoding Green Fluorescent Protein (GFP) is convenient for evaluation of success 




RNA or DNA injection into the cell at the one-cell stage of zebrafish should lead 
to expression in all subsequent daughter cells, but mosaicism is frequently observed. 
If RNA is micro-injected at a late one-cell stage or whilst the first cell division is in 
progress mosaicism in the form of patchy expression, with only small clusters of cells 
translating the RNA, may arise (Fig. 3A). When RNA is micro-injected accurately there 
may be considerably less mosaicism but it will still be present (Fig. 3b). Depending on 
the purpose of the experiment, the presence of mosaicism can offer some advantages 
in that a comparison can be made, for example, between the same population of cells 
expressing the micro-injected protein and those without in the same embryo.
A B
H3.3
Fig. 3. examples of non-ubiquitous expression following micro-injection of RNA. (A) Example of 
patchy expression from RNA micro-injection. An embryo micro-injected with RNA encoding wild-
type human Pten tagged with mCherry is imaged at 2dpf. Mosaic mCherry expression is found in a 
few clusters of cells scattered around the body of the embryo (arrow heads), suggesting RNA was 
not micro-injected at the one-cell stage. (b) Example of mosaic expression in the trunk of an embr-
yo at five days post fertilization. A transgenic embryo expressing flt4:mCit to mark the vasculature, 
shown in green, is micro-injected with plasmid DNA encoding prox1a:KalTA4,UAS:tagRFP, shown 
in red, at the one-cell stage. Despite accurate micro-injection only some vessels express RFP (red 
arrow heads), demonstrating mosaicism. Yellow arrow heads show similar vessels without RFP 
expression for comparison.
H3.2
Fig. 2. 24 hours post fertilization zebrafish 
embryos, still in their chorion, displaying 
variation in gFP protein expression 
between embryos following micro-injec-




1. Dechorionate embryos using tweezers
2. Anaesthetise embryos by transferring to 0.1% MS222 in E3 medium with 0.01% 
methylene blue for 2-4mins (see Note 13).
3. Place the lid of a 10cm plastic dish over the light source of a stereo-microscope (see 
Note 14).
4. Transfer one embryo at a time to surface of plastic lid in a droplet of 0.1% MS222 
in E3 medium with 0.01% methylene blue using a plastic Pasteur pipette (see Note 
15).
5. Use a stainless steel surgical blade to amputate the caudal fin-fold of the zebrafish 
embryo immediately distal to the notochord under the stereo-microscope (see 
Note 16).
6. Use a glass Pasteur pipette to transfer embryo to fresh 0.1% MS222 in E3 medium 
with 0.01% methylene blue (see Note 17).
7. Capture wound margin of amputated zebrafish embryo caudal fin-fold using a 
stereo-microscope (Leica M165FC) with an attached camera (Leica DFC420C) (see 
Note 18).
8. Wash embryo in fresh E3 medium.
9. Use a glass Pasteur pipette to transfer embryo to a well in a multi-well plate contai-
ning fresh E3 medium with 0.01% methylene blue (see Note 19).
10. Repeat steps 4-9 until multi-well plates of both amputated and uncut controls are 
filled. Incubate embryos at 28.5°C for 3 days (see Note 20).
11. Prepare 0.2% MS222 in E3 medium by mixing half volume 0.4% MS222 and half vo-
lume E3 medium. Use a plastic Pasteur pipette to add 3-4 droplets of 0.2% MS222 
in E3 medium to each well.
12. Use a glass Pasteur pipette to transfer one embryo per time to a 10cm plate contai-
ning fresh 0.1% MS222 in E3 medium with 0.01% methylene blue.
13. Capture size of zebrafish embryo caudal fin-fold using a stereo-microscope (e.g. 
Leica M165FC) with an attached camera (e.g. Leica DFC420C) (see Note 21).
14. Repeat steps 12-13 until all embryos of multi-well plates for both amputated and 
uncut controls have been imaged.
The images captured at 2 and 5 days post fertilization are of uncut controls and am-
putated embryos (Fig. 4). The change in zebrafish embryo caudal fin-fold length after 
three days is calculated by subtracting the length of the fin-fold from the tip of the 
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notochord at day five from that at day two for each embryo. This is easily quantified 











Fig. 4. brightfield images of the caudal fin-fold 
of zebrafish embryos. Fin-fold margins are cap-
tured at 48 hours post fertilization (A, C), and 
again at 5 days post fertilization (b, d), of uncut 
controls (A, b) and embryos amputated adja-
cent to the notochord (C, d). Scale bar is equi-
valent for all panels.
3.3 tissue lysis for protein extraction
1. Dechorionate embryos using tweezers (see Note 22).
2. Transfer embryos to a 1.5ml tube, 96-well plate or similar. Remove as much system 
water or E3 medium as possible.
3. Prepare Ginzburg fish Ringers solution by adding protease and phosphatase inhi-
bitors (10µl/ml Sodium Fluoride, 5µl/ml beta-Glycerophosphate, 5µl/ml Sodium 
Orthovanadate, 1µl/ml Aprotinin, 1µl/ml Leupeptin) and add sufficient volume to 
the embryos to allow repeated pipetting with a P200 tip (~600µm wide).
4. Repeatedly pipette up and down in a gentle steady motion or invert regularly. Do 
not create air bubbles. Alternatively, place multiple embryos in a well of a 6-well 
plate filled with Ginzburg fish Ringers solution and place plate on a thermomixer 
set to 28.5°C and 400-800rpm for 30-45mins (see Note 23).
5. Wash de-yolked embryos with fresh Ginzburg fish Ringers solution and transfer to 
chosen vessel (1.5ml tube or 96-well plate)
6. Centrifuge briefly at 4°C to collect embryos at bottom of tube or well.
7. Aspirate Ginzburg fish Ringers solution and snap-freeze embryos in liquid nitrogen 
(see Note 24).
8. Defrost frozen tissue on ice.
9. Prepare chosen lysis buffer by adding protease and phosphatase inhibitors (10µl/
ml Sodium Fluoride, 5µl/ml beta-Glycerophosphate, 5µl/ml Sodium Orthovana-
date, 1µl/ml Aprotinin, 1µl/ml Leupeptin) and add volume according to age:
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Adult fin clips >10µl
Next, there are three homogenization options available for proceeding with tissue ly-
sis; the steps required for homogenization using a mini-pestle (A), a syringe and needle 
(B), or sonication (C), are described below. 
A. Mini-pestle homogenization (1.5ml tubes only):
10A.  Quickly, with the tissue still frozen, start applying pressure using a mini-pestle 
that fits in a 1.5ml tube (see Note 25).
11A.  Withdraw pestle and use a pipette to wash head of pestle to maximize amount 
of lysate collected.
12A.  Clean pestle by rinsing with 70% ethanol followed by water and repeat steps 
10-11 for each sample.
13A. Rest on ice.
B. Syringe and needle homogenization:
10B. Wait for tissue to defrost in lysis buffer.
11B.  Attach a sterile needle, width 0.2-0.8mm, to a 1ml syringe. No larger than 
0.2mm is highly recommended for 24hpf.
12B.  Aspirate and dispense suspension repeatedly until tissue has been completely 
sheared (see Note 26).
13B. Rest on ice.
C. Sonication homogenization:
10C. Wait for tissue to defrost in lysis buffer.
11C. Incubate on ice for 30mins
12C.  Sonicate at “high” intensity for 15mins. with a repeated cycle of 30sec. ON, 
followed by 30sec. OFF.
13C. Rest on ice.
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14. Once homogenized with chosen method centrifuge samples at 14,000xrpm and 
4°C for 20mins.
15. Transfer supernatant to a fresh tube or plate and discard the pellet. Can store 
supernatant at -80°C at this point if required. 
16. Mix equal volume lysate and 2x laemmli buffer. 
17. Boil samples for 5-10mins (see Note 27).
18. Store at -20°C or continue loading samples onto an SDS gel.
Please note that there are many variations on the de-yolking and homogenization pro-
cedures. For example, de-yolking can be carried out after mini-pestle homogenization 
by centrifuging lysate and re-suspending the pellet in Ginzburg fish Ringers solution. 
The sample is then centrifuged again to remove the Ginzburg fish Ringers solution and 
re-suspended in 1x sample buffer (created by mixing equal volumes of chosen lysis 
buffer and 2x laemmli buffer). This way the de-yolking procedure is more convenient 
but a possible consequence is greater variation in protein concentration between sam-
ples as some lysed protein may have been lost in the multiple centrifugations where 
supernatants are discarded. Another alternative is to only disrupt the integrity of the 
embryos a little using mini-pestle homogenization and follow that with sonication 
to achieve more efficient lysis. One’s choice will be determined by a combination of 
purpose for the lysate, embryo age and, ultimately, experience. 
Preparation of zebrafish embryo lysates requires more diligence than for cell 
lysates. This is partly due to the high protein content compared to cultured cells, 
resulting in the bands being “fatter” and more “smiley” (Fig. 5). This can also cause 
protein bands to run slightly slower, but offsets size estimation by no more than 5kDa.
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The right combination of de-yolking, lysis buffer and homogenization optimizes 
the result. For example, embryos can be lysed in RIPA buffer prepared for SDS-PAGE 
using mini-pestle homogenization without dechorionating and de-yolking (Fig. 6A). 
But when embryos are dechorionated, de-yolked, lysed using degassed lysis buffer 
and prepared for SDS-PAGE using mini-pestle homogenization the result is less yield 
but almost as clean as that obtained from pure cell lysate (Fig. 6b).  Then again, Fig. 
6b clearly shows that de-yolking can lead to unequal protein concentration between 


















Fig. 6. Coomassie stains of PvdF membranes containing zebrafish embryo samples. (A) Samples, 
not dechorionated or de-yolked, lysed in RIPA buffer and subjected to mini-pestle homogenization (5 
embryo equivalents per lane). Zebrafish embryos were lysed at 6, 24 and 48 hours post fertilization 
(hpf). Notice how “fat” and “smiley” the bands are. (b) Samples after dechorionating, de-yolking,lysis 
in degassed lysis buffer and subjected to mini-pestle homogenization (1 embryo per lane). Zebrafish 
embryos were lysed at 48hpf. Notice that the protein content is considerably less, but that the lysate 
profile is more “clean” and similar to that of the cell lysates seen in figure 5. A typical experiment 













Fig. 5. Coomassie stain of PvdF membrane 
showing differences between heK293t cells 
lysed with RiPA buffer (lanes 2-4) and zebra-
fish embryos lysed with RiPA buffer and sub-
jected to mini-pestle homogenization (lanes 
5 and 6). A typical experiment comparing non-
transfected (Unt) and transfected (Tfx) HEK 
293T cells with non-injected control (NIC) and 
micro-injected (MI) zebrafish embryo samples 
(7.5 embryo equivalents per lane). Lane 1 con-




1. The plastic mould is embossed with ramps with a 45° bevelled side (Fig. 1b). This 
aids micro-injection as the embryo will be pushed into the corner of the lane, al-
lowing the needle to more easily penetrate the chorion and yolk or cell.
2. The agarose microinjection plates will keep for 1-2 weeks, after which moulds will 
begin to grow and the borders of the lanes begin to soften and break. The moulds 
do not interfere with the embryos as long as the embryos are washed afterwards 
but the breaks in the lanes can inconvenience injections.
3. In general, not more than 500pg of RNA is injected in zebrafish embryos (this is 
achieved using 1nl of RNA at 500ng/µl). The phenol red is only used as a dye to 
observe successful injection (once competent this aid is no longer required) and 
1µl for every 15µl is more than sufficient.
4. Heating the RNA removes secondary structures such as hair-pin loops. This ensures 
that most of the RNA injected is available for translation and ultimately increases 
the efficiency of micro-injection. This step is not necessary if injecting DNA.
5. This action removes air bubbles from the RNA. The RNA is now under pressure. If 
“hold” pressure is too great the RNA will now begin to leak from the needle tip, 
adjust if necessary.
6. Calibration of the RNA droplet to 1nl is measured using a 0.01mm micrometre 
slide. Briefly, according to V = 4/3πr3, a droplet of 1nl has a radius of 62µm and the 
diameter is hence 124µm. The micrometre slide has divisions of 10µm; meaning 
1nl is equivalent to 12 divisions. The needle width is measured to approximately 
20µm wide prior to mounting and the width of each new needle then needs to be 
adjusted to create a 1nl droplet using the micrometre slide to calibrate.
7. Duration of ejection MUST NOT be <70ms (“period” not <0.70) as this results in 
ejection of unreliable droplet size with repeated injections. If needle tip is shor-
tened by too much a new needle will have to be prepared. Resting the needle tip 
in mineral oil avoids RNA drying up and forming a plaque that blocks the ejection 
of RNA. If, despite best efforts, the needle does become blocked there are two 
options; switch the pneumatic pump back to “gated” and try to flush the plaque off, 
or if the duration of ejection is still set relatively high (>100ms for example) remove 
the tip of the needle with the tweezers and re-calibrate droplet size using the 
micrometre slide and reducing the duration of ejection by lowering the “period.”
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8. If too much time is lost and RNA is micro-injected at the two-cell stage, the mosai-
cism that arises will be considerable (Fig. 3A).
9. Under the stereo-microscope the lanes will be clearly visible. Use a truncated mi-
croloader pipette tip to position embryos in the lanes. At this point it is prudent to 
eject a single RNA droplet and check it is still 1nl on the micrometre slide. It is good 
to do this before every round of micro-injecting as well in case the yolk from the 
embryos micro-injected in the previous round has blocked the needle and causes 
<1nl to be ejected in subsequent rounds of micro-injecting.
10. Brightfield is usually sufficient for identifying the cell and micro-injecting but 
Nomarski optics can be used to improve contrast between the yolk and the trans-
parent cell of the zebrafish embryo.
11. This movement is extremely fluid such that it’s one move, once competent a rate 
of >50 embryos per minute is achievable. If the cell is missed and instead the RNA 
is deposited into the yolk of the embryo then continue. During development most 
of the RNA from the yolk will be taken up into the cell. Especially when learning the 
technique the first few times it is easier to aim right under the cell, providing a wider 
target area, as the RNA will be taken up within minutes following injection through 
cytoplasmic streaming. If injecting DNA be aware that DNA is a considerably larger 
molecule and is therefore barely taken up through cytoplasmic streaming!
12. If development needs to be accelerated or decelerated for any reason then incubate 
at maximum 31°C (faster development) or minimum 21.5°C (slower development), 
respectively.
13. MS222 is sensitive to light and loses potency with time. For this reason, I often 
wrap the plastic dish with 0.1% MS222 in E3 medium 0.01% methylene blue in 
aluminium foil when intending to amputate many embryos.
14. Preferably cut on the lid so the rim does not obstruct the motion of incision. The 
plastic will not break. A Leica MDG17 is preferable for the amputations as the small 
base provides free vertical movement of the arm when performing amputations.
15. In parallel I usually transfer an uncut control embryo to the plastic 10cm dish with 
fresh 0.1% MS222 in E3 medium with 0.01% methylene blue mentioned in step 6.
16. The main focus area for improvement in this technique is accuracy to perform 
the amputation as close to the notochord as possible without damaging the no-
tochord. The notochord does not regenerate, hence if nicked or amputated the 
embryo will die. Also, avoiding tearing of the fin-fold tissue by pulling the surgical 
blade away from wound margin is desirable to simplify the analysis of regenerative 
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outgrowth. The optimal incision motion is made using downward pressure to sever 
the zebrafish embryo caudal fin-fold tissue and not slicing towards you, as this can 
create a pulling force on the fin-fold tissue and lead to a sheared fin-fold instead of 
a clean cut.
17. Preferably use a glass Pasteur pipette from this point forward as the amputated 
zebrafish embryo caudal fin-fold readily sticks to plastic, causing damage to the 
caudal fin-fold.
18. Use microloader pipette tips to position embryo with the posterior end flat on the 
bottom of the plastic dish. Nomarski optics can be used to improve contrast of 
the transparent caudal fin-fold of the zebrafish embryo. For comparing different 
embryos it’s paramount to use the same zoom settings on the stereo-microscope. 
Using the above-mentioned Leica set-up there is enough space to take a picture of 
both the amputated embryo and the uncut control in the same image.
19. Smaller than a 24-well plate is not recommended as the embryos have insufficient 
space to grow.
20. By performing the assay this way each uncut control is near enough at the same 
developmental stage as the amputated embryos and changes in embryonic growth 
rate can be accounted for.
21. The caudal fin-fold of 5dpf zebrafish embryos is substantially bigger than at 2dpf. 
Hence, each zebrafish embryo for both amputated and uncut controls requires a 
separate image.
22. The chorion contains maternal DNA and proteins, this need to be removed for ac-
curate estimation of embryonic protein content.
23. The temperature is simply set to a comfortable temperature in which the embryo 
will survive. If using a 1.5ml tube or multi-well plate it is easy to look under a 
standard stereo-microscope to check how much of the yolk has dissociated from 
the embryo.
24. If not de-yolking, any excess system water or E3 medium can be removed from adult 
zebrafish fin-clips or embryos respectively and directly subjected to snap-freezing 
in liquid nitrogen. By snap-freezing the tissue becomes more brittle, increasing 
homogenization efficiency. Can store tissue at this point at -80°C.
25. Accompany a firm up-down motion with a gentle rotation for maximum efficiency. 




26. Creating air bubbles is practically unavoidable with this method but if the appro-
priate needle is used the tissue will be better sheared than it would have been with 
a mini-pestle. A small amount of suspension is always lost in the tip of the syringe 
which cannot be dispensed.
27. This removes quaternary and tertiary structures of proteins. Take into considera-
tion that, after preparation with sample buffer and boiling, the sample may be 
very viscous, especially if little lysis buffer is used for many embryos. Upon such 
an occurrence, the sample usually needs to be diluted with more sample buffer 
for accurate loading to be feasible. It is therefore very important to follow the 
guidelines set out in step 9 to avoid this complication.
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Zebrafish are able to completely regrow their caudal fin-folds after amputation. Follo-
wing injury, wound healing occurs, followed by the formation of a blastema, that pro-
duces cells to replace the lost tissue in the final phase of regenerative outgrowth. Here 
we show that surprisingly, the phosphatase and tumour suppressor Pten, an antagonist 
of PI3K signalling, is required for zebrafish embryo caudal fin-fold regeneration. We 
found that homozygous knock-out mutant (ptena-/-ptenb-/-) zebrafish embryos, lacking 
functional Pten, did not regenerate their caudal fin-folds. AKT phosphorylation was 
enhanced, which is consistent with the function of Pten. Re-expression of Pten, but 
not catalytically inactive mutant Pten-C124S, rescued regeneration, as did pharmaco-
logical inhibition of PI3K. Blastema formation, determined by in situ hybridization for 
the blastema marker junbb, was induced normally upon caudal fin-fold amputation of 
ptena-/-ptenb-/- zebrafish embryos. Whole-mount immunohistochemistry using specific 
markers indicated that proliferation was arrested in zebrafish embryos lacking functi-
onal Pten, and that apoptosis was enhanced. Together, these results suggest a critical 
role for Pten by limiting PI3K signalling during the regenerative outgrowth phase of 




Zebrafish (Danio rerio) fully regenerate multiple organs after injury, including the 
heart, retina, spinal cord, and caudal fin, in a process termed epimorphic regenera-
tion (Pfefferli & Jaźwińska, 2015; Poss, Keating, & Nechiporuk, 2003). In broad terms, 
regeneration of the zebrafish caudal fin proceeds sequentially through three distinct 
phases: wound healing, blastema formation, and regenerative outgrowth. Adult ze-
brafish regenerate their caudal fin-folds within two weeks, whilst zebrafish embryos 
regenerate their caudal fin-folds within 72 hours (Kawakami, Fukazawa, & Takeda, 
2004). The mechanism of embryonic caudal fin-fold regeneration is the same as adult 
caudal fin regeneration. Following injury, nearby cells migrate to cover the wound and 
form an apical epidermal cap that is essential to initiate blastema formation and rege-
nerative outgrowth (Poleo, Brown, Laforest, & Akimenko, 2001). To date, many genes 
have been implicated in the regenerative process (Padhi et al., 2004) and multiple 
signalling pathways have been validated to be essential for regeneration, including 
fibroblast growth factor, sonic hedgehog, bone morphogenetic protein, Wnt, and 
Notch (Gemberling, Bailey, Hyde, & Poss, 2013).
Phosphatase and Tensin Homologue (PTEN) is one of the most frequently mutated 
tumor suppressor genes and has a central role in cell signalling. PTEN is a protein-
tyrosine phosphatase and lipid phosphatase with selectivity for the 3-position of 
phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) and hence, PTEN is an antagonist of 
phosphoinositide-3-kinase (PI3K). Activation of PI3K leads to attraction of AKT (also 
known as PKB) to the plasma membrane and subsequently to phosphorylation of 
AKT on threonine 308 and serine 473 to activate it (Burgering & Coffer, 1995). The 
importance of PI3K signalling is highlighted by activated AKT (p-AKT) interacting with 
and stimulating many factors presiding over various cellular processes. Notably, p-AKT 
promotes cell cycle progression to drive cell proliferation, and enhances cell survival 
by inhibiting pro-apoptotic transcription factors (Vara et al., 2004). Elevated p-AKT has 
been reported in regenerating caudal fins of medaka (Oryzias latipes), and inhibition 
of PI3K activity using the inhibitor LY294002, inhibits medaka, as well as adult caudal 
fin and embryonic zebrafish caudal fin-fold regeneration (Nakatani, Nishidate, Fujita, 
Kawakami, & Kudo, 2008; Rojas-Muñoz et al., 2009). Inhibition of downstream mecha-
nistic target of rapamycin (mTOR) signalling with rapamycin also inhibits regeneration 
(Hirose, Shiomi, Hozumi, & Kikuchi, 2014). These studies highlight the importance 
of PI3K signalling in regeneration. However, the role of PTEN in zebrafish caudal fin 
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regeneration has not been addressed. It is evident that PI3K inhibition attenuates re-
generation and hence, one would expect that PTEN inhibition has the opposite effect, 
and enhances regeneration.
To date, the only implication of PTEN in regeneration has been limited to the 
promotion of central nervous system (CNS) axon regeneration. Various mouse PTEN 
knockdown or conditional knock-outs have been generated that show enhanced axon 
regeneration (Liu et al., 2010; Ohtake, Hayat, & Li, 2015). Also C. elegans mutants 
of daf-18, the PTEN homologue in C. elegans, display improved axon regeneration 
through enhanced mTOR signalling (Byrne et al., 2014). These studies investigated 
axon regeneration following crushing or axotomy, and suggest that PTEN plays a role in 
regeneration by limiting regenerative outgrowth of axons. However, axon connections 
are predominantly rescued by compensatory sprouting from spared neural fibres, and 
true regenerative outgrowth of injured axons rarely occurs in the adult mouse CNS 
(He, 2010). Hence, the importance of PTEN in regeneration remains to be determined.
To investigate the role of Pten in the regeneration of whole tissue and to test if 
pten knock-out mutants have enhanced regeneration, we tested the regenerative 
capacity of caudal fin-folds of zebrafish embryos lacking functional Pten (i.e. mutants 
homozygous for nonsense mutations in both ptena and ptenb) (Faucherre, Taylor, 
Overvoorde, Dixon, & Hertog, 2008). Surprisingly, we found that the caudal fin-fold of 
ptena-/-ptenb-/- zebrafish embryos did not regenerate. AKT phosphorylation was eleva-
ted in amputated caudal fin-folds of ptena-/-ptenb-/- zebrafish embryos and inhibition of 
excess PI3K activity restored regeneration. Blastema formation following amputation 
occurred normally. However, compared to siblings, cell proliferation was arrested and 
apoptosis enhanced close to the site of amputation.  
mAteRiAls ANd methods
Zebrafish husbandry
All procedures involving experimental animals were approved by the local animal 
experiments committee (Koninklijke Nederlandse Akademie van Weterschappen-
Dierexperimenten commissie KNAW-DEC protocol HI12.0701) and performed accor-
ding to local guidelines and policies in compliance with national and European law. 
The ptena+/-ptenb-/- and ptena-/ ptenb+/- zebrafish lines in the Tuebingen Long fin (TL) 
background were previously created by target-selected gene inactivation (TSGI), and 
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both ptenahu1864 and ptenbhu1435 alleles result from non-sense mutations that lead to 
a premature stop codon upstream of the catalytic cysteine, Cys124 (Faucherre et al., 
2008). Adult ptena+/-ptenb-/- and ptena-/-ptenb+/- zebrafish were in-crossed to gene-
rate ptena-/-ptenb-/- zebrafish embryos for all experiments. Zebrafish were raised and 
maintained as described by Westerfield (Westerfield, 2000) under a 14 hours light/ 10 
hours dark cycle at 28.5°C.
mRNA synthesis and micro-injections
The constructs pCS2+-zfPtenb-mCherry, pCS2+-zfPtena-mCherry, pCS2+-hPTEN-
mCherry, and pCS2+-zfPtenb-C124S-mCherry were obtained as described (Faucherre 
et al., 2008). Sense messenger RNA (mRNA) synthesis and micro-injection into one-cell 
stage zebrafish embryos was performed as described (Stumpf & Den Hertog, 2016).
Caudal fin-fold amputation
Zebrafish embryos were amputated as previously described (Hale & den Hertog, 2016), 
amputations were performed at 2 days post fertilisation (dpf) for all experiments. 
Regeneration was allowed to proceed until analysis at 3 days post amputation (dpa) 
or fixation at either 1dpa or 2dpa. LY294002 hydrochloride (Sigma) was administered 
directly following recovery of amputated zebrafish embryos in E3 medium. Whole 
zebrafish embryos were lysed for genotyping or fixed in 4% PFA, in PBS, either 3hpa 
for in situ hybridization, or at 1dpa and 2dpa for immunohistochemistry.
In situ hybridization
In situ hybridizations were performed as previously described (Thisse, Thisse, Schil-
ling, & Postlethwait, 1993), using junbb and and1 digoxigenin-UTP-labelled anti-sense 
riboprobes. Parts of junbb and and1 were amplified from zebrafish cDNA using specific 
primers (Table S1) and the resulting PCR products were cloned into vectors and used 
as DNA templates for synthesis of riboprobes. Digoxigenin-UTP-labelled anti-sense 
riboprobes were synthesized from and1 plasmid DNA, or junbb PCR product, pro-
duced using fwd: TACACGACGCTGAACGCATA and rev: TAATACGACTCACTATAGGTGTC-
CGTTCTCTTCCGTCC. Caudal fin-folds of zebrafish embryos were severed and mounted 
in 70% glycerol in PBS for imaging on a Zeiss Axioskop 2 Mot Plus microscope with 
either a Plan-NEOFLUAR 10x/0.30 or 20x/0.50 objective. The rest of the zebrafish 




Zebrafish embryos fixed in 4% PFA were washed in PBS 0.1% Tween-20 and antigen 
retrieval performed depending on the antibody used: ice-cold acetone for 20mins 
for PCNA; ice-cold methanol for 20mins for activated Caspase-3 (Sorrells, Toruno, 
Stewart, & Jette, 2013); and 10mM Tris, 1mM EDTA, pH 9.0 for p-AKT (Ser473) (van 
der Velden et al., 2011). Whole zebrafish embryos were incubated overnight at 4°C 
in mouse anti-PCNA (1:200, #M0879; DAKO Agilent Pathology Solutions), rabbit anti-
activated Caspase-3 (1:200, #9661 Cell Signaling Technology), or rabbit anti–p-AKT 
(Ser473) (1:50; #4060; Cell Signaling Technology). Secondary antibodies conjugated to 
Cy5 goat anti-mouse or goat anti-rabbit IgG were used 1:500 and 1:200 respectively 
(#115-175-146 and #111-175-144; Jackson ImmunoResearch). Nuclei were shown by 
DAPI (4′,6-diamidino-2-phenylindole) staining. Caudal fin-folds of zebrafish embryos 
were mounted for imaging in 70% glycerol in PBS, and the rest of the zebrafish embryo 
was lysed for genotyping. Z-stacks (6µm step size) of the caudal fin-fold were acquired 
for every zebrafish embryo with a Leica Sp8 confocal microscope. ImageJ software 
(http://rsb.info.nih.gov./ij/) was used to generate maximum intensity (z) projections 
and merge channels. Quantification was performed on the original z-projections (1024 
x 1024px, 300dpi) following rolling ball background subtraction with an average from 
50px. Particles were counted for activated Caspase-3 following a black and white 
thresholding of 121-255 and using a size restriction of 0.000009-0.000144inch2. Mean 
intensity of p-AKT was measured from the wound margin inwards using an ROI with di-
mensions equivalent to h: 1.58µm (475px) and w: 0.78µm (235px) for uncut zebrafish 
embryos and w: 0.45µm (135px) for amputated zebrafish embryos.
genotyping
All zebrafish embryos that were used in these assays were genotyped to establish 
ptena and/or ptenb status. To this end, genomic zebrafish DNA was extracted through 
lysis of zebrafish embryos in 100µg/ml proteinase K (Sigma) diluted in SZL buffer 
(50mM KCl, 2.5mM MgCl, 10mM Tris pH 8.3, 0.005% NP40, 0.005% Tween-20, and 
10% 0.1% Gelatine). Lysis was performed by incubating at 60°C for 1 hour, followed 
by 95°C for 15 minutes in a thermal cycler (BioRad T100). Primers of ptena and ptenb, 
containing the non-sense mutations of the ptenahu1864 and ptenbhu1435 alleles (Table S1), 
were mixed with genomic zebrafish DNA and Kompetitive Allele Specific PCR (KASP) 
master mix (LGC Group). Amplification was carried out according to the manufacturer’s 
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instructions and the resulting PCR products were analysed in a PHERAstar microplate 
reader (BMG LABTECH). Klustercaller software was used to identify the mutations.
statistics
For analysis of caudal fin-fold lengths, histograms of whole data sets were examined 
to determine non-normal distribution of the data. Statistical analysis of unequal 
variances was obtained through a Kruskall-Wallis test. Differences between diffe-
rent experimental conditions were assessed for significance using a Mann-Whitney 
U test. Differences were considered significant when p<0.001, and if they satisfied 
a confidence interval of 99% in a Monte Carlo exact test.  All tests for regenerating 
caudal fin-folds were performed in SPSS (IBM). For analysis of immunohistochemistry 
measurements, differences between different experimental condition were assessed 
for significance using a Mann-Whitney U test with a confidence level set to 95%. All 
tests for immunohistochemistry measurements were performed in GraphPad Prism 
(GraphPad Software). Differences were considered significant when p<0.05.
Results
Pten catalytic activity is required for zebrafish embryo caudal fin-fold 
regeneration 
To address the role of Pten in regeneration, we first investigated whether zebrafish 
embryos regenerate their caudal fin-fold in the absence of functional Pten protein. 
Zebrafish carry two pten genes: ptena and ptenb, encoding Pten proteins that are 
functionally redundant (Faucherre et al., 2008). Zebrafish carrying a single wild-type 
(WT) pten allele (ptena+/-ptenb-/- or ptena-/-ptenb+/-) show no detectable defects during 
development or as adults, and they are viable and fertile, but are predisposed to the 
development of hemangiosarcomas (Choorapoikayil, Kuiper, de Bruin, & den Hertog, 
2012). In-crossing adult ptena+/-ptenb-/- zebrafish produces ptena-/-ptenb-/- zebrafish 
embryos and their sibling controls, ptena+/-ptenb-/- and ptena+/+ptenb-/-, that resemble 
wild-type zebrafish embryos for experimentation. Homozygous knock-out mutant 
zebrafish embryos (ptena-/-ptenb-/-) develop severe abnormalities during development 
and are embryonic lethal after 6 dpf. This is consistent with mouse PTEN knock-outs 
that are not viable either (Cristofano et al., 1998). The developmental abnormalities 
of Pten deficient zebrafish embryos are apparent from 3dpf onwards and are characte-
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rized by heart oedema, curvature and swelling of the body axis, cranial deformations, 
and vascular hyper-branching (Choorapoikayil, Weijts, Kers, de Bruin, & den Hertog, 
2013). To investigate if Pten protein is required for caudal fin-fold regeneration, the 
caudal fin-folds of zebrafish embryos were amputated immediately posterior to the 
notochord at 2dpf and allowed to regenerate for 3 days. Representative pictures of 
regenerating fin-folds at 3dpa and the fin-folds of uncut controls are depicted (Fig. 1A). 
Caudal fin-fold lengths were determined and are presented as percentage caudal fin-
fold growth, normalized to uncut controls of ptena+/+ptenb-/- zebrafish embryos (Fig. 
1b and S1B). In contrast to their siblings, ptena-/-ptenb-/- zebrafish embryos displayed 
severely impaired regeneration. We also observe that the shape of the amputated 
caudal fin-fold of ptena-/-ptenb-/- zebrafish embryos was more rectangular compared 
to the rounded caudal fin-folds of their siblings. Fin-fold growth in uncut controls was 












+/+ +/+ +/+ +/- +/- +/- -/- -/-  -/-
- WT CS - WT CS - WT CS 





















- 5dpf, 3dpa -
H4.1
Fig. 1. impaired caudal fin-fold regeneration in Pten deficient embryos. (A) Embryos from a 
ptena+/-ptenb-/- in-cross were micro-injected at the one-cell stage with synthetic mRNA encoding 
WT Ptenb (WT), catalytically inactive Ptenb-C124S (CS), or were not injected (-). At 2dpf the caudal 
fin-fold was amputated and regeneration was assessed at 3dpa (i.e. 5dpf, 3dpa), equivalent uncut 
controls were included (i.e. 5dpf, uncut). All embryos were genotyped. Representative images of 
non-injected embryo caudal fin-folds are shown, and of WT Ptenb or Ptenb-C124S-injected em-
bryos in Fig. s1. (b) The means of caudal fin-fold growth following amputation are depicted rela-
tive to caudal fin-fold growth of uncut ptena+/+ptenb-/- controls. Means of micro-injected amputa-
ted ptena-/-ptenb-/- embryos were compared to non-injected amputated ptena-/-ptenb-/- embryos. 
Significance: *** p<0.001; n.s. not significant; error bars indicate standard error of the mean. Data 
pooled from multiple experiments.
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To confirm that the absence of functional Pten is responsible for the lack of zebrafish 
embryo caudal fin-fold regeneration, one-cell stage zebrafish embryos from a ptena+/-
ptenb-/- in-cross were micro-injected with mRNA encoding either WT Ptenb, or cataly-
tically inactive Ptenb-C124S (Myers et al., 1998). These Ptenb proteins are tagged with 
C-terminal mCherry and only positively fluorescent zebrafish embryos, expressing the 
Pten-mCherry fusion proteins, had their caudal fin-folds amputated and regeneration 
documented. WT Ptenb rescued caudal fin-fold regeneration in ptena-/-ptenb-/- zebrafish 
embryos, whereas expression of the catalytically inactive Ptenb-C124S had no effect on 
caudal fin-fold regeneration compared to non-injected controls (-) (Fig. 1, s1A).
To test whether Ptena and Ptenb proteins are indeed functionally redundant in caudal 
fin-fold regeneration, we repeated the experiment using ptena-/-ptenb-/- zebrafish 
embryos obtained from in-crossing adult ptena-/-ptenb+/- zebrafish. Again, ptena-/-
ptenb-/- zebrafish embryos displayed severely impaired caudal fin-fold regeneration, 
and siblings carrying one or two WT ptenb alleles regenerated normally, like zebrafish 
embryos carrying one or two WT ptena alleles (cf. Fig. 1A and s2A). To further show 
that Ptena and Ptenb are functionally redundant in caudal fin-fold regeneration, ptena-
/-ptenb-/- zebrafish embryos were micro-injected with mRNA encoding WT Ptena. In 
addition, as Pten is highly conserved amongst species (Stumpf, Choorapoikayil, & den 
Hertog, 2015), we tested whether human PTEN could also fulfil the functions of zebra-
fish Pten in rescuing caudal fin-fold regeneration by micro-injecting mRNA encoding 
human WT PTEN. Both zebrafish Ptena and Ptenb, as well as human PTEN rescued 
caudal fin-fold regeneration (Fig. 2). In conclusion, Pten catalytic activity is required for 
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Fig. 2. expression of zebrafish Pten, or human PteN rescues caudal fin-fold regeneration in Pten 
deficient embryos. (A) Embryos from a ptena+/-ptenb-/- in-cross were micro-injected at the one-cell 
stage with synthetic mRNA encoding zebrafish WT Ptena, zebrafish WT Ptenb, or human WT PTEN, 
or were not injected (-). At 2dpf the caudal fin-fold was amputated and regeneration was assessed 
at 3dpa (i.e. 5dpf, 3dpa), equivalent uncut controls (i.e. 5dpf, uncut) are shown in (b). All em-
bryos were genotyped. The caudal fin length measurements of ptena+/+ptenb-/- and ptena+/-ptenb-/- 
embryos were pooled and represented above as “sib” for both amputated and uncut embryos. 
The means of caudal fin-fold growth following amputation are depicted relative to caudal fin-
fold growth of uncut “sib” controls. Means of micro-injected amputated ptena-/-ptenb-/- embryos 
were compared to non-injected amputated ptena-/-ptenb-/- embryos. Significance: *** p<0.001; ** 
p<0.01; error bars indicate standard deviation.
elevated Pi3K signalling blocks caudal fin-fold regeneration in Pten 
deficient zebrafish embryos
PTEN loss, resulting in enhanced PI3K signal transduction, leads to hyper-active AKT 
(Stambolic et al., 1998). To confirm that this is also the case in our ptena-/-ptenb-/- 
zebrafish embryos, we performed whole-mount immunohistochemistry for p-AKT 
(p-S473). At both 3dpf and 4dpf ptena-/-ptenb-/- zebrafish embryos displayed elevated 
p-AKT levels compared to siblings with a more pronounced effect following fin-fold 
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Fig. 3. elevated p-AKt in the caudal fin-folds of Pten deficient embryos by 4dpf. (A) Caudal fin-
folds of embryos from a ptena+/-ptenb-/- in-cross were amputated and fixed at 2dpa (i.e. 4dpf, 2dpa) 
and subjected to whole-mount immunohistochemistry using a p-AKT-specific antibody (p-S473) 
(yellow). The embryos were counterstained with DAPI (blue). Representative images of amputated 
embryo caudal fin-folds are shown and in the left panels the edge of the fin-fold is indicated with 
a dashed line. Number of embryos showing similar patterns/ total number of embryos analysed is 
indicated in the bottom right corner. The scale bar represents 100μm. (b) p-AKT was quantified by 
mean intensity of the region between the notochord and the edge of the caudal fin-fold. Equiva-
lent uncut controls were also quantified (representative pictures depicted in Fig. s3A). Means wit-
hin amputated or uncut groups are compared to ptena+/+ptenb-/- embryos. Significance: ** p<0.01; 
error bars represent standard deviation.
We hypothesized that the observed hyper-activation of AKT in Pten deficient zebrafish 
embryos causes impaired regeneration. If this is the case, then restoring p-AKT levels, 
by inhibiting over-active PI3K, should rescue regeneration in Pten deficient mutants. 
To test this hypothesis, the caudal fin-folds of zebrafish embryos obtained from a 
ptena+/-ptenb-/- in-cross were amputated at 2dpf and allowed to regenerate for 3 days 
in the presence or absence of the PI3K inhibitor LY294002. Treatment of ptena-/-ptenb-/- 
zebrafish embryos with LY294002 resulted in caudal fin-fold regeneration comparable 
with regeneration in siblings (Fig. 4). Uncut controls showed that LY294002 treatment 
by itself does not have any detrimental effects on caudal fin-fold growth. These results 
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Fig. 4. inhibition of Pi3K rescues impaired caudal fin-fold regeneration in Pten deficient em-
bryos. (A) At 2dpf the caudal fin-fold of embryos from a ptena+/-ptenb-/- in-cross was amputated 
and incubated with 10µM LY294002, or 1% DMSO. Regeneration was assessed at 3dpa (i.e. 5dpf, 
3dpa). (b) Equivalent uncut controls treated with LY294002, or 1% DMSO from 2dpf onwards were 
included (i.e. 5dpf, uncut). All embryos were genotyped. Regeneration was quantified by mea-
suring the distance from the tip of the notochord to the edge of the caudal fin-fold. The means 
of caudal fin-fold growth are depicted relative to caudal fin-fold growth of DMSO treated uncut 
ptena+/+ptenb-/- controls. Mean of LY294002 treated amputated ptena-/-ptenb-/- embryos is com-
pared to DMSO treated amputated ptena-/-ptenb-/- embryos. The number of embryos is indicated 
(n). Significance: *** p<0.001; error bars indicate standard error of the mean. Data pooled from 
multiple experiments.
Normal blastema formation in zebrafish embryos deficient for Pten
We further characterised the ptena-/-ptenb-/- mutants by assessing regeneration at 
two distinct stages: blastema formation and regenerative outgrowth. Amputated 
zebrafish embryos obtained from a ptena+/-ptenb-/- in-cross were fixed at 3 hours post-
amputation (hpa) and subjected to in situ hybridization for detection of junbb and 
and1 transcription, both of which have previously been shown to be upregulated in 
the blastema (Thorimbert et al., 2015; Yoshinari, Ishida, Kudo, & Kawakami, 2009). 
Junbb was clearly induced by amputation of the caudal fin-fold, and ptena-/-ptenb-/- 
mutant zebrafish embryos expressed junbb to a similar extent as their siblings (Fig. 5). 
There was no obvious difference in and1 expression between ptena-/-ptenb-/- zebrafish 
embryos and their siblings. However, and1 expression was already high in uncut con-
trols and was not enhanced in amputated zebrafish embryos, suggesting that and1 
expression is not a good marker for blastema formation in zebrafish embryos (Fig. s4). 














Fig. 5. blastema is formed normally in Pten deficient embryos. At 2dpf the caudal fin-fold of 
embryos from a ptena+/-ptenb-/- in-cross was amputated and allowed to regenerate. Embryos were 
fixed at 3hpa, or equivalent for uncut controls, and subjected to hybridization for junbb. Represen-
tative images of embryo caudal fin-folds are shown, and the number of embryos showing similar 
patterns/ total number of embryos analysed is indicated in the bottom right corner of each panel.
Arrested proliferation and enhanced apoptosis in regenerating caudal 
fin-fold of Pten deficient zebrafish embryos
Proliferation is upregulated during regenerative outgrowth to generate the cells re-
quired to form and replace the lost tissue (Kawakami et al., 2004; Poss et al., 2003), 
and apoptosis is also enhanced and may be required for successful regeneration to 
proceed (Gauron et al., 2013). Considering that PI3K signalling promotes cell prolifera-
tion and enhances cell survival, we analysed both during the regenerative outgrowth 
stage. Zebrafish embryos obtained from a ptena+/-ptenb-/- in-cross were fixed at 1dpa 
or 2dpa and subjected to whole-mount immunohistochemistry for detection of proli-
ferating cell nuclear antigen (PCNA) expression. PCNA immunofluorescence was high 
in amputated caudal fin-folds of siblings (Fig. 6), but remained low in uncut controls 
(Fig. s5A, b). At 1dpa PCNA immunofluorescence was found concentrated between 
the amputation plane and the wound margin at the edge of the caudal fin-fold, and 
there was no apparent difference between Pten deficient zebrafish embryos and their 
siblings (Fig. s5C). By 2dpa however, PCNA immunofluorescence was dispersed at the 
edge of the amputated caudal fin-fold of ptena-/-ptenb-/- zebrafish embryos, whereas 
in siblings, that regenerated normally, PCNA immunofluorescence remained concen-
trated between the amputation plane and the wound margin (Fig. 6). Because PCNA 
positive cells were predominantly concentrated in the regenerating caudal fin-fold of 
siblings, which was absent in ptena-/-ptenb-/- zebrafish embryos, quantification of PCNA 
staining was not meaningful. Nevertheless, from the representative images in Fig. 6 it 
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Fig. 6. Arrested proliferation at the edge of the amputated caudal fin-fold of Pten deficient em-
bryos by 2dpa. At 2dpf the caudal fin-fold of embryos from a ptena+/-ptenb-/- in-cross was ampu-
tated and allowed to regenerate. Embryos were fixed at 2dpa (i.e. 4dpf, 2dpa) and subjected to 
whole-mount immunohistochemistry using an antibody specific for the cell proliferation marker 
PCNA (red). The embryos were counterstained with DAPI (blue). Maximum intensity projection 
images were taken of the caudal fin-folds and all embryos were genotyped. Representative images 
of amputated embryo caudal fin-folds are shown, and in the left panels the edge of the fin-fold is 
indicated with a dashed line. The number of embryos showing similar patterns/ total number of 
embryos analysed is indicated in the bottom right corner of the right panels. The scale bar repre-
sents 100µm. Representative pictures of equivalent uncut controls are depicted in Fig. s5A.
We used whole-mount immunohistochemistry with an activated caspase-3-specific an-
tibody to assess apoptosis. At both 1dpa and at 2dpa activated Caspase-3 is enhanced 
in ptena-/-ptenb-/- zebrafish embryos compared to siblings (Fig. 7, s6). Representative 
images of caudal fin-folds of live zebrafish embryos stained with acridine orange, for 
cells undergoing apoptosis (Tucker & Lardelli, 2007), confirmed that ptena-/-ptenb-/- ze-
brafish embryos experienced enhanced apoptosis compared to siblings (Fig. s7). Taken 
together, the lack of regeneration in ptena-/-ptenb-/- zebrafish embryos is likely due to 














+/+ +/ - -/- +/+ +/- -/-





















Fig. 7. enhanced apoptosis in the caudal fin-folds of Pten deficient embryos by 4dpf. (A) Embryos 
from a ptena+/-ptenb-/- in-cross were amputated and fixed at 2dpa (i.e. 4dpf, 2dpa) and subjected 
to whole-mount immunohistochemistry using an antibody specific for the apoptosis marker ac-
tivated Caspase-3 (green). The embryos were counterstained with DAPI (blue). Representative 
images of amputated embryo caudal fin-folds are shown, and in the left panels the edge of the fin-
fold is indicated with a dashed line. Number of embryos showing similar patterns/ total number 
of embryos analysed is indicated in the bottom right corner. The scale bar represents 100µm. (b) 
Caspase-3 immunofluorescence was quantified by mean particle count of the caudal fin-fold. Equi-
valent uncut controls were also quantified (representative pictures depicted in Fig. s6A). Means 
within amputated or uncut groups were compared to ptena+/+ptenb-/- embryos. Significance: ** 
p<0.01; * p<0.05; error bars represent standard deviation.
disCussioN
Our results demonstrate a critical role for Pten in zebrafish embryo caudal fin-fold 
regeneration. Zebrafish embryos lacking functional Pten (ptena-/-ptenb-/-) do not 
regenerate their caudal fin-folds following amputation (Fig. 1). We propose that the 
increased p-AKT levels in ptena-/-ptenb-/- zebrafish embryos (Fig. 3, s3) inhibit caudal 
fin-fold regeneration, which is consistent with our experiments to restore caudal fin-
fold regeneration by balancing the increased PI3K signalling, by either re-expressing 
WT Ptenb (Fig. 1b, s1A), or inhibiting excess PI3K activity with LY294002 (Fig. 4). 
Although we cannot exclude that the inability of ptena-/-ptenb-/- zebrafish embryos 
to regenerate their caudal fin-folds is secondary to developmental abnormalities, the 
lack of caudal fin-fold regeneration at 1 dpa (3 dpf), when no morphological abnorma-
lities are present, suggests this is unlikely. Furthermore, the rescue of caudal fin-fold 
regeneration by treatment with LY294002, specifically during regenerative outgrowth, 
strongly suggests that Pten has a specific role during caudal fin-fold regeneration. 
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Normally, fin amputation induces three sequential steps to replace the lost fin: 
wound healing, blastema formation and regenerative outgrowth. Following wound 
healing, an apical epidermal cap is produced that signals for the formation of the 
blastema, and, thus, successful blastema formation is indicative of successful wound 
healing. Junbb expression is maintained well into the initial stage of regenerative 
outgrowth (Ishida, Nakajima, Kudo, & Kawakami, 2010), indicating that junbb is a 
definitive blastema marker. We show that the amputated caudal fin-folds of ptena-
/-ptenb-/- zebrafish embryos express junbb, like their siblings (Fig. 5), indicating that 
both wound healing and blastema formation occur normally in the absence of Pten. 
Whereas inhibition of PI3K with LY294002 has been shown to prevent blastema for-
mation (Nakatani et al., 2008), our results demonstrate that excess PI3K activity is not 
detrimental to blastema formation. 
Regenerative outgrowth is characterized by proliferation and differentiation of cells 
to replace the lost tissue. Whilst cells of amputated ptena-/-ptenb-/- zebrafish embryo 
caudal fin-folds initially proliferate as normal (Fig. s5C), by 2dpa proliferation is arres-
ted compared to siblings (Fig. 6). This result is surprising as it is well demonstrated that 
PTEN loss leads to increased proliferation (Shaw & Cantley, 2006). However, this res-
ponse occurs in tumour cells, whereas the cells of developing ptena-/-ptenb-/- zebrafish 
embryos are otherwise normal. Oncogenes expressed in normal healthy cells induce 
senescence (Gorgoulis & Halazonetis, 2010), and hyper-active AKT has been shown to 
do the same in mouse embryonic- and human-fibroblasts (Astle et al., 2012; Chen et 
al., 2005). Moreover, T-cell senescence occurs in some immunodeficient patients with 
germline gain-of-function mutations in PI3K (Lucas et al., 2014). Therefore, elevated 
p-AKT in our ptena-/-ptenb-/- zebrafish embryos (Fig. 3, s3) may induce senescence that 
results in proliferation arrest by 2dpa.
Activated Caspase-3 positive cells are increased in caudal fin-folds of ptena-/-
ptenb-/- zebrafish embryos compared to siblings (Fig. 6, s6, s7), which is surprising 
because loss of PTEN is often associated with suppression of apoptosis and enhanced 
cell survival (Brunet et al., 1999; Kulik, Klippel, & Weber, 1997). These responses are 
elicited in immortalized cell lines, or cell lines following irradiation-induced DNA da-
mage though, which are not normal, wild-type cells or conditions. Hyper-active AKT 
in normal human cells initiates the release of pro-inflammatory cytokines, a hallmark 
of senescence-associated secretory phenotype (SASP) (Astle et al., 2012), which is 
thought to induce apoptosis of senescent cells (Freund, Orjalo, Desprez, & Campisi, 
2010). Thus, the elevated p-AKT in ptena-/-ptenb-/- zebrafish embryos may induce se-
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nescence and apoptosis. However, one would expect apoptosis to follow arrested 
proliferation in AKT-induced senescence, whilst in ptena-/-ptenb-/- zebrafish embryos 
enhanced apoptosis precedes arrested proliferation (cf. Fig. 7 and s6 with Fig. 6 and 
s5).
In addition, arrested proliferation was not observed in the uncut caudal fin-folds 
of ptena-/-ptenb-/- zebrafish embryos (Fig. s5A, s5b), suggesting elevated p-AKT alone 
is not sufficient to induce senescence, and that caudal fin-fold amputation has an 
additional effect that leads to arrested proliferation in amputated ptena-/-ptenb-/- ze-
brafish embryos. In Rxra knock-out mouse embryos, where gastrulation defects during 
embryogenesis lead to cardiac defects and ultimately lethality by E15.5, apoptosis 
precedes reduced proliferation (Kubalak, Hutson, Scott, & Shannon, 2002). That study 
attributed this to upregulated transforming growth factor β (TGFβ) signalling. Identi-
fying the consequences of pten knock-out on other signalling pathways implicated in 
caudal fin-fold regeneration may explain why apoptosis is enhanced and proliferation 
becomes arrested by 2dpa.
In conclusion, we demonstrate for the first time that Pten is required for embryonic 
zebrafish caudal fin-fold regeneration. Loss of Pten inhibits caudal fin-fold regenera-
tion associated with reduced proliferation, enhanced apoptosis, and elevated AKT 
activation. Restoring Pten expression, or inhibiting PI3K activity during regenerative 
outgrowth rescues caudal fin-fold regeneration in zebrafish embryos lacking functional 
Pten protein. Pten likely functions to balance PI3K signalling to coordinate proper 
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Fig. s1. impaired caudal fin-fold regeneration in Pten deficient embryos. Embryos from a ptena+/-
ptenb-/- in-cross were micro-injected at the one-cell stage with synthetic mRNA encoding WT 
Ptenb (WT), catalytically inactive Ptenb-C124S (CS), or were not injected (-). At 2dpf the caudal 
fin-fold was amputated and regeneration was assessed after 3 days (i.e. 5dpf, 3dpa), equivalent 
uncut controls were included (i.e. 5dpf, uncut). All embryos were genotyped. Representative ima-
ges of micro-injected embryo caudal fin-folds are shown (A). Uncut caudal fin-fold growth was 
quantified by measuring the distance from the tip of the notochord to the edge of the caudal fin-
fold. The means of uncut caudal fin-fold growth are depicted relative to caudal fin growth of uncut 
ptena+/+ptenb-/- controls. Means of micro-injected ptena-/-ptenb-/- embryos were compared to non-
injected ptena-/-ptenb-/- embryos using a Mann-Whitney U-test. Error bars indicate standard error 
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Fig. s2. impaired caudal fin-fold regeneration in Pten deficient embryos. Embryos from a ptena-
/-ptenb+/- in-cross were micro-injected at the one-cell stage with synthetic mRNA encoding WT 
Ptenb (WT), catalytically inactive Ptenb-C124S (CS), or were not injected (-). At 2dpf the caudal 
fin-fold was amputated and regeneration was assessed after 3 days (i.e. 5dpf, 3dpa) (A), equivalent 
uncut controls were included (i.e. 5dpf, uncut) (b). All embryos were genotyped. Caudal fin growth 
was quantified by measuring the distance from the tip of the notochord to the edge of the caudal 
fin-fold. The means of caudal fin-fold growth are depicted relative to caudal fin growth of uncut 
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Fig. s3. elevated p-AKt in the caudal fin-folds of Pten deficient embryos. Uncut embryos from a 
ptena-/-ptenb+/- in-cross were fixed at 4dpf (4dpf, uncut) in parallel to the embryos depicted in Fig. 
3A (A). At 2dpf the caudal fin-fold of embryos from a ptena+/-ptenb-/- in-cross was amputated and 
allowed to regenerate. Embryos were fixed at 1dpa (i.e. 3dpf, 1dpa) (C), or equivalent for uncut 
controls (3dpf, uncut) (b). Embryos were subjected to whole-mount immunohistochemistry using 
a p-AKT-specific antibody (p-S473) (yellow). The embryos were counterstained with DAPI (blue). 
Maximum intensity projection images were taken of the caudal fin-folds and all embryos were 
genotyped. Representative images of embryo caudal fin-folds are shown, and in the left panels the 
edge of the fin is indicated with a dashed line. The number of embryos showing similar patterns/ 
total number of embryos analysed is indicated in the bottom right corner of the right panels. The 
scale bar represents 100µm. p-AKT immunofluorescence was quantified by mean intensity of the 
region between the notochord and the edge of the caudal fin-fold. Means within amputated or 
uncut groups are compared to ptena+/+ptenb-/- embryos using a Mann-Whitney U-test. The num-
ber of embryos analysed is indicated (n). Significance: *** p<0.001; error bars represent standard 













Fig. s4. In-situ hybridization staining of and1 in Pten deficient embryos. At 2dpf the caudal fin-
fold of embryos from a ptena+/-ptenb-/- in-cross was amputated and allowed to regenerate. Em-
bryos were fixed at 3hpa, or equivalent for uncut controls, and subjected to in situ hybridization for 
and1. Representative images of embryo caudal fin-folds are shown with the number of embryos/ 







































Fig. s5. Normal proliferation in the caudal fin-folds of Pten deficient embryos. Uncut embryos 
from a ptena+/-ptenb-/- in-cross were fixed at 4dpf (4dpf, uncut) in parallel to the embryos depicted 
in Fig. 6 (A). At 2dpf the caudal fin-fold of embryos from a ptena+/-ptenb-/- in-cross was amputated 
and allowed to regenerate. Embryos were fixed at 1dpa (i.e. 3dpf, 1dpa) (C), or equivalent for 
uncut controls (3dpf, uncut) (b). Embryos were subjected to whole-mount immunohistochemistry 
using an antibody specific for the cell proliferation marker PCNA (red). The embryos were counter-
stained with DAPI (blue). Maximum intensity projection images were taken of the caudal fin-folds 
and all embryos were genotyped. Representative images of embryo caudal fin-folds are shown, 
and in the left panels the edge of the fin-fold is indicated with a dashed line. The number of em-
bryos showing similar patterns/ total number of embryos analysed is indicated in the bottom right 
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Fig. s6. enhanced apoptosis in the caudal fin-folds of Pten deficient embryos. Uncut embryos 
from a ptena+/-ptenb-/- in-cross were fixed at 4dpf (4dpf, uncut) in parallel to the embryos depicted 
in Fig. 7A (A). At 2dpf the caudal fin-fold of embryos from a ptena+/-ptenb-/- in-cross was amputated 
and allowed to regenerate. Embryos were fixed at 1dpa (i.e. 3dpf, 1dpa) (C), or equivalent for uncut 
controls (3dpf, uncut) (b). Embryos were subjected to whole-mount immunohistochemistry using 
an antibody specific for the apoptosis marker activated Caspase-3 (green). The embryos were 
counterstained with DAPI (blue). Maximum intensity projection images were taken of the caudal 
fin-folds and all embryos were genotyped. Representative images of embryo caudal fin-folds are 
shown, and in the left panels the edge of the fin-fold is indicated with a dashed line. The number 
of embryos showing similar patterns/ total number of embryos analysed is indicated in the bottom 
right corner of the right panels. The scale bar represents 100µm. Caspase-3 immunofluorescence 
was quantified by mean particle count of the caudal fin-fold. Means within amputated or uncut 
groups are compared to ptena+/+ptenb-/- embryos using a Mann-Whitney U-test. The number of 
embryos analysed is indicated (n). Significance: * p<0.05; ** p<0.01; error bars represent standard 
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Fig. s7. enhanced apoptosis in the caudal fin-folds of live Pten deficient embryos. At 2dpf the 
caudal fin-fold of embryos from a ptena+/-ptenb-/- in-cross was amputated and allowed to regene-
rate. Embryos were stained at 2dpa (i.e. 4dpf, 2dpa) or 1dpa (i.e. 3dpf, 1dpa), or equivalent for 
uncut controls (i.e. 4dpf, uncut; or 3dpf, uncut), with a dye for cells undergoing apoptosis, acridine 
orange, for 30mins. Representative images of embryo caudal fin-folds at 4dfp and 3dpf are shown, 
and the edge of the fin-fold is indicated with a dashed line. The number of embryos showing si-
milar patterns/ total number of embryos analysed is indicated in the bottom right corner of each 
panel.
table s1. Primers used for amplifying junbb and and1 from zebrafish embryo cdNA, and ptena 
and ptenb from genomic zebrafish dNA.
Primer Sequence 
and1 FWD CAAGACAGGCCTTGAGGAAG 
and1-T7 REV TAATACGACTCACTATAGTTGGGAACTTAGTGGGATGC 
junbb FWD 1 TGGGTTACGGTCACAACGAC 
junbb REV 1 CAGTGTCCGTTCTCTTCCGT 
BamHI-junbb 
FWD (nested 1) ATAGGATCCTACACGACGCTGAACGCATA 
junbb-EcoRI REV 
(nested 2) CTCGAATTCGTGTCCGTTCTCTTCCGTCC 
junbb FWD 2 TACACGACGCTGAACGCATA 
junbb-T7 REV 2 TAATACGACTCACTATAGGTGTCCGTTCTCTTCCGTCC 
ptena WT FWD GAAGGTGACCAAGTTCATGCTTGGGCTTTCCAGCCGAAC 
ptena KO FWD GAAGGTCGGAGTCAACGGATTTGGGCTTTCCAGCCGAAT 
ptena REV TCAATGTTGTTTCGGTAAACACCTTCCAA 
ptenb WT FWD GAAGGTGACCAAGTTCATGCTGTTTCTTGATTCAAAGCATAAAGATCATTAC 
ptenb KO FWD GAAGGTCGGAGTCAACGGATTGTTTCTTGATTCAAAGCATAAAGATCATTAA 
ptenb REV CTGAAGTTTTTGAAACACACTTACAGGTT 
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Zebrafish have the capacity to regenerate lost tissues and organs. In response to 
amputation of the zebrafish caudal fin, a rapid, transient increase in H2O2 levels was 
observed emanating from the wound margin, which is essential for regeneration, 
because quenching of reactive oxygen species blocks regeneration. We hypothesized 
that protein-tyrosine phosphatases (PTPs), which are susceptible to oxidation-media-
ted inactivation, might become oxidized in response to amputation of the caudal fin. 
Using the oxidized PTP-specific (ox-PTP) antibody and liquid chromatography-mass 
spectrometry, we identified 33 PTPs in adult zebrafish fin clips of the total of 44 PTPs 
that can theoretically be detected based on sequence conservation. Of these 33 PTPs, 
8 were significantly more oxidized 40 min after caudal fin amputation. Surprisingly, 
Shp2, one of the PTPs that were oxidized in response to caudal fin amputation, was 
required for caudal fin regeneration. In contrast, Rptpα, which was not oxidized upon 
amputation, was dispensable for caudal fin regeneration. Our results demonstrate that 
PTPs are differentially oxidized in response to caudal fin amputation and that there is 




Epimorphic regeneration is the perfect replacement of lost tissue, organs, or limbs. 
Zebrafish can fully regenerate multiple organs after injury, including the heart, retina, 
spinal cord, and caudal fin1,2. Many genes have been implicated and multiple signalling 
pathways have been validated to be essential for regeneration to proceed, including 
fibroblast growth factor (FGF), sonic hedgehog, bone morphogenetic protein, Wnt, 
and Notch3,4. However, it remains unclear how this complex process is initiated. One 
of the first responses following amputation of the zebrafish caudal fin is a burst of 
hydrogen peroxide (H2O2) that emanates from the wound site and extends into the 
tissue5. Inhibition of this burst of H2O2 impairs zebrafish caudal fin regeneration6, 
demonstrating it is essential for this process. 
H2O2 is a reactive oxygen species (ROS) that, as well as a chemoattractant, acts as 
a second messenger molecule to regulate intracellular signalling including mitogen 
activated protein kinase (MAPK), phosphoinositide-3-kinase (PI3K)/AKT, and NF-κB 
signal transduction7,8. H2O2 reversibly oxidizes cysteine residues that are in the thiolate 
anion form due to a low pKa, which results from their microenvironment. Often, the 
active-site cysteine of enzymes has a low pKa, which actually confers catalytic activity. 
Reversible oxidation of these cysteine residues temporarily activates or inactivates 
these enzymes9. 
Protein-tyrosine phosphatases (PTPs) constitute a family of active-site cysteine 
enzymes that mediate tyrosine dephosphorylation 10–12. A total of 125 genes encoding 
enzymes with PTP activity have been identified in the human genome, 116 of which 
are cysteine-based, and constitute an enzyme superfamily divided into classical PTPs, 
dual-specificity PTPs, and low molecular weight PTPs13,14. The classical PTPs are further 
subdivided into receptor and non-receptor PTPs. Classical PTPs are defined by having 
at least one catalytic domain with a conserved signature motif (I/V)HCSAGXXR(S/T)G, 
containing the catalytic cysteine (in bold), which is essential for catalysing the removal 
of the phosphate group from phospho-tyrosine residues. The sulphur atom in the ca-
talytic cysteine of active PTPs is in the thiolate anion form (S-). H2O2 inactivates PTPs by 
reversibly oxidizing this sulphur atom to sulphenic acid (SOH), a labile state that rapidly 
rearranges to form a sulphenylamide with an adjacent nitrogen15 or a disulphide bond 
with a nearby cysteine16. These states help protect the catalytic cysteine from further 
irreversible hyperoxidation to sulphinic acid (SO2H) or sulphonic acid (SO3H) states17. 
A monoclonal antibody (ox-PTP Ab) was raised against a hexapeptide encoding the 
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conserved PTP signature motif with a triply oxidized cysteine, VHCSO3HSAG, which can 
be used to detect reversible and irreversible oxidation of PTPs18,19. The susceptibility to 
oxidation differs from PTP to PTP10,20, suggesting dose-dependent specificity in ROS sig-
nalling. Mechanistically, oxidation-mediated inhibition of PTPs results in the selective 
amplification or attenuation of specific signalling pathways, such as FGF, PI3K/AKT, and 
MAPK, ultimately regulating fundamental cellular processes, including proliferation, 
differentiation, and cell-cell adhesion21.
Considering the high susceptibility of PTPs to oxidation, we hypothesized that 
the H2O2 burst following zebrafish caudal fin amputation may oxidize PTPs. Using the 
ox-PTP-specific antibody and mass spectrometry, we detected 37 out of 52 predicted 
zebrafish PTP motif peptides, 8 of which were oxidized following zebrafish caudal fin 
amputation. We next functionally assessed the role of PTPs during regeneration. Shp2, 
a cytoplasmic PTP with a central role in signalling was one of the 8 oxidized PTPs. 
Interestingly, zebrafish mutant embryos lacking functional Shp2 displayed impaired 
caudal fin-fold regeneration. Zebrafish embryos lacking Rptpα, which was not oxidized 
upon caudal fin amputation, regenerated their caudal fin-folds normally. These results 
reveal differential oxidation of PTPs following caudal fin amputation in vivo, and sug-
gest a differential requirement for PTPs in zebrafish caudal fin regeneration.
Results
detecting in vivo PtP oxidation following zebrafish caudal fin 
amputation 
To investigate PTP oxidation following amputation, we isolated zebrafish caudal fin 
tissue by performing two sequential amputations with a 40 min interval to allow for 
the H2O2 gradient that emanates from the wound margin to form5 (Fig. 1). Repeated 
amputation does not affect the regenerative capacity of zebrafish22. The first (control) 
and second (sample) zebrafish caudal fin clips were snap-frozen immediately following 
amputation and lysed in reducing or alkylating lysis buffer to detect all PTPs or oxidized 
PTPs, respectively (Fig. 1). 
Under normal conditions, cells contain reduced PTPs (PTP-S-) and reversibly oxidi-
zed PTPs (PTP-SOH)11. Reduction of all PTPs in the lysate by treatment with dithiotrei-
tol (DTT), followed by hyperoxidation using pervanadate (PV), converts all catalytic 
cysteines into the sulphonic acid (SO3H) state, allowing detection of all PTPs with the 
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ox-PTP-specific antibody. Reversibly oxidized PTPs can be detected by first lysing in the 
presence of N-ethylmaleimide (NEM), which alkylates all reduced cysteines, followed 
by reduction of the oxidized catalytic cysteines using DTT, and hyperoxidation using 
pervanadate (PV). As the reduced catalytic cysteines are protected from detection 
by NEM, only the catalytic cysteines that were oxidized at the time of lysis will be 
detected using the ox-PTP-specific antibody. Comparison of oxidized PTPs with all PTPs 
in a sample facilitates assessment of the extent of oxidation of the PTP family. Here, 
we employed protocols that we and others developed10,18–20 to detect in vivo PTP oxi-
dation following amputation of the zebrafish caudal fin using liquid chromatography 


































Fig. 1. detection of total and oxidized PtPs in zebrafish caudal fins. Zebrafish caudal fin tissue was 
obtained by sequential amputation. The first fin clips (control) were snap-frozen immediately. The 
second fin clips (sample) were taken after 40 min to allow for H2O2 to form and oxidize proteins, 
and were snap-frozen immediately as well. The PTP pool in cells consists of reduced (PTP-S-) and 
reversibly oxidized (PTP-SOH) PTPs. Caudal fin clips were either lysed in reducing (DTT-containing) 
or alkylating (NEM-containing) lysis buffer to detect total and oxidized PTPs, respectively, for both 
control and sample caudal fin clips. As the ox-PTP antibody only binds hyperoxidized PTPs (PTP-
SO3H), a sequential reduction and oxidation process is required for detection by immunoprecipi-
tation. 1. NEM in the lysis buffer protects reduced PTPs from hyperoxidation. 2. DTT reduces all 
oxidized PTPs to allow hyperoxidation. 3. pervanadate (PV) hyperoxidizes all reduced PTPs to an 
irreversibly oxidized state (PTP-SO3H). 4. PTP-SO3H PTPs are recognized by the ox-PTP-specific anti-
body. Immunoprecipitation allows detection by LC-MS/MS. Lysis in the absence of NEM results in 
detection of total PTPs. Comparison of the NEM treated first and second fin clips allows detection 
of the change in oxidized PTPs.
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identification of oxidized PtPs following zebrafish caudal fin 
amputation
We searched the zebrafish Uniprot+trEMBL database24 for entries containing the [I/V]
HCS[A/V]GXGR[S/T]G motif, and found 52 distinct PTP peptides containing this consensus 
motif, indicating that those may serve as the epitope for the ox-PTP antibody (Fig. s1). 
Given the tandem PTP domains in some receptor PTPs, the 52 PTP peptides represent 44 
distinct PTP proteins. It is noteworthy that the zebrafish genome was duplicated early in 
evolution. Whilst some of the duplicated chromosomes were lost, the duplicated genes 
that remain have complementary or diverging expression patterns and exhibit redundant 
or complementary functions25,26. Among the zebrafish classical PTPs, 5 non-receptor PTPs 
and 9 receptor PTPs are duplicated, the “a” and “b” entries (Fig. s1). It is noteworthy that 
the annotation of proteins in the Uniprot+trEMBL database is incomplete and the majo-
rity of sequences submitted for zebrafish PTPs have not been reviewed or validated. The 
A0A1L1QZV1 and F1QWY5_CA16B entries (Fig. s1) actually represent Ptprr and Ptprgb, 
respectively, based on sequence comparison with human PTPs. 
In order to unambiguously identify which PTPs are oxidized, first fin clips (control) 
and second fin clips (40 min) were isolated and processed as outlined in Fig. 1. Fin 
clips were isolated from 10 adult zebrafish per condition and the lysates were pooled 
to average out biological differences between individual fish. The experiment was 
performed in triplicate. Following PV treatment, fin lysates were digested with trypsin 
and ox-PTP peptides were immunoprecipitated by the ox-PTP-specific antibody. Im-
munoprecipitated peptides were subsequently analysed by LC-MS/MS. Since trypsin 
cleaves after the amino acids lysine and arginine, all PTP peptide sequences detec-
ted end with an arginine residue within the catalytic domain ([I/V]HCS[A/V]GXGR). 
Unambiguous identification of PTPs was thus achieved using the sequence upstream 
of the consensus sequence (VHCSA/VG) of every unique PTP peptide, where low se-
quence conservation is observed. Using this approach, we identified 37 PTP peptides 
containing an active-site catalytic cysteine in zebrafish caudal fin lysates (Fig. 2a, b, 
table s1). These 37 PTP peptides are derived from 33 distinct PTP proteins, indicating 
that 75% (33 of 44) of all PTPs were expressed and detected in the zebrafish caudal 
fin. The immunoprecipitation with the ox-PTP antibody resulted in great enrichment 
of PTP peptides. For comparison, we analysed fin lysate by LC-MS/MS and detected 
2698proteins, amongst which only 2 were PTPs. In the ox-PTP immunoprecipitates, we 
identified peptides derived from 124 proteins in total, 33 of which represent distinct 
PTPs, demonstrating the enrichment achieved by ox-PTP immunoprecipitation. 
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A representative spectrum obtained for the NFFSGPIVVHcSAGVGR peptide from 
Ptprc (CD45) is shown in Fig. 2c, where the peptide was almost fully sequenced with 
near complete y- and b-ion ladder. Representative spectra for all zebrafish PTP ca-
talytic site peptides detected are presented in Fig. s2. The high quality of our data 
facilitated the observation of diagnostic ions in the raw MS/MS spectra and allowed 
us to distinguish between highly homologous PTP peptides, such as Ptpn1 and Ptpn2a 
(2 residue difference), or Rptpα_2 and Rptpεb_2 (single residue difference) (Fig. s2, 
p1, 6, 21 and 30). Several receptor-type PTPs contain two catalytic site cysteine mo-
tifs, representing the two PTP domains, and both PTP peptides were detected in one 
experiment (table s1), albeit with different MS signal intensities. This is presumably 
due to the primary peptide sequences having different precursor ionization and MS 
fragmentation efficiencies. 
Differences in abundance of the PTPs were assessed by comparing the spectral 
counts from the samples lysed in a reducing buffer of both the first and second fin 
clips (Fig.1, Total PTP) (table s2). These results show large differences in abundance 
of distinct PTPs in zebrafish caudal fins (Fig. 3a). However, for the same PTP, only small 
differences in abundance were observed between the first and second fin clip (Fig. 3a). 
The abundance of oxidized PTPs was assessed by analysis of samples lysed in an 
alkylating buffer of the first and second fin clip (Fig. 1, Oxidized PTP). A difference in 
spectral counts between the first and second fin clip represents a change in PTP oxida-
tion upon amputation of the zebrafish caudal fin. Out of 37 PTP peptides, 8 were found 
significantly more oxidized in the second fin clip than in the first fin clip (p<0.05; Fig. 
3b). We conclude that in vivo oxidation of those 8 PTPs (asterisks in Fig. 2a) was enhan-
ced in response to zebrafish caudal fin amputation. As an additional control, the first 
and second fin clip were lysed in reducing buffer to reduce all reversibly oxidized PTPs, 
then treated with NEM to block all reduced cysteines and subsequently processed to 
detect oxidized PTPs. This control resulted in detection of background levels of PTPs in 
the first and second fin clips (table s2), indicating that there are no triply oxidized PTPs 
in these lysates before processing. Moreover, these results indicate that the 8 PTPs 
that were detected to be oxidized in response to amputation of the zebrafish caudal 
fin, were all reversibly oxidized, because DTT-mediated reduction of the lysates of the 
second fin clip prior to processing for detection of oxidized PTPs reduced the signal to 
background levels. These results demonstrate that our approach effectively detected 
















Fig. 2. detection of PtP peptides using lC-ms/ms. Caudal fin lysates were isolated and processed 
as described in Fig. 1 and LC-MS/MS was used to identify PTP peptides. (a) Clustal Omega align-
ment of 37 PTP peptides that were detected. Intensity of shading represents degree of sequence 
conservation. Oxidation of 8 out of 37 PTP active sites (*) was detected in the second fin clips 
40min after the first fin clips. (b) Sequence logo obtained from 37 PTP catalytic sites and 20 flan-
king residues. Overall height of stack at each position indicates sequence conservation; height of 
symbols within the stack indicates relative frequency of each amino acid in the position. Low con-
servation in sequences preceding the catalytic site allows unambiguous identification of PTP spe-
cies. (c) Representative MS/MS spectrum of a NFFSGPIVVHcSAGVGR peptide from PTPRC (CD45). 
Inset: peptide sequence, annotated with matched y-ions (blue) and b-ions (red). Consensus PTP 






Fig. 3. differential PtP oxidation following caudal fin amputation. (a) Total detectable PTP reper-
toire in zebrafish caudal fin clips. Spectral counts ± SE do not differ significantly between first and 
second fin clips (paired t-test, p>0.05; n=3). (b) Oxidized PTPs detected from first and second fin 
clips. Ptprea_QQQQ, Ptprh, Ptpn1, Ptpn11a, Ptpn11b, Ptpn2a, Ptpn4b and Ptpn9a are significantly 
more oxidized in the second fin clip compared to the first fin clip (paired t-test, p<0.05; n=3).
differential requirement for PtP function in zebrafish caudal fin 
regeneration
Our results reveal that many PTPs are detected to be expressed in the zebrafish caudal 
fin, but only 8 are abundantly oxidized following caudal fin amputation. We next inves-
tigated whether PTPs have a functional role in zebrafish caudal fin regeneration. To this 
end, we performed caudal fin-fold regeneration assays on zebrafish embryos lacking 
functional Shp2 (ptpn11a-/- ptpn11b-/-) or Rptpα (ptpra-/-). It is noteworthy that Shp2a 
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and Shp2b were both abundantly oxidized following caudal fin amputation, whereas 










































































































Fig. 4. impaired caudal fin regeneration in shp2 deficient, but not Rptpα deficient embryos. Ze-
brafish embryos from a ptpn11a+/-ptpn11b-/- in-cross and a ptpra+/- in-cross were amputated at 2 
dpf and caudal fin regeneration was assessed at 3dpa (i.e. 5dpf, 3dpa). Equivalent uncut embryos 
were monitored as controls (i.e. 5dpf, uncut). (a, d) Representative images of embryo caudal fins 
are shown. (b, c) Means of caudal fin growth of embryos lacking Shp2 (ptpn11a-/-ptpn11b-/-) em-
bryos following amputation and uncut controls are depicted relative to caudal fin growth of uncut 
ptpn11a+/+ptpn11b-/- embryos. (e, f) Means of caudal fin growth of embryos lacking Rptpα (ptpra-/-) 
following amputation and uncut controls are depicted relative to caudal fin growth of uncut pt-
pra+/+ embryos. Regeneration was quantified by measuring the distance from the tip of the noto-
chord to the edge of the caudal fin as indicated. Means of amputated ptpn11-/-ptpn11b-/- or ptpra-/- 
embryos were compared to amputated ptpn11a+/+ptpn11b+/+ or ptpra+/+ embryos, respectively, 
using a Mann-Whitney U-test. Significance: *** p<0.001; n.s. not significant; error bars indicate 
standard error of the mean. All embryos were genotyped. Data pooled from multiple experiments.
The ptpn11a-/- ptpn11b-/- zebrafish have been previously validated and characteri-
zed27. Zebrafish heterozygous for Rptpα (ptpra+/-) were obtained from the European 
Zebrafish Resource Centre (EZRC) and the (ptpra-/-) offspring did not express Rptpα 
protein at 4 days post fertilisation (dpf) (Fig. s3), indicating that these are bona fide 
knock-outs. Both ptpn11a-/-ptpn11b-/- and ptpra-/- zebrafish embryos are embryonically 
lethal at 6-8 dpf27,28. Because homozygous zebrafish adults were not viable, we inves-
115
5
tigated caudal fin-fold regeneration during embryogenesis between 2 dpf and 5 dpf. It 
is noteworthy that the mechanism of zebrafish embryo caudal fin-fold regeneration is 
identical to adult zebrafish caudal fin regeneration29. Normally, amputated caudal fin-
folds of 2 dpf zebrafish embryos almost completely regenerate in the course of 3 days 
(5dpf, 3dpa). Surprisingly, ptpn11a-/-ptpn11b-/- zebrafish embryos showed severely 
impaired regeneration of their caudal fin-folds (Fig. 4a, b). The normal developmental 
growth rate of the caudal fins was unaffected in ptpn11a-/-ptpn11b-/- zebrafish embryos 
(Fig. 4a, c). In contrast, ptpra-/- zebrafish embryos regenerated their caudal fin-folds to 
the same extent as their siblings and no significant differences were observed in fin 
growth between ptpra-/- zebrafish embryos and siblings (Fig. 4d-f). These results show 
differential requirement for PTPs to facilitate caudal fin-fold regeneration in zebrafish 
embryos.
disCussioN
Our results demonstrate successful detection and identification of PTPs in zebrafish 
caudal fin tissue, and reversible oxidation of a subset of PTPs following caudal fin 
amputation (Fig. 3, table s2). PTP active site peptides were efficiently immunoprecipi-
tated and identified by LC-MS/MS. According to the Uniprot+trEMBL database, these 
peptides belong to 33 distinct PTPs, including 17 non-receptor and 16 receptor type 
PTPs, covering 75% of all theoretically observable PTPs (cf. Fig. 2a, s1). This is to our 
knowledge the largest repertoire of zebrafish PTPs identified in a single proteomics 
experiment, and serves to confirm the existence of numerous PTP species that were 
previously annotated only at the transcript level. As not all predicted PTP peptides 
may be expressed in the zebrafish caudal fin, the local coverage may be even greater. 
Of the 33 PTPs that were detected in zebrafish caudal fin clips, 8 were oxidized 40 
minutes after amputation, including 6 non-receptor and 2 receptor type PTPs (Fig. 
2a, 3b): Ptpn1, Ptpn2a, Ptpn4b, Ptpn9a, Ptpn11a, Ptpn11b, Rptph, and Rptpεa. Abun-
dance of the 8 oxidized PTP peptides and the remaining 29 PTP peptides that were 
identified was not significantly different between the first and second fin clips, based 
on semi-quantitative spectral counting (Fig. 3a, table s2), indicating that the increase 
in spectral counts of these 8 peptides was caused by enhanced oxidation. Oxidation 
of these 8 PTPs was also not related to baseline PTP expression level (cf. Fig. 3a, b). 
In general, this indicates that not all PTPs are equally susceptible to oxidation and 
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that PTPs are oxidized differentially, consistent with our earlier work in vitro10. To our 
knowledge, our results demonstrate for the first time that differential PTP oxidation 
occurs in response to endogenous ROS production in vivo. 
Interestingly, only the membrane-distal PTP domain (D2, QQQQSGNHPIIVHcSA-
GAGR) of Ptprεa becomes oxidized following zebrafish caudal fin amputation (Fig. 
2a, 3b). This suggests that D2 is more sensitive to oxidation. We previously reported 
differential oxidation of the two catalytic domains of a close relative of Ptprεa, RPTPα. 
In in vitro experiments, the D2 domain of RPTPα is more sensitive to oxidation and 
appears to act as a redox sensor, regulating catalytic activity of RPTPα in an allosteric 
manner19,30. Our current results in zebrafish caudal fins suggest that Ptprεa-D2 may 
function in a similar manner as the redox sensor for Ptprεa.  
Little is known about the role of PTPs in regeneration. The PTP superfamily mem-
ber, Phosphatase and Tensin Homologue (PTEN), a lipid phosphatase, is an essential 
regulator of PI3K/AKT signalling and has been implicated in limiting central nervous 
system axon regeneration31. PTP type IVA 1 belongs to the phosphatase of regenera-
ting liver (PRL)-subfamily of PTPs and was originally identified as PRL-1 because it was 
upregulated following liver injury and it is required for proper cell cycle progression 
during liver regeneration32,33. To date, the function of classical PTPs in regeneration had 
not been addressed. We performed caudal fin-fold regeneration assays on zebrafish 
embryos lacking either Shp2 or Rptpα. Surprisingly, zebrafish embryos lacking Shp2 
(ptpn11a-/-ptpn11b-/-) did not regenerate their caudal fin-folds (Fig. 4). Yet, zebrafish 
embryos lacking Rptpα (ptpra-/-) regenerated their caudal fin-folds normally. These 
results indicate that Shp2, but not Rptpα, has a specific and essential role in zebrafish 
embryo caudal fin-fold regeneration. The requirement for functional Shp2 in caudal 
fin-fold regeneration on the one hand and oxidation-mediated inactivation of Shp2 
upon caudal fin amputation on the other, results in an apparent conundrum: functio-
nal Shp2 is required for caudal fin regeneration and, at the same time, Shp2 is oxidized 
and thus inactivated in response to zebrafish caudal fin amputation. Presumably, 
oxidation of Shp2 is transient. Following a lag-time, Shp2 becomes active again and 
exerts its essential function. However, we cannot exclude that oxidized, inactive, Shp2 
has another, phosphatase-independent function in zebrafish caudal fin regeneration. 
The function of oxidation of the 8 PTPs that are oxidized in response to zebrafish 
caudal fin regeneration remains to be determined. In general, whereas it is evident 
that PTPs become oxidized in vitro, analysis of the function of PTP oxidation in vivo is 
only recently emerging. For instance, oxidation of PTP1B and TC-PTP has a role in the 
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progression of type 2 diabetes mellitus34. PTP1B is oxidized following platelet derived 
growth factor stimulation35,36, resulting in an enhanced mitogenic response, and is 
also transiently oxidized in response to insulin, promoting insulin receptor and leptin 
signalling 37. Oxidation of TC-PTP has been reported in response to hepatic oxidative 
stress, an early event in type 2 diabetes progression, and exacerbates obesity and 
insulin resistance38. Both PTP1B and TC-PTP have various roles in tumour biology, 
metabolism, inflammation and autoimmunity, reviewed in 39–41, and their oxidation is 
likely important in many other processes. In immune cells, activation of the T-cell re-
ceptor results in transient ROS-induced inactivation of SHP2, activating integrin signal-
ling and promoting T cell adhesion42. The cytoplasmic isoform of PTPε, cyt-PTPε43, has 
an important role in maintaining osteoclast function44, and translocates to the nucleus 
following oxidative stress45. However, the function of this translocation remains to be 
determined. To date, nothing is known about oxidation of Ptpn4, Ptpn9, or Rptph. 
In conclusion, we used a highly sensitive and robust approach to detect and iden-
tify PTPs in zebrafish caudal fin tissue. This method facilitated the identification of 
the oxidation of 8 different zebrafish PTPs following zebrafish caudal fin amputation. 
Moreover, we provide evidence that Shp2, one of the oxidized PTPs, is essential for 
zebrafish caudal fin regeneration. Considering the importance of ROS signalling in 
various physiological processes and the susceptibility of PTPs to ROS-mediated inac-
tivation, screening for PTP oxidation in various conditions, including wound healing, 
cancer, diabetes, and ageing, could identify a general role for the inactivation of PTPs 
in these physiological processes.
methods
Zebrafish husbandry
All procedures involving experimental animals were approved by the local animal 
experiments committee (Koninklijke Nederlandse Akademie van Weterschappen-Dier-
experimenten commissie) and performed according to local guidelines and policies in 
compliance with national and European law. The ptpra+/- zebrafish line was purchased 
from EZRC (allele ptptrasa14038, item #15584). The ptpn11a+/- ptpn11b-/- zebrafish line 
in the Tuebingen Long fin (TL) background was previously created by target-selected 
gene inactivation (TSGI), and both ptpn11ahu3459 and ptpn11bhu5920 alleles result from 
non-sense mutations that lead to a premature stop codon upstream of the catalytic 
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domain27. Adult ptpra+/- or ptpn11a+/- ptpn11b-/- zebrafish were in-crossed to generate 
ptpra-/- or ptpn11a-/-ptpn11b-/- zebrafish embryos, respectively, for all experiments. 
Zebrafish were raised and maintained as described by Westerfield46 under a 14 hours 
light/ 10 hours dark cycle at 28.5°C.
Caudal fin amputation
Adult wild-type TL zebrafish of at least 3 months old were anaesthetized in 0.6 mM 
Tricaine and amputated with a stainless steel surgical blade (Swann-Morton no.24). 
Amputated zebrafish were allowed to recover from anaesthesia in separate tanks (one 
individual per tank) at 28.5°C. The second amputation was performed, as the first, after 
40mins or 8h of recovery on the same fin area. Fin clips were placed in individual 1.5ml 
tubes and snap-frozen in liquid nitrogen immediately following amputation. Zebrafish 
embryos were amputated as previously described 47. Whole zebrafish embryos were 
lysed for genotyping at 72 hpa (5 dpf).
Protein extraction, alkylation and hyperoxidation
Snap-frozen fin clips were sonicated in lysis buffer (50 mM HEPES, 150 mM NaCl, 10% 
glycerol, 1% NP-40, 1x protease inhibitor (Roche), 1x phosphatase inhibitor (Roche)), 
supplemented with either DTT (Biorad) or NEM (Sigma-Aldrich) to create reducing 
or alkylating environments respectively. Alkylation and hyperoxidation of PTPs were 
performed as described previously20, with the following modifications: (i) lysis buffers 
were degassed by bubbling 100% helium gas; (ii) zebrafish fin clips were sonicated 
in lysis buffer; (iii) buffer exchange before hyperoxidation was performed with 3kDa 
centrifugal devices to 50 mM HEPES; (iv) hyperoxidation was performed overnight. 
For mass spectrometry measurements, snap-frozen amputated zebrafish caudal fin 
clips were divided equally into 3 conditions to measure: (1) total PTPs; (2) oxidized 
PTPs; or (3) control for efficiency of alkylation and baseline oxidation. In condition (1), 
fin clips were lysed and reduced in lysis buffer containing 10 mM DTT; in condition 
(2), fin clips were lysed and alkylated in lysis buffer containing 20 mM NEM for 30min, 
then reduced in 20 mM DTT; and in condition (3), fin clips were lysed and reduced in 
lysis buffer containing 10 mM DTT, alkylated in 20 mM NEM for 30min, then reduced 
again in 10 mM DTT. Subsequently, all three conditions were hyperoxidized with 1 mM 
PV (1 mM orthovanadate and 1 mM H2O2, mixed and left at room temperature for at 
least 5 min before use). Second fin clips were divided into the same 3 conditions and 
processed similarly. 10 fin clips per condition were used, and each of the 6 conditions, 
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representing one biological replicate, performed in triplicate. Protein recovery after 
buffer exchange was >80%, such that 400µg of fin lysate input material was obtained 
for each of 18 immunoprecipitations. For immunoblotting of hyperoxidized PTPs, 30 
fin clips were used per condition per time point.
immunoprecipitation of hyperoxidized PtP peptides and PtP proteins
Mouse monoclonal antibody against oxidized PTP active site (R&D Systems) was cross-
linked to protein A/G-coated sepharose beads (Santa Cruz Biotechnology) with 2.5 
mM disuccinimidyl suberate (Thermo Fisher Scientific) to prevent antibody co-elution. 
Upon elution of PTPs or PTP peptides, antibody-crosslinked beads were regenerated for 
sequential immunoprecipitations from the same sample, by re-using the flowthrough. 
In immunoprecipitations at the protein level, five sequential immunoprecipitation 
eluates were combined and vacuum-concentrated for immunoblotting. In PTP peptide 
immunoprecipitations, fin lysates were digested sequentially at 37°C in Lys C (1:100) 
and Trypsin (1:50) for 4 and 12 hours respectively, and diluted in 50 mM HEPES, pH 7.4. 
PTP peptides isolated from 5 sequential immunoprecipitations were further purified 
by strong cation exchange STAGE tips and analysed individually by LC-MS/MS as 5 
technical replicates.
LC-MS/MS analysis and database search
Immuno-precipitated PTP peptides were separated on a 40-min reverse-phase 
gradient on the UHPLC 1290 system (Agilent), and analysed on an Orbitrap Q Exactive 
HF mass spectrometer (Thermo Scientific). Peptides were first trapped on a 2cm x 
100μm Reprosil C18 pre-column (3μm) and then separated on a 50cm x 75μm Po-
roshell EC-C18 analytical column (2.7μm). Trapping was performed for 5min in 0.1M 
acetic acid (Solvent A) and elution with 80% ACN in 0.1M acetic acid (Solvent B) in 
gradients as follows: 13-44% solvent B in 20 min, 44-100% in 3 min and 100% for 2min, 
before equilibrating back to Solvent A for another 10min. Flow was passively split to 
300nl/min. MS data were obtained in data-dependent acquisition mode. Full scans 
were acquired in the m/z range of 375-1500 at the resolution of 60,000 (m/z 400), with 
AGC target 3E6 and a maximum injection time of 150ms. Top 7 most intense precursor 
ions were selected for HCD fragmentation performed at normalized collision energy 
(NCE) 27%, after accumulation to target value of 1E5, also in a maximum injection time 
of 150ms. MS/MS acquisition was performed at a resolution of 30,000, and dynamic 
exclusion was set to 6.0s. 
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Raw spectral files were processed using MaxQuant version 1.5.3.30 and searched 
against the Danio rerio Uniprot database (version Feb 2017, including TrEMBL) using 
Andromeda. Cysteine carbamidomethylation was set to fixed modification, while 
variable modifications of methionine oxidation, cysteine hyperoxidation, as well as up 
to 2 missed cleavages were allowed. False discovery rate (FDR) was restricted to 1% in 
both protein and peptide identification.  
genotyping
All zebrafish embryos that were used in these assays were genotyped to establish 
ptpra or ptpn11a status. To this end, genomic zebrafish DNA was extracted through 
lysis of zebrafish embryos in 100µg/ml proteinase K (Sigma) diluted in SZL buffer (50 
mM KCl, 2.5 mM MgCl, 10 mM Tris pH 8.3, 0.005% NP40, 0.005% Tween-20, and 10% 
0.1% Gelatine). Lysis was performed by incubating at 60°C for 1 hour, followed by 
95°C for 15 minutes in a thermal cycler (BioRad T100). Kompetitive Allele Specific PCR 
(KASP) using specific primers (table s2) was carried out according to the manufactu-
rer’s instructions (LGC Group) and a PHERAstar microplate reader (BMG LABTECH) and 
Klustercaller software were used to identify the mutations.
statistics
Semi-quantitative analysis of hyperoxidized PTP peptides was performed by spectral 
counting. Spectra obtained in five technical replicate MS runs were summed, and 
averaged across three biological replicates. Mean spectral count and student t-test 
statistics for difference between first and second fin clips are reported as exact two-
tailed p-value (table s2).
Histograms of whole data sets were examined to determine non-normal distri-
bution of the data. Statistical analysis of unequal variances was obtained through a 
Kruskall-Wallis test. Differences between different experimental conditions were 
assessed for significance using a Mann-Whitney U test. Differences were considered 
significant when p<0.001, and if they satisfied a confidence interval of 95% in a Monte 
Carlo exact test. All tests for regenerating zebrafish embryo caudal fin-folds were 
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Fig. s1. sequence alignments and logos of all predicted PtP peptides in the zebrafish 
uniprot+trembl database. (a) Sequence alignment of 52 predicted catalytic sites ±20 flanking 
residues, representing 44 distinct PTPs, in the zebrafish Uniprot+trEMBL database (release Feb 
2017). PTPs containing two catalytic sites are aligned as separate entries. Alignment generated 
with Boxshade 3.21, shading indicates sequence conservation >80%. (b) Sequence logo visualized 
with WebLogo, overall height of stack at each position indicates sequence conservation; height of 











B3DJL5_site1 (C7U129) Ptpra protein ptpra Receptor QQQQSGNHPITVHcSAGAGR C14(hyper) 76























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Control +/+ +/- -/-
ptpra
Sup5.5
Fig. s3. Zebrafish ptpra knock-out embryos (ptpra-/-) lack RPtPα protein. Adult zebrafish hete-
rozygous for ptpra (ptpra+/-) were in-crossed to generate ptpra knock-out embryos (ptpra-/-). At 
4 dpf, individual embryos were cut in half: one half lysed for protein, and the other half lysed for 
DNA extraction. Protein lysates of ptpra+/+, ptpra+/-, and ptpra-/- embryos were pooled, and 5 em-
bryo equivalents per condition were run on an SDS-PAGE gel, immunoblotted and probed with an 
Rptpα-specific antibody and with tubulin to monitor equal loading. Control lane represents wild-
type TL zebrafish embryos at 3 dpf.

Chapter 6
An Essential Role for Shp2-MAPK Signalling during 
Zebrafish Embryo Caudal Fin-Fold Regeneration 
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Zebrafish completely regrow their caudal fins after amputation. Following injury, 
wound healing occurs, followed by the formation of a blastema, which produces cells 
to replace the lost tissue in the final phase of regenerative outgrowth. Here, we show 
that ptpn11a-/-ptpn11b-/- zebrafish embryos, which lack functional Shp2, did not re-
generate their caudal fin-folds following amputation. Rescue experiments revealed 
that catalytic activity and the SH2 domains, but not the two tyrosine phosphorylation 
sites in the C-terminal domain of Shp2a were required for caudal fin-fold regenera-
tion. Normal expression of the blastema marker junbb indicated normal blastema 
formation in ptpn11a-/-ptpn11b-/- zebrafish embryos. Cell proliferation was arrested in 
zebrafish embryos lacking functional Shp2, and MAPK phosphorylation was reduced. 
Consistent with these Shp2 results, we found that inhibition of MEK1 in wild-type ze-
brafish embryos inhibited caudal fin-fold regeneration and arrested cell proliferation, 
indicating that MAPK activation was required for regenerative outgrowth. Collectively, 
our results suggest an essential role for Shp2a-MAPK signalling in promoting cell pro-





In a process termed epimorphic regeneration, zebrafish (Danio rerio) fully regenerate 
their heart, retina, spinal cord, and caudal fin after injury (1, 2). Regeneration of the ze-
brafish caudal fin proceeds sequentially through three distinct phases: wound healing, 
blastema formation, and regenerative outgrowth. The mechanism of zebrafish embry-
onic caudal fin-fold regeneration is the same as adult zebrafish caudal fin regeneration, 
though reaches completion within 72 hours, instead of within two weeks (3). Following 
injury, nearby cells migrate to cover the wound and form an apical epidermal cap that 
is essential to initiate blastema formation and regenerative outgrowth (4). Many genes 
have been implicated in the regenerative process (5) and multiple signalling pathways 
have been validated to be essential for regeneration, including fibroblast growth factor 
(FGF), sonic hedgehog, bone morphogenetic protein, Wnt, and Notch (6).
Src homology 2 domain containing phosphatase (SHP2) is a protein tyrosine phosp-
hatase (PTP), encoded by the PTPN11 gene, that dephosphorylates phosphorylated 
tyrosine residues of target substrates. The zebrafish genome contains two ptpn11 ge-
nes, ptpn11a and ptpn11b, encoding Shp2a and Shp2b, respectively. Both Shp2a and 
Shp2b are highly homologous to human SHP2 and harbour catalytic activity. Shp2b 
is dispensable, but Shp2a is not, which is due to differential expression of ptpn11a 
and ptpn11b during early development. Ptpn11a+/+ptpn11b-/- and ptpn11a+/-ptpn11b-/- 
zebrafish are viable and fertile, yet homozygous ptpn11a-/-ptpn11b-/- double knock out 
zebrafish are embryonically lethal from 5-7 days post fertilization (dpf) onwards (7).
SHP2 is involved in signalling initiated by various growth factors, such as epidermal 
growth factor (EGF), fibroblast growth factor (FGF), platelet derived growth factor 
(PDGF), and insulin-like growth factor 1 (IGF1) (8, 9). SHP2 has a role in promoting 
mitogen activated protein kinase (MAPK) signalling in response to growth factor stimu-
lation. Yet, SHP2-mediated regulation of phosphoinositide 3-kinase (PI3K) signalling 
depends on the growth factor stimulus. SHP2 inhibits PI3K signalling in response to 
EGF, but activates PI3K signalling in response to PDGF and IGF in the same cell type 
(10). Hence, the effects of SHP2 on PI3K signalling are stimulus and cell-type depen-
dent. We refer to (11) for a recent overview of SHP2 signalling. 
The SHP2 protein consists of two SH2 domains, followed by a catalytically active 
PTP domain, and a C-terminal domain (12). SHP2, like all classical PTPs, mediates 
dephosphorylation of its substrates through a mechanism involving a catalytic cys-
teine (C460 in zebrafish Shp2a) and an assisting arginine (R466 in zebrafish) in the PTP 
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domain (13). SHP2 requires catalytic activity to promote MAPK and PI3K signalling, as 
mutation of the catalytic cysteine results in reduced downstream signalling (14, 15). 
Importantly, the SH2 domains and C-terminal domain of SHP2 are required for the 
function of SHP2 in response to growth factor stimulation. Both SH2 domains contain 
conserved arginine residues (R32 and R138) that are required for binding to phospho-
tyrosine-containing target proteins, such as insulin receptor substrate 1 (IRS-1), PDGF 
receptor, and GAB1, and are essential for the function of SHP2 (16). The SH2 domains 
also have an ERK-independent, anti-apoptotic function, as expression of a zebrafish 
Shp2 mutant lacking the PTP domain and C-terminal domain rescued apoptosis induced 
by zebrafish Shp2 knockdown. The C-terminal SH2 domain was particularly important 
for this function, as full-length zebrafish Shp2a R138M failed to block apoptosis (17). 
The C-terminal domain of SHP2 contains serine and tyrosine phosphorylation sites, 
as well as a proline-rich domain, that mediate interactions with other proteins. Two 
tyrosines (Y542 and Y580) are particularly important, because when phosphorylated, 
they constitute binding sites for SH2 domain containing proteins, such as growth factor 
receptor-bound protein 2 (GRB2) (18, 19). Binding of GRB2 modulates the interaction 
of the C-terminal domain with the SH2 domains of SHP2 (20), and is required for Shp2 
mediated MAPK signalling in response to EGF (21). 
Collectively, the studies on the function of the domains of SHP2 show that both 
the SH2 and C-terminal domain potentiate, but are not definitively required for the 
stimulation of MAPK and PI3K signalling by the PTP domain of SHP2. Activated MAPK 
promotes cell proliferation, migration, and differentiation (22) and activated PI3K/AKT 
promotes cell cycle progression to drive cell proliferation, and enhances cell survival 
by inhibiting pro-apoptotic transcription factors (23). It is not surprising that SHP2 has 
been implicated to play a role in a plethora of cellular processes, including proliferation 
(24, 25), cell migration (26–28), and stem cell self-renewal and differentiation (29–32). 
SHP2, MAPK, and PI3K signalling are indispensable for proper embryonic development 
(7, 16, 33–37).
Regeneration requires cell survival, migration, proliferation and differentiation for 
effective wound healing and replacement of the lost tissue (4, 38, 39). MAPK activation 
following injury is associated with regenerative competence across species (40, 41). 
The need for MAPK signalling in zebrafish caudal fin regeneration has been implicated 
by demonstrating that inhibition of FGF receptor (FGFR) signalling (42–44) impairs 
regeneration. However, activation of the FGFR results in the promotion of not only 
MAPK, but also PI3K, Phospholipase C γ (PLCγ), and signal transducer and activator of 
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transcription (STAT) (45), convoluting the conclusion that MAPK signalling is required. 
Similarly, the requirement for activation of the EGF receptor (EGFR) family member 
ErbB2 for zebrafish caudal fin regeneration (46) eludes to a requirement for MAPK 
and PI3K signalling (47). Whereas PI3K signalling is essential for zebrafish caudal fin 
regeneration (38, 46), the evidence supporting a role for MAPK signalling is incon-
clusive. Rojas-Muñoz et al. showed that treatment of zebrafish embryos with the 
ErbB2/3 inhibitor PD168393 or the PI3K inhibitor LY294002 effectively blocked caudal 
fin regeneration, but treatment with the MEK1 inhibitor PD098059 had no effect (46). 
However, it has recently been shown that MAPK signalling is essential for zebrafish 
cardiac regeneration, as inhibition with the MEK1 inhibitor AZD6244 or expression 
of dominant-negative MEK1 impaired zebrafish cardiac regeneration (48). Hence, the 
role of SHP2 and MAPK signalling in zebrafish caudal fin regeneration remains to be 
determined definitively.
We investigated the role of Shp2 in zebrafish embryo caudal fin-fold regeneration 
using homozygous ptpn11a-/-ptpn11b-/- zebrafish embryos, that lack functional Shp2 (7), 
and found that Shp2 is required for normal caudal fin-fold regeneration. Re-expression 
of wild-type Shp2a rescued regeneration, indicating that the lack of regeneration in 
mutant zebrafish embryos was indeed attributable to lack of functional Shp2. Rescue 
experiments with mutant Shp2a indicated that Shp2a catalytic activity and functional 
SH2 domains were required, whereas the two tyrosine residues in the C-terminus of 
Shp2a that are essential for certain aspects of Shp2 signalling, were dispensable for 
its capacity to rescue regeneration. Characterization of the regeneration defect in 
ptpn11a-/-ptpn11b-/- zebrafish embryos by in situ hybridization using a junbb-specific 
probe indicated normal blastema formation. PCNA staining indicated that cell pro-
liferation during regenerative outgrowth was reduced in ptpn11a-/-ptpn11b-/- zebra-
fish embryos. MAPK phosphorylation was reduced in amputated caudal fin-folds of 
ptpn11a-/-ptpn11b-/- zebrafish embryos. Pharmacological inhibition of MEK1, upstream 
of MAPK, in wild-type zebrafish embryos inhibited regeneration and reduced prolife-
ration during regenerative outgrowth. The similarity with the lack of regeneration in 
ptpn11a-/-ptpn11b-/- zebrafish embryos is consistent with Shp2a acting through MAPK 
in regeneration. Collectively, our results demonstrate that catalytically active Shp2a is 
required for zebrafish embryo caudal fin-fold regeneration and may exert its effects 





All procedures involving experimental animals were performed under licence number 
GZB/VVB 2041019 of the Hubrecht Institute/ Royal Academy of Arts and Sciences 
(Koninklijke Nederlandse Akademie van Wetenschappen, KNAW), approved by the 
local animal experiments committee according to local guidelines and policies in com-
pliance with national and European law. 
The ptpn11a+/-ptpn11b-/- zebrafish lines in the Tuebingen Long fin (TL) background 
were previously created by target-selected gene inactivation (TSGI), and both pt-
pn11ahu3459 and ptpn11bhu5920 alleles result from non-sense mutations that lead to a 
premature stop codon upstream of the catalytic cysteine, C460 (7). Adult ptpn11a+/-pt-
pn11b-/- zebrafish were in-crossed to generate ptpn11a-/-ptpn11b-/- zebrafish embryos 
for all experiments. Zebrafish were raised and maintained as described by Westerfield 
(49) under a 14 hours light/ 10 hours dark cycle at 28.5°C.
mRNA synthesis and micro-injections
All constructs contain a C-terminal eGFP connected by a peptide-2a cleavage sequence 
(50). The constructs pCS2+-eGFP-2a-Shp2a (WT), pCS2+-eGFP-2a-Shp2a-R466M (RM), 
pCS2+-eGFP-2a-Shp2a-R32M-R138M (SH), and pCS2+-eGFP-2a-Shp2a-Y542F-Y580F 
(YF) were obtained as described (51). Sense messenger RNA (mRNA) synthesis and 
micro-injection into one-cell stage zebrafish embryos was performed as described (52).
Caudal fin-fold amputation
Zebrafish embryos were amputated as previously described (53), amputations were 
performed at 2 days post fertilisation (dpf) for all experiments. Regeneration was al-
lowed to proceed until analysis at 3 days post amputation (dpa) or fixation at 3 hours 
post amputation (hpa), 1dpa or 2dpa. PD184352 (Sigma) or Dimethylsulfoxide (Sigma) 
was administered directly following recovery of amputated zebrafish embryos in E3 
medium. Whole zebrafish embryos were lysed for genotyping or fixed in 4% parafor-





In situ hybridizations were performed as previously described (54), using junbb 
digoxigenin-UTP-labelled anti-sense riboprobes. Parts of junbb were amplified from 
zebrafish cDNA using specific primers (table s1) and the resulting PCR products 
were cloned into vectors and used as DNA templates for synthesis of riboprobes. 
Digoxigenin-UTP-labelled anti-sense riboprobes were synthesized from junbb PCR 
product, produced using fwd: TACACGACGCTGAACGCATA and rev: TAATACGACTCACTA-
TAGGTGTCCGTTCTCTTCCGTCC. Caudal fin-folds of zebrafish embryos were severed and 
mounted in 70% glycerol in PBS for imaging on a Zeiss Axioskop 2 Mot Plus microscope 
with either a Plan-NEOFLUAR 10x/0.30 or 20x/0.50 objective. The rest of the zebrafish 
embryo was lysed for genotyping.
immunohistochemistry
Zebrafish embryos fixed in 4% PFA were washed in PBS 0.1% Tween-20 and antigen 
retrieval performed depending on the antibody used: ice-cold acetone for 20mins for 
PCNA; and 10mM Tris, 1mM EDTA, pH 9.0 for phospho-p44/42 MAPK (Thr202/Tyr204). 
Whole zebrafish embryos were incubated overnight at 4°C in mouse anti-PCNA (1:200, 
#M0879; DAKO Agilent Pathology Solutions), or rabbit anti-phospho-p44/42MAPK 
(Thr202/Tyr204) (1:100, #4370 Cell Signaling Technology). Secondary antibodies 
conjugated to Cy5 goat anti-mouse or goat anti-rabbit IgG were used 1:500 and 1:200 
respectively (#115-175-146 and #111-175-144; Jackson ImmunoResearch). Nuclei 
were shown by DAPI (4′,6-diamidino-2-phenylindole) staining. Caudal fin-folds of ze-
brafish embryos were mounted for imaging in 70% glycerol in PBS, and the rest of the 
zebrafish embryo was lysed for genotyping. Z-stacks (6µm step size) of the caudal fin-
fold were acquired for every zebrafish embryo with a Leica Sp8 confocal microscope. 
ImageJ software (http://rsb.info.nih.gov./ij/) was used to generate maximum intensity 
(z) projections and merge channels. Quantification was performed on the original 
z-projections (1024 x 1024px, 300dpi) following rolling ball background subtraction 
with an average from 50px. Mean intensity of phospho-p44/42 MAPK (Thr202/Tyr204) 
(hereafter p-MAPK) was measured from the wound margin inwards using an ROI with 
dimensions equivalent to: h: 2.08µm (625px) and varying widths for each sample: for 
zebrafish embryos at 24hpa: w: 0.32µm (95px) for amputated zebrafish embryos; w: 
0.75µm (225px) for uncut zebrafish embryos; for embryos at 48hpa: w: 0.82µm (246px) 




All zebrafish embryos that were used in these assays were genotyped to establish 
ptpn11a status. To this end, genomic zebrafish DNA was extracted through lysis of 
zebrafish embryos in 100µg/ml proteinase K (Sigma) diluted in SZL buffer (50mM KCl, 
2.5mM MgCl, 10mM Tris pH 8.3, 0.005% NP40, 0.005% Tween-20, and 10% 0.1% Ge-
latine). Lysis was performed by incubating at 60°C for 1 hour, followed by 95°C for 15 
minutes in a thermal cycler (BioRad T100). The ptpn11ahu1864 allele in non-fixed tissue 
was analysed by Kompetitive Allele Specific PCR (KASP): primers of ptpn11a contai-
ning the non-sense mutations of the ptpn11ahu1864 allele (table s1), were mixed with 
genomic zebrafish DNA and KASP master mix (LGC Group). Amplification was carried 
out according to the manufacturer’s instructions and the resulting PCR products were 
analysed in a PHERAstar microplate reader (BMG LABTECH). Klustercaller software 
(LGC Group) was used to identify the mutations. For fixed tissue genotyping for the 
ptpn11ahu1864 allele was performed by nested PCR with primer sets 1-4 (table s1) fol-
lowed by Sanger sequencing (Macrogen Inc., Europe) to detect the mutations.
immunoblotting
Whole cell protein extracts from human embryonic 293 T cells transfected with and 
overexpressing zebrafish ptpn11a were prepared by lysis in ice-cold buffer (25mM 
HEPES pH 7.4, 150mM NaCl, 0.25% deoxycholate, 1% triton X-100, 10mM MgCl2, 1mM 
EDTA and 10% glycerol) containing protease and phosphatase inhibitors. Samples 
were centrifuged at 12,000g for 20mins and the supernatant collected. Proteins were 
resolved in 10% SDS-PAGE gels under reducing conditions and transferred to PVDF 
membranes (IPVH00010, Merck Millipore). Immunoblotting was performed using anti-
SHP2 (SH-PTP2 C-18, #SC-280, Santa Cruz Technology) or anti-Tubulin (#CP06, Merck 
Millipore) antibodies followed by horseradish peroxidase (HRP)-conjugated anti-rabbit 
or anti-mouse antibodies, respectively. Detection was done by enhanced chemilumi-
nescence (#34095, Thermo Fischer Scientific).
statistics
For analysis of caudal fin-fold lengths, histograms of whole data sets were examined 
to determine non-normal distribution of the data. Statistical analysis of unequal 
variances was obtained through a Kruskall-Wallis test. Differences between diffe-
rent experimental conditions were assessed for significance using a Mann-Whitney 
U test. Differences were considered significant when p<0.001, and if they satisfied 
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a confidence interval of 95% in a Monte Carlo exact test. All tests for regenerating 
caudal fin-folds were performed in SPSS (IBM). For analysis of immunohistochemistry 
measurements, differences between different experimental condition were assessed 
for significance using a Mann-Whitney U test with a confidence level set to 95%. All 
tests for immunohistochemistry measurements were performed in GraphPad Prism 
(GraphPad Software). Differences were considered significant when p<0.05.
Results
Functional shp2a is required for zebrafish embryo caudal fin-fold 
regeneration
To investigate the role of Shp2 in regeneration, homozygous ptpn11a-/-ptpn11b-/- ze-
brafish embryos, lacking functional Shp2, were analysed for the potential to regene-
rate their caudal fin-fold following amputation. The caudal fin-fold of offspring from a 
ptpn11a+/-ptpn11b-/- in-cross were amputated at 2 dpf and allowed to regenerate for 3 
days. Regeneration of individual zebrafish embryos was assessed at 5 dpf (i.e. 3 days 
post amputation, dpa), and, subsequently, the zebrafish embryos were genotyped. 
In contrast to sibling ptpn11a+/+ptpn11b-/- and ptpn11a+/-ptpn11b-/- zebrafish embryos, 
which do regenerate their caudal fin-folds, regeneration of the caudal fin-fold of 
ptpn11a-/-ptpn11b-/- zebrafish embryos is severely impaired (Fig. 1). Quantification of 
caudal fin-fold lengths, obtained by measuring the distance from the tip of the noto-
chord to the edge of the fin-fold, were determined and are presented as percentage 
caudal fin-fold growth, normalized to uncut controls of ptpn11a+/+ptpn11b-/- zebrafish 
embryos (Fig. 1b). Regeneration of the caudal fin-fold of ptpn11a-/-ptpn11b-/- zebrafish 
embryos is significantly impaired, compared with sibling embryos (p<0.001). Normal 
growth rate of the caudal fin-fold of ptpn11a-/-ptpn11b-/- zebrafish embryos is unaf-
fected by the lack of functional Shp2. These results demonstrate that functional Shp2 
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Fig. 1. Functional shp2 is required for regeneration. Zebrafish embryos from a ptpn11a+/-ptpn11b-/- 
in-cross were amputated at 2 dpf and caudal fin-fold regeneration was assessed at 3dpa (i.e. 5dpf, 
3dpa). Equivalent uncut embryos were included as controls (i.e. 5dpf, uncut). All embryos were 
genotyped. (A) Representative images of amputated embryo caudal fin-folds at 3dpa are shown 
together with uncut controls for comparison. (b, C) Regeneration was quantified by measuring the 
distance from the tip of the notochord to the edge of the caudal fin-fold as indicated. The means of 
caudal fin-fold growth are depicted relative to caudal fin-fold growth of uncut ptpn11a+/+ptpn11b-/- 
controls. Means of ptpn11a-/-ptpn11b-/- embryos were compared ptpn11a+/+ptpn11b-/- embryos 
using a Mann-Whitney U-test. Significance: *** p<0.001; n.s. not significant; error bars indicate 
standard error of the mean. Data pooled from multiple experiments.
shp2a catalytic activity and the sh2 domains of shp2a are required for 
zebrafish embryo caudal fin-fold regeneration
To validate that impaired regeneration in ptpn11a-/-ptpn11b-/- zebrafish embryos 
is indeed due to the lack of functional Shp2, rescue experiments were performed. 
Zebrafish embryos from a ptpn11a+/-ptpn11b-/- in-cross were micro-injected at the 
one-cell stage with synthetic mRNA encoding Shp2a, and at 2 dpf the caudal fin-fold 
was amputated and allowed to regenerate for 3 days. Expression of wild-type Shp2a 
resulted in a significant rescue (p<0.001) of regeneration in ptpn11a-/-ptpn11b-/- zebra-
fish embryos (Fig. 2A-b).
The catalytic activity of SHP2 is important for the function of SHP2, although 
PTP-independent functions have been identified as well. The SH2 domains and the 
C-terminal domain of SHP2 are required for downstream signalling (17, 18, 21, 55–58). 
To determine which domains of Shp2a are required for caudal fin-fold regeneration, 
the following mutants of Shp2a were used in rescue experiments: catalytically inactive 
Shp2a-R466M (RM); the SH2 domain mutant Shp2a-R32M-R138M (SH), in which the 
essential arginine residues in both SH2 domains were mutated; and the C-terminal do-
main mutant Shp2a-Y542F-Y580F (YF), which lacks the two tyrosine phosphorylation 
sites that are important for signalling. We used the R466M mutant of Shp2a in our 
experiments rather than the catalytic cysteine mutant (C460S in zebrafish Shp2a), be-
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cause Shp2a-C460S may trap substrates (59, 60), and thus have inadvertent dominant 
effects. Indeed, expression of Shp2a-C460S in wild-type zebrafish embryos induced 
developmental defects, and expression in ptpn11a-/-ptpn11b-/- zebrafish embryos 
induced more severe developmental defects than non-injected Shp2 deficient zebra-
fish embryos (data not shown). In contrast, the Shp2a-R466M mutant is catalytically 
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Fig. 2. the catalytic activity and sh2 domains of shp2 are required to rescue caudal fin-fold re-
generation in shp2 deficient embryos. Embryos from a ptpn11a+/-ptpn11b-/- in-cross were micro-
injected at the one-cell stage with synthetic mRNA encoding wild-type Shp2a (WT), catalytically 
inactive Shp2a-R466M (RM), SH2 domain mutant Shp2a-R32M-R138M (SH), C-terminal tyrosines 
mutant Shp2a-Y542F-Y580F (YF), or were not injected (-). At 2dpf the caudal fin-fold was amputa-
ted and regeneration was assessed at 3dpa (i.e. 5dpf, 3dpa), equivalent uncut controls were inclu-
ded (i.e. 5dpf, uncut). All embryos were genotyped. (A) Representative images of amputated ptp-
n11a-/-ptpn11b-/- embryos caudal fin-folds at 3dpa are shown together with a non-injected sibling 
(ptpn11a+/+ptpn11b-/-) for comparison. (C) Representative images of uncut ptpn11a-/-ptpn11b-/- 
embryos caudal fin-folds at 3dpa. (b, d) Regeneration was quantified by measuring the distance 
from the tip of the notochord to the edge of the caudal fin-fold as indicated. The means of caudal 
fin-fold growth are depicted relative to caudal fin-fold growth of uncut ptpn11a+/+ptpn11b-/- con-
trols. Means of micro-injected amputated ptpn11a-/-ptpn11b-/- embryos were compared to non-
injected amputated ptpn11a-/-ptpn11b-/- embryos using a Mann-Whitney U-test. Significance: *** 




The mRNAs encoding (mutant) Shp2a proteins also encode eGFP linked by a peptide-
2a cleavage sequence, resulting in a single polypeptide that is cleaved prior to protein 
folding (50). At 2dpf, eGFP-positive zebrafish embryos were selected and their caudal 
fin-folds were amputated. Zebrafish embryos were allowed to regenerate for 3 days. 
Representative pictures of regenerated caudal fin-folds of ptpn11a-/-ptpn11b-/- zebra-
fish embryos expressing mutant Shp2a protein at 3dpa are depicted (Fig. 2A). The 
equivalent uncut fin-folds (i.e. 5dpf, uncut) are all normal (Fig. 2C). Caudal fin-fold 
lengths were determined and are presented as percentage caudal fin-fold growth, 
normalized to uncut controls of ptpn11a+/+ptpn11b-/- zebrafish embryos (Fig. 2b, d). 
In contrast to their siblings, ptpn11a-/-ptpn11b-/- zebrafish embryos displayed severely 
impaired regeneration, which was rescued by expression of wild-type Shp2a (WT), 
but not by catalytically inactive Shp2a-R466M (RM). Furthermore, expression of the 
SH2 domain mutant of Shp2a (SH) was unable to rescue regeneration. In contrast, 
the mutant lacking two tyrosine phosphorylation sites in its C-terminal domain (YF) 
rescued regeneration of ptpn11a-/-ptpn11b-/- zebrafish embryos (Fig. 2b). A trivial 
explanation for the inability of the catalytically inactive mutant of Shp2a (RM), or the 
SH2 domain mutant of Shp2a (SH) to rescue caudal fin-fold regeneration might be 
that these proteins have reduced stability. Due to low expression levels of all mutant 
Shp2a proteins in zebrafish embryos, it was not possible to monitor protein expression 
in these zebrafish embryos. However, transfection of constructs encoding the mutant 
Shp2a proteins in human embryonic kidney 293 T cells revealed similar expression 
levels of all mutant Shp2a proteins (Fig. s1). This suggests that the differences in abi-
lity to rescue caudal fin-fold regeneration are not due to large differences in protein 
expression or stability, but rather to differences in Shp2a function. Together, these 
results demonstrate that although the two tyrosine phosphorylation sites in the C-
terminal domain are dispensable, the catalytic activity as well as the SH2 domains of 
Shp2 are required for zebrafish embryo caudal fin-fold regeneration.
Normal blastema formation in zebrafish embryos deficient for shp2
Following amputation, three sequential steps can be discerned in the regeneration 
process: wound healing, blastema formation and regenerative outgrowth. Following 
wound healing, an apical epidermal cap is produced that signals for the formation 
of the blastema, and, thus, successful blastema formation is indicative of successful 
wound healing (1, 2). In the ptpn11a-/-ptpn11b-/- zebrafish embryos, we assessed blas-
tema formation at 3hpa by in situ hybridization using a junbb-specific probe, which 
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has previously been shown to be upregulated in the blastema (61, 62). All zebrafish 
embryos were subsequently genotyped. Junbb was clearly expressed in amputated 
caudal fin-folds, but not in uncut controls, and ptpn11a-/-ptpn11b-/- mutant zebrafish 
embryos expressed junbb to a similar extent as their siblings following caudal fin-fold 
amputation (Fig. 3). These results indicate that blastema formation was normal in 












Fig. 3. Normal blastema formation in zebrafish embryos lacking functional shp2. At 2dpf the 
caudal fin-folds of embryos from a ptpn11a+/-ptpn11b-/- in-cross were amputated and allowed to 
regenerate. Embryos were fixed at 3hpa, or equivalent for uncut controls, and subjected to hybri-
dization for junbb. Representative images of caudal fin-folds of genotyped embryos are shown, 
and the number of embryos showing similar patterns/ total number of embryos analysed is indi-
cated in the bottom right corner of each panel.
Arrested proliferation in zebrafish embryos deficient for shp2 during 
regenerative outgrowth
Proliferation is upregulated during regenerative outgrowth to generate the cells re-
quired to form and replace the lost tissue (2, 3). We analysed cell proliferation during 
the regenerative outgrowth stage by immunohistochemistry using an antibody specific 
for proliferating cell nuclear antigen (PCNA). Zebrafish embryos from a ptpn11a+/-
ptpn11b-/- in-cross were fixed at 1dpa or 2dpa and subjected to whole-mount immuno-
histochemistry for detection of PCNA expression. All zebrafish embryos were subse-
quently genotyped. By 2dpa, PCNA immunofluorescence was dispersed at the edge 
of the amputated caudal fin-fold of ptpn11a-/-ptpn11b-/- zebrafish embryos, whereas 
in siblings that regenerated normally, PCNA immunofluorescence was concentrated 
between the amputation plane and the wound margin (Fig. 4). Because PCNA positive 
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cells were predominantly concentrated in the regenerating tissue in siblings, which 
was absent in ptpn11a-/-ptpn11b-/- zebrafish embryos, quantification of PCNA staining 
was not meaningful. Nevertheless, from the representative images in Fig. 4 it is evi-
dent that proliferation was severely arrested in ptpn11a-/-ptpn11b-/- zebrafish embryos 
at 2dpa. PCNA immunofluorescence remained low in uncut controls (Fig. s2). At 1dpa 
PCNA immunofluorescence was found between the amputation plane and the wound 
margin at the edge of the caudal fin-fold of siblings, whereas PCNA immunofluores-
cence was less pronounced in the same region of Shp2 deficient zebrafish embryos 
(Fig. s2). These results indicate that proliferation is reduced in ptpn11a-/-ptpn11b-/- 














Fig. 4. Proliferation arrest at the amputated caudal fin-fold margin of shp2 deficient embryos. At 
2dpf the caudal fin-folds of embryos from a ptpn11a+/-ptpn11b-/- in-cross were amputated and al-
lowed to regenerate. Embryos were fixed at 2dpa (i.e. 4dpf, 2dpa) and subjected to whole-mount 
immunohistochemistry using an antibody specific for the cell proliferation marker PCNA (red). The 
embryos were counterstained with DAPI (blue). Maximum intensity projection images were taken 
of the caudal fin-folds and all embryos were genotyped. Representative images of amputated em-
bryo caudal fin-folds are shown, and in the left panels the edge of the fin-fold is indicated with a 
dashed line. The number of embryos showing similar patterns/ total number of embryos analysed 
is indicated in the bottom right corner of the right panels. The scale bar represents 100µm. Repre-
sentative pictures of equivalent uncut controls are depicted in Fig. s2.
Reduced mAPK signalling in zebrafish embryos deficient for shp2
Loss of SHP2 in tissue culture cells or in knock-out mice results in reduced MAPK 
signalling, leading to reduced proliferation, differentiation, and developmental defects 
(22, 29, 30, 63–65). Furthermore, activated MAPK signalling following injury is asso-
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ciated with regenerative competence across species (40, 41). To determine if loss of 
Shp2 affected MAPK signalling in ptpn11a-/-ptpn11b-/- zebrafish embryos, we perfor-
med whole-mount immunohistochemistry using a phospho-MAPK-specific antibody 
(p-MAPK, phospho-p44/42 MAPK (Thr202/Tyr204)). In comparison to their siblings, 
ptpn11a-/-ptpn11b-/- zebrafish embryos displayed significantly reduced p-MAPK levels 
following caudal fin-fold amputation at 4 dpf (2 dpa) as well as 3 dpf (1 dpa) (Fig. 5, 
s3). Note that p-MAPK levels were very low in the caudal fin-folds of uncut control 
zebrafish embryos (Fig. s3). These immunohistochemistry experiments indicate that 

































Fig. 5. Reduced p-mAPK in regenerating caudal fin-folds of shp2 deficient embryos. At 2dpf the 
caudal fin-folds of embryos from a ptpn11a+/-ptpn11b-/- in-cross were amputated and allowed to 
regenerate. Embryos were fixed at 2dpa (i.e. 4dpf, 2dpa) and subjected to whole-mount immuno-
histochemistry using a p-MAPK-specific antibody (Thr202/Tyr204) (green). The embryos were 
counterstained with DAPI (blue). Maximum intensity projection images were taken of the caudal 
fin-folds and all embryos were genotyped. (A) Representative images of amputated embryo caudal 
fin-folds are shown and in the left panels the edge of the fin-fold is indicated with a dashed line. 
The number of embryos showing similar patterns/ total number of embryos analysed is indicated 
in the bottom right corner of the right panels. The scale bar represents 100µm. (b) p-MAPK was 
quantified by mean intensity of the region between the notochord and the edge of the caudal fin-
fold. Equivalent uncut controls were also quantified (representative pictures depicted in Fig. s3). 
Means within amputated groups are compared to ptpn11a+/+ptpn11b-/- embryos using a Mann-
Whitney U-test. Significance: ** p<0.01; error bars represent standard deviation.
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impaired caudal fin-fold regeneration and reduced cell proliferation by 
inhibition of mAPK signalling
To test if reduced MAPK signalling by itself is sufficient to inhibit zebrafish em-
bryo caudal fin-fold regeneration, the caudal fin-folds of wild-type zebrafish embryos 
(ptpn11a+/+ptpn11b+/+) were amputated at 2dpf and allowed to regenerate for 3 days 
in the presence of 50nM MEK1 inhibitor PD184352 (also known as CI-1040) or solvent 
(1% DMSO) as a control. Treatment of zebrafish embryos with PD184352 significantly 
impaired caudal fin-fold regeneration (Fig. 6A). Uncut controls showed that PD184352 
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Fig. 6. impaired regeneration and arrested cell proliferation by mAPK inhibition during caudal 
fin-fold regeneration. At 2dpf the caudal fin-folds of wild-type embryos were amputated and allo-
wed to regenerate in the presence of 50nM PD184352 or 1% DMSO (solvent control). (A) Regene-
ration was quantified by measuring the distance from the tip of the notochord to the edge of the 
caudal fin-fold. The means of caudal fin-fold growth are depicted relative to caudal fin-fold growth 
of DMSO treated uncut controls. Mean of PD184352 treated amputated embryos is compared 
to DMSO treated amputated embryos using a Mann-Whitney U-test. The number of embryos is 
indicated (n). Significance: *** p<0.001; n.s. not significant; error bars indicate standard error of 
the mean. (b) Embryos were fixed at 2dpa (i.e. 4dpf, 2dpa) and subjected to whole-mount im-
munohistochemistry using an antibody specific for the cell proliferation marker PCNA (red). The 
embryos were counterstained with DAPI (blue). Maximum intensity projection images were taken 
of the caudal fin-folds. Representative images of amputated embryo caudal fin-folds are shown, 
and in the left panels the edge of the fin-fold is indicated with a dashed line. The number of em-
bryos showing similar patterns/ total number of embryos analysed is indicated in the bottom right 
corner of the right panels. The scale bar represents 100µm. Representative pictures of equivalent 
uncut controls are depicted in Fig. s4.
We next investigated if the impaired regeneration of wild-type zebrafish embryos tre-
ated with PD184352 was associated with arrested cell proliferation by whole-mount 
immunohistochemistry for PCNA expression. At both 3dpf and 4dpf PCNA immunof-
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luorescence was dispersed in zebrafish embryos treated with PD184352 compared to 
control zebrafish embryos treated with DMSO (Fig. 6b, s4). Baseline PCNA staining in 
the caudal fin-folds of uncut control zebrafish embryos at 3dpf and 4dpf was low, but 
also appeared to be reduced following PD184352 treatment (Fig. s4). These results 
demonstrate that MAPK signalling is required for normal caudal fin-fold regeneration 
and promotes proliferation during regenerative outgrowth.
disCussioN
Our results demonstrate a critical role for Shp2 in zebrafish embryo caudal fin-fold 
regeneration. Zebrafish embryos lacking functional Shp2 (ptpn11a-/-ptpn11b-/-) show 
severely impaired regeneration of their caudal fin-folds following amputation (Fig. 1). 
Expression of wild-type Shp2a (WT) rescues regeneration, which relies on its catalytic 
activity and SH2 domains (Fig. 2). Whilst blastema formation was normal in Shp2 
deficient zebrafish embryos (Fig. 3), proliferation was arrested during the regenerative 
outgrowth phase (Fig. 4). We propose that the reduced p-MAPK levels in ptpn11a-/-pt-
pn11b-/- zebrafish embryos (Fig. 5) cause impaired caudal fin-fold regeneration, which 
is consistent with our observation that regeneration is inhibited by MEK1 inhibition 
(Fig. 6).
As the catalytic activity of SHP2 is often paramount to regulating MAPK or PI3K 
signalling (14, 15), we first asked whether catalytic activity is required for zebrafish 
embryo caudal fin-fold regeneration. Caudal fin-fold regeneration was rescued by ex-
pressing wild-type Shp2a (WT), but not the catalytically inactive Shp2a R466M mutant 
(Fig. 2A-b), indicating that Shp2a catalytic activity is required for zebrafish embryo 
caudal fin-fold regeneration. As the Shp2a R466M mutant still retains functional SH2 
domains, we exclude the possibility that the SH2 domains alone are sufficient for 
caudal fin-fold regeneration. In addition, caudal fin-fold regeneration was rescued by 
expressing the C-terminal domain mutant (YF), but not the SH2 domain mutant (SH), 
indicating that the SH2 domains are required for the function of Shp2a in zebrafish 
embryo caudal fin-fold regeneration, but that the two tyrosine phosphorylation sites, 
Y542 and Y580, in the C-terminus are not (Fig. 2A-b). Mutating R32 or R138 impairs the 
association of SHP2 with phosphorylated growth factor receptors and substrates (56), 
and has been shown to inhibit EGF stimulation of MAPK activation in cells (55). Thus, 
the inability of Shp2a-R32M-R138M to rescue caudal fin-fold regeneration suggests 
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that Shp2a requires recruitment or binding to a substrate for its function in caudal 
fin-fold regeneration. In comparison, mutating Y542 or Y580 prevents binding of SHP2 
to GRB2, and reduces, but importantly does not abolish, the activation of MAPK in 
response to stimulation by some growth factors in tissue culture cells, suggesting that 
the SHP2-GRB2 interaction is dispensable in some contexts (14, 18, 58). We conclude 
that expression of Shp2a-Y542F-Y580F (YF) in ptpn11a-/-ptpn11b-/- zebrafish embryos 
apparently mediated sufficient MAPK activation to rescue caudal fin-fold regeneration.
Following amputation, regeneration proceeds through wound healing, blastema 
formation, and then regenerative outgrowth to replace the lost tissue (1, 2). Junbb 
expression is maintained well into the initial stage of regenerative outgrowth (62), 
indicating that junbb is a definitive blastema marker. We show that the amputated 
caudal fin-folds of ptpn11a-/-ptpn11b-/- zebrafish embryos express junbb, like their 
siblings (Fig. 3), indicating that both wound healing and blastema formation occur 
normally in the absence of Shp2. This appears to be in contrast with previous results 
showing that Fgfr1 signalling is required for blastema formation (43, 66). Whereas 
there are overlaps in FGFR1 and SHP2 signalling (45), apparently, Fgfr1 and Shp2a 
signalling in zebrafish differ to such an extent that blastema formation is dependent 
on Fgfr1, but not on Shp2. In addition to promoting MAPK signalling, SHP2 has been 
shown to promote or inhibit phosphoinositide 3-kinase (PI3K) signalling (10, 67). Inte-
restingly, the symptoms that present in vivo as a result of loss of ptpn11 or activating 
mutations of SHP2 (11) appear to be primarily due to the effect on MAPK signalling. 
For example, mice expressing the activating SHP2 mutant Q79R display MAPK hyper-
phosphorylation and congenital heart defects, whilst both these phenotypes are 
ameliorated in Q79R x Erk1-/- mice (68). In comparison, genetic ablation of PTPN11 in 
retinal cells results in reduced MAPK phosphorylation but does not affect AKT phosp-
horylation (64). The defects that result are also not rescued by mutating the antagonist 
of PI3K signalling, phosphatase and tensin homolog (PTEN), which normally increases 
PI3K signalling (23). However, hyper-active KRas, which has been shown to alleviate 
the requirement for SHP2 in the maintenance of hematopoietic stem cells (29), does 
rescue the retinal defects. As PI3K signalling has previously been shown to be required 
for blastema formation (38), and blastema formation was normal in zebrafish embryos 
lacking functional Shp2, we conclude that it is unlikely that Shp2 acts through PI3K 
signalling. 
Regenerative outgrowth is characterized by proliferation and differentiation of cells 
to replace the lost tissue. Our results from whole-mount immunohistochemistry using 
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an antibody specific for PCNA, suggest that cell proliferation is arrested in the regene-
rating caudal fin-folds of ptpn11a-/-ptpn11b-/- zebrafish embryos, compared to siblings 
(Fig. 4, s2). In addition, p-MAPK staining in ptpn11a-/-ptpn11b-/- zebrafish embryos is 
reduced compared to siblings (Fig. 5, s3), suggesting the arrested proliferation is due 
to reduced MAPK signalling. Moreover, inhibiting MAPK signalling using an inhibitor 
of MEK1, upstream of MAPK, was sufficient to inhibit regeneration and arrest cell 
proliferation during caudal fin-fold regeneration (Fig. 6, s4). Our results are consistent 
with previous work demonstrating a requirement for Fgfr1 signalling in proliferation 
during zebrafish caudal fin regeneration (42, 44, 66), and reduced proliferation and 
regeneration in response to MEK1 inhibition during zebrafish heart regeneration (48). 
Recent work shows that loss of SHP2 in mice, resulting in reduced MAPK signalling and 
reduced proliferation, leads to impaired muscle regeneration, and this was attributed 
to satellite cell quiescence (69). Possibly, the loss of Shp2 in zebrafish embryo caudal 
fin-folds induces quiescence in dedifferentiated cells of the blastema. This would 
certainly be in concordance with our results showing that regenerative outgrowth 
was impaired, despite normal blastema formation. Collectively, our results suggest 
an essential role for Shp2a-MAPK signalling in promoting cell proliferation during the 
regenerative outgrowth phase of regenerating zebrafish embryo caudal fin-folds.
In conclusion, we demonstrate for the first time that Shp2 is required for embryonic 
zebrafish embryo caudal fin-fold regeneration. Loss of Shp2 inhibits zebrafish embryo 
caudal fin-fold regeneration associated with reduced proliferation and reduced MAPK 
phosphorylation. Rescue of regeneration by re-expression of Shp2a is dependent on 
the catalytic activity and the SH2 domains of Shp2a. Consistent with Shp2a promoting 
MAPK signalling, zebrafish embryo caudal fin-fold regeneration is inhibited by MEK1 
inhibition, and is associated with reduced proliferation. Hence, our results suggest 
Shp2 is indispensable during zebrafish embryo caudal fin-fold regeneration, and is 
required to coordinate proper proliferation mediated by MAPK signalling during the 
regenerative outgrowth of the zebrafish embryo caudal fin-fold.
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Fig. s1. similar expression levels of ptpn11a mutants. Human embryonic kidney 293 T cells were 
transfected with CMV-promoter driven expression vector for zebrafish Shp2 mutants: Shp2a wild-
type (WT); Shp2a Y542F, Y580F (YF); Shp2a R32M, R138M (SH); or Shp2a R466M (RM). Cells were 
lysed and the lysates run on an SDS-PAGE gel. Blots were probed using a SHP2-specific antibody 
and developed using enhanced chemiluminescence. Blots were stripped and re-probed for Tubu-
lin as a loading control. All samples were loaded on the same blot, samples between SH and RM 








































Fig. s2. Normal proliferation in uncut caudal fin-folds of shp2 deficient embryos. Uncut embryos 
from a ptpn11a+/-ptpn11b-/- in-cross were fixed at 4dpf (4dpf, uncut) in parallel to the embryos 
depicted in Fig. 4 (A). At 2dpf the caudal fin-fold of embryos from a ptpn11a+/-ptpn11b-/- in-cross 
was amputated and allowed to regenerate. Embryos were fixed at 1dpa (i.e. 3dpf, 1dpa) (b), or 
equivalent for uncut controls (3dpf, uncut) (C). Embryos were subjected to whole-mount immuno-
histochemistry using an antibody specific for the cell proliferation marker PCNA (red). The em-
bryos were counterstained with DAPI (blue). Maximum intensity projection images were taken 
of the caudal fin-folds and all embryos were genotyped. Representative images of embryo caudal 
fin-folds are shown, and in the left panels the edge of the fin-fold is indicated with a dashed line. 
The number of embryos showing similar patterns/ total number of embryos analysed is indicated 





























































































Fig. s3. Reduced p-mAPK in the caudal fin-folds of shp2 deficient embryos. Uncut embryos from 
a ptpn11a+/-ptpn11b-/- in-cross were fixed at 4dpf (4dpf, uncut) in parallel to the embryos depicted 
in Fig. 5A (A, b). At 2dpf the caudal fin-fold of embryos from a ptpn11a+/-ptpn11b-/- in-cross was 
amputated and allowed to regenerate. Embryos were fixed at 1dpa (i.e. 3dpf, 1dpa) (C, d), or equi-
valent for uncut controls (3dpf, uncut) (e, F). Embryos were subjected to whole-mount immuno-
histochemistry using a p-MAPK-specific antibody (Thr202/Tyr204) (green). The embryos were 
counterstained with DAPI (blue). Maximum intensity projection images were taken of the caudal 
fin-folds and all embryos were genotyped. Representative images of embryo caudal fin-folds are 
shown, and in the left panels the edge of the fin-fold is indicated with a dashed line. The number 
of embryos showing similar patterns/ total number of embryos analysed is indicated in the bottom 
right corner of the right panels. The scale bar represents 100µm. p-MAPK immunofluorescence 
was quantified by mean intensity of the region between the notochord and the edge of the caudal 
fin-fold. Means within amputated or uncut groups are compared to ptpn11a+/+ptpn11b-/- embryos 
using a Mann-Whitney U-test. The number of embryos analysed is indicated (n). Significance: ** 
p<0.01; * p<0.05; error bars represent standard deviation (d). Quantification of p-MAPK immunof-



























Fig. s4. Arrested proliferation in the caudal fin-folds of wild-type embryos following mAPK inhi-
bition. Uncut wild-type embryos treated with 50nM PD184352 (CI-1040) were fixed at 4dpf (4dpf, 
uncut) in parallel to the embryos depicted in Fig. 6A (A). At 2dpf the caudal fin-fold of wild-type 
embryos was amputated and allowed to regenerate whilst incubated with 50nM PD184352 (CI-
1040). Embryos were fixed at 1dpa (i.e. 3dpf, 1dpa) (b), or equivalent for uncut controls (3dpf, 
uncut) (C). Embryos were subjected to whole-mount immunohistochemistry using an antibody 
specific for the cell proliferation marker PCNA (red). The embryos were counterstained with DAPI 
(blue). Maximum intensity projection images were taken of the caudal fin-folds. Representative 
images of embryo caudal fin-folds are shown, and in the left panels the edge of the fin-fold is 
indicated with a dashed line. The number of embryos showing similar patterns/ total number of 
embryos analysed is indicated in the bottom right corner of the right panels. The scale bar repre-
sents 100µm. PCNA immunofluorescence at 4dpf, 2dpa is depicted in Fig. 6b.
table s1. Primers used for amplifying junbb from zebrafish embryo cdNA, and ptpn11a from 
genomic zebrafish dNA.
Table S1. Primers used for amplifying junbb from zebrafish embryo cDNA, and ptpn11a from genomic 
zebrafish DNA. 
Primer Sequence 
junbb FWD 1 TGGGTTACGGTCACAACGAC 
junbb REV 1 CAGTGTCCGTTCTCTTCCGT 
BamHI-junbb FWD (nested) ATAGGATCCTACACGACGCTGAACGCATA 
junbb-EcoRI REV (nested) CTCGAATTCGTGTCCGTTCTCTTCCGTCC 
junbb FWD 2 TACACGACGCTGAACGCATA 
junbb-T7 REV 2 TAATACGACTCACTATAGGTGTCCGTTCTCTTCCGTCC 
Ptpn11a WT FWD GAAGGTGACCAAGTTCATGCTACATGGAGCATCATGGAC 
Ptpn11a KO FWD GAAGGTCGGAGTCAACGGATTACATGGAGCATCATGGAT 
Ptpn11a REV AGCTCAATGACGTCTCCGTTTTTCTCTTT 
Ptpn11a FWD 1 GCGCTGTCACACACATTAAGA 
Ptpn11a REV 2 TCACAGCCAATAAAGAGAAGC 
Ptpn11a FWD (nested) 3 CGACCTGTATGGTGGAGAGAA 
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The production of reactive oxygen species (ROS) directly following amputation of the 
zebrafish embryo caudal fin-fold is essential for proper caudal fin-fold regeneration. 
Protein-tyrosine phosphatases (PTPs) are enzymes that dephosphorylate phospho-
tyrosine through a mechanism involving a catalytic cysteine, and are susceptible to 
reversible inactivation by ROS. Although Src homology 2 domain containing phospha-
tase Shp2a is oxidized following zebrafish caudal fin amputation, the catalytic activity 
of Shp2a is required for caudal fin-fold regeneration. Here, we show that mutation of 
the back-door cysteines C334 and C368 of Shp2a, which are proposed to protect the 
catalytic cysteine from irreversible oxidation, reduced the catalytic activity of Shp2a 
and enhanced the susceptibility of Shp2a to oxidation. Surprisingly, expression of 
these back-door cysteine mutants in ptpn11a-/-ptpn11b-/- zebrafish embryos, which 
lack functional Shp2, rescued caudal fin-fold regeneration. As the back-door cysteine 
mutants of Shp2a demonstrated reduced catalytic activity, we investigated the level 
of Shp2a catalytic activity required for its function in zebrafish embryo caudal fin-fold 
regeneration by using two mutants of Shp2a, Shp2a-D61G and Shp2a-A462T, which 
have increased and reduced catalytic activity respectively. Interestingly, expression of 
Shp2a-D61G or Shp2a-A462T in ptpn11a-/-ptpn11b-/- zebrafish embryos rescued caudal 
fin-fold regeneration to a similar extent. Collectively, our results suggest that the level 
of Shp2a catalytic activity does not affect the function of Shp2a in the regenerative 




Protein tyrosine phosphorylation is at the core of many essential signalling cascades, 
and the balance between the activity of protein tyrosine kinases and protein tyrosine 
phosphatases (PTPs) allows for an appropriate cellular response to stimuli (Hunter 
2009). In humans, the PTP superfamily consists of 116 cysteine-based enzymes di-
vided into three subgroups based on their structure and function: the classical PTPs, 
dual-specificity PTPs, and the low molecular weight PTPs (Alonso and Pulido 2016; 
Tonks 2013). Catalysis by all cysteine-based PTPs is mediated by a conserved cysteine 
in the PTP domain. The catalytic cysteine residues of PTPs are in the thiolate anion 
form due to a low pKa, which results from their microenvironment. Reactive oxygen 
species (ROS), such as H2O2, readily reversibly oxidize cysteine residues that are in the 
thiolate anion form, temporarily inactivating the catalytic activity of the PTP (Ostman 
et al. 2011). Mild oxidation results in conversion of the sulphur atom of the catalytic 
cysteine from its reduced thiolate anion form (S-) to sulphenic acid (SOH), a labile state 
that rapidly rearranges to form an intra- or inter-molecular disulphide bond with a 
nearby cysteine or a sulphenylamide with an adjacent nitrogen (Salmeen et al. 2003). 
In the case of an intramolecular disulphide bond, the nearby cysteine is referred to as 
a “back-door cysteine” (Cumming et al. 2004; Sone et al. 1997). Rather unusually, the 
Src homology 2 (SH2) domain containing phosphatases SHP1 and SHP2 appear to have 
two back-door cysteines. Under oxidizing conditions, the catalytic cysteine is oxidized 
and forms a disulphide bond with one of the two back-door cysteines. However, the 
disulphide bond between the catalytic cysteine and one of the back-door cysteines is 
rapidly re-reduced, and the two backdoor cysteines form an intramolecular disulphide 
bond with each other to stabilize the protein under oxidizing conditions (Chen, Willard, 
and Rudolph 2009). The disulphide and sulphenylamide bonds are otherwise readily 
reduced to the catalytically active form of the PTP by endogenous glutathione and 
thioredoxin systems (Dagnell et al. 2013; Lee et al. 2002; Ostman et al. 2011). Howe-
ver, in extreme oxidizing conditions the PTPs can be hyperoxidized to form irreversible 
sulphinic acid (SO2H) or sulphonic acid (SO3H) states, permanently inactivating the PTP 
(Lo Conte and Carroll 2013a, 2013b). 
The classical cytoplasmic PTP SHP2, encoded by the PTPN11 gene, has two SH2 
domains, a PTP domain, and a C-terminal domain (Hof et al. 1998), and is readily 
oxidized by ROS (Karisch et al. 2011; Meng, Fukada, and Tonks 2002). The catalytic 
cysteine, C459, in the PTP domain is essential for catalytic activity, and mutation to 
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a serine results in an inactive substrate-trapping mutant of SHP2 (Hartman, Schaller, 
and Agazie 2013; Kolli et al. 2004; Zhang et al. 2004). In addition, the neighbouring 
arginine, R465, is required for substrate binding and stabilizing the phospho-cysteine 
intermediate during the catalytic process (Zhang, Wang, and Dixon 1994). The crystal 
structure of SHP2 shows that SHP2 is in a closed conformation with the N-terminal 
SH2 domain folding back onto itself and interacting with residues close to the catalytic 
pocket. In this closed conformation, access of substrates to the catalytic site is blocked, 
impairing catalytic activity (Hof et al. 1998). Activation of SHP2 is facilitated by dis-
sociation of the SH2 domains from the PTP domain, for instance by binding of the SH2 
domains to phospho-tyrosine containing proteins, engendering an open conformation 
of SHP2, which is able to dephosphorylate its target substrates (Neel, Gu, and Pao 
2003). Mutation of some key residues, such as D61 in the N-terminal SH2 domain, also 
results in an open conformation of SHP2 and increased catalytic activity (Darian et al. 
2011). In comparison, mutations of residues close to the catalytic cysteine C459, such 
as R465 or A461 in the PTP domain, result in reduced catalytic activity (Keilhack et al. 
2005; Stewart et al. 2010; Yu et al. 2013).
SHP2 is activated in response to growth factor stimulation, and mediates trans-
duction of mitogen activated kinase (MAPK) and phosphatidylinositide-3-kinase (PI3K) 
signalling (Wu et al. 2001; Zhang, Liu, and Tu LIU 2002). SHP2 regulates a variety of 
cellular processes, including adipogenesis (He et al. 2013; Tao et al. 2016), haema-
topoiesis (Chan et al. 2011; Qu et al. 1997), and embryonic development (Bonetti, 
Rodriguez-Martinez, et al. 2014; Yang et al. 2006), and is mutated in a variety of human 
diseases (Hendriks et al. 2013). Notably, the activating D61G mutation is commonly 
found in patients with Noonan Syndrome (NS), whilst the inactivating A461T mutation 
is commonly found in patients with Noonan Syndrome with Multiple Lentigines (NSML, 
formerly LEOPARD syndrome). Both mutations result in aberrant MAPK signalling, 
leading to developmental defects (Araki et al. 2004; Jopling, van Geemen, and den 
Hertog 2007; Lauriol, Jaffre, and Kontaridis 2015). 
ROS are able to coordinate signal transduction in multiple signalling pathways and 
thereby modulate cellular responses (Finkel 2011; Ray, Huang, and Tsuji 2012; Than-
nickal and Fanburg 2000). Moreover, ROS regulation of the activity of PTPs is evident 
in a variety of contexts: VE-PTP and PTP-PEST in endothelial cell migration (Frijhoff et 
al. 2014); PTP1B and TC-PTP in type 2 diabetes mellitus (Gurzov et al. 2014; Meng et 
al. 2004); and oxidation of various PTPs in cancer (Karisch et al. 2011; Liou and Storz 
2010). SHP2 is oxidized following platelet derived growth factor (PDGF) stimulation, 
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promoting PDGF receptor signalling (Meng et al. 2002). In addition, SHP2 is associated 
with the linker of activated T-cells (LAT) at the plasma membrane through its SH2 do-
mains, where it dephosphorylates associated proteins, adhesion and degranulation-
promoting adapter protein (ADAP) and Vav1, to prevent T-cell adhesion. Activation of 
the T-cell receptor stimulates ROS production, inactivating SHP2 and enabling T-cell 
adhesion (Kwon et al. 2005). Therefore, SHP2 oxidation, which inactivates SHP2, ap-
pears to be induced by extracellular stimuli to promote cellular signalling and cellular 
responses. 
Immediately following zebrafish embryo caudal fin-fold amputation, a burst of 
H2O2 emanates from the wound margin and extends into the tissue (Niethammer et 
al. 2009). The zebrafish genome contains two ptpn11 genes, ptpn11a and ptpn11b, 
encoding Shp2a and Shp2b, respectively. Although both Shp2a and Shp2b are highly 
homologous to human SHP2 and harbour catalytic activity, they differ in their expres-
sion during early embryonic development, resulting in Shp2b being dispensable. 
Furthermore, the key residues discussed above are conserved in Shp2a (Fig. 1A). 
Whilst ptpn11a+/+ptpn11b-/- and ptpn11a+/-ptpn11b-/- zebrafish are viable and fertile, 
ptpn11a-/-ptpn11b-/- double knock-out zebrafish are embryonically lethal from 5-7 
days post fertilization (dpf) onwards (Bonetti, Rodriguez-Martinez, et al. 2014). The 
oxidation of Shp2a following caudal fin amputation (demonstrated in Chapter 5), and 
the requirement for a catalytically active signalling function of Shp2a during caudal 
fin-fold regeneration (demonstrated in Chapter 6) presents an apparent conundrum. 
Presumably, oxidation of Shp2a is transient and, following a lag-time, Shp2a becomes 
active again and exerts its essential function. 
To investigate the role of Shp2a oxidation during zebrafish embryo caudal fin-fold 
regeneration further, we mutated the back-door cysteines of zebrafish Shp2a, C334 
and C368, to a serine. We show that the catalytic activity of the back-door cysteine 
mutants of Shp2a, Shp2a-C334S, Shp2a C368S, and the double mutant Shp2a-C334S-
C368S (2CS), in vitro was greatly reduced. Furthermore, immunoprecipitation of 
Shp2a following H2O2 treatment of cultured cells revealed increased reversible and 
irreversible oxidation of the back-door cysteine mutants of Shp2a, suggesting these 
mutants of Shp2a have enhanced susceptibility to oxidation. Surprisingly, expressing 
the back-door cysteine mutants of Shp2a in ptpn11a-/-ptpn11b-/- zebrafish embryos, 
which normally do not regenerate their caudal fin-folds, rescued caudal fin-fold re-
generation. To investigate to what extent catalytic activity of Shp2a was required for 
its function in caudal fin-fold regeneration, we used catalytic mutants of Shp2a with 
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increased (D61G) or reduced (A462T) catalytic activity. Expression of Shp2a-D61G or 
Shp2a-A462T rescued caudal fin-fold regeneration in ptpn11a-/-ptpn11b-/- zebrafish 
embryos with similar efficiency, whereas catalytically inactive Shp2a-R466M did not. 
Collectively, our results suggest that the level of Shp2a catalytic activity does not affect 
its function in the regenerative outgrowth of the zebrafish embryo caudal fin-fold.
Results
back-door cysteine mutants of shp2a have reduced catalytic activity
Mutation of the back-door cysteines in SHP1, which is highly similar to SHP2 (Pao et al. 
2007), leads to irreversible oxidation of the catalytic cysteine, and mutation of C334 and 
C368 in Shp2a will likely have the same effect (Chen et al. 2009). We therefore created 
cysteine to serine mutations in either, or both, of the back-door cysteines of full-length 
zebrafish Shp2a, C334 and C368. N-terminal glutathione-S-transferase (GST) tagged 
constructs, encoding GST-Shp2a-C334S, GST-Shp2a-C368S, or GST-Shp2a-C334S-C368S 
(2CS), were expressed in E. coli bacteria and purified. We tested the catalytic activity of 
these zebrafish Shp2a mutant proteins in in vitro phosphatase assays, under reducing 
conditions, using para-nitrophenylphosphate (pNPP) as a chromogenic substrate. The 
absorbance measurements in in vitro phosphatase assays indicated that mutating the 
back-door cysteines of Shp2a reduced catalytic activity (Fig. 1b). Mutation of C334 
or C368 reduced catalytic activity to ~50% or ~30% of wild-type GST-Shp2a (WT), 
respectively. The catalytic activity of the double back-door cysteine mutant of Shp2a, 
GST-Shp2a-2CS, was reduced to only ~20% of wild-type GST-Shp2a. 
Considering the reduced activity of the back-door cysteine mutants of Shp2a, we 
decided to include several mutants in our study: in SHP2, the D61G mutation in the 
N-terminal SH2 domain results in enhanced catalytic activity, whereas the A461T 
mutation in the PTP domain results in reduced catalytic activity (Keilhack et al. 2005). 
We mutated the conserved residues in zebrafish Shp2a, D61 and A462, and tested the 
catalytic activity of the mutant Shp2a proteins in in vitro phosphatase assays under 
reducing conditions. As expected, the D61G mutation enhanced catalytic activity 
approximately 4-fold, whereas the A462T mutation reduced catalytic activity approxi-
mately 5-fold, compared to wild-type GST-Shp2a (Fig. 1C). 
As a negative control, we included a mutant where the conserved arginine (R466 
in zebrafish Shp2a) is mutated, which abolishes catalytic activity (Stewart et al. 2010). 
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To confirm that the R466M mutant of Shp2a has no catalytic activity, we introduced 
the R466M mutation in GST-Shp2a-D61G. Indeed, compared to GST-Shp2a-D61G, GST-
Shp2a-D61G-R466M (RM) showed no detectable catalytic activity (Fig. 1d).
To exclude the possibility that the differences in catalytic activity between the dif-
ferent Shp2a mutants measured in in vitro phosphatase assays were due to differences 
in concentration of the purified proteins, we resolved the purified proteins on a SDS-
PAGE gel. All GST-Shp2a proteins were purified and diluted to similar concentrations 
(Fig. 1e), indicating that the differences in catalytic activity were specifically due to the 
mutations that were introduced. Collectively, these results indicate that the catalytic 
activity of zebrafish Shp2a is disrupted by mutation of the back-door cysteines C334 
and C368. Furthermore, as expected, mutation of D61G and A462T results in incre-
ased and reduced catalytic activity respectively, whereas mutation of R466 abolishes 
catalytic activity.
back-door cysteine mutants of shp2 are more sensitive to oxidation
Reversibly oxidized PTPs can be detected by lysing cells in the presence of iodoacetic 
acid (IAA), which alkylates all reduced cysteines, followed by reduction of the rever-
sibly oxidized catalytic cysteines using dithiothreitol (DTT), and hyperoxidation using 
pervanadate (effectively shifting SOH to SO3H). As the reduced catalytic cysteines are 
blocked by IAA, only the catalytic cysteines that were oxidized at the time of lysis 
(i.e. by H2O2 treatment) will be detected using an antibody specific for the sulphonic 
acid (SO3H) state of PTPs (ox-PTP) (Persson et al. 2004, 2005). To address whether the 
back-door cysteine mutants of Shp2a experience enhanced sensitivity of the catalytic 
cysteine to oxidation, we transfected human embryonic kidney 293 T (HEK293T) cells 
with mammalian expression vectors encoding full-length Shp2a containing one or 
both back-door cysteine mutations. HEK293T cells expressing wild-type Shp2a, Shp2a-
C334S, Shp2a-C368S, or Shp2a-C334S-C368S (2CS) were treated with 1mM H2O2 for 
15 minutes and lysed in a buffer containing IAA. Shp2a was immunoprecipitated from 
the alkylated lysate, and the immunoprecipitates were treated with DTT, followed by 
pervanadate, to hyperoxidize all non-alkylated proteins for detection. Immunoblotting 
using the ox-PTP specific antibody revealed that H2O2 treatment increased oxidation 
in all immunoprecipitates (Fig. 2A). The difference in signal between H2O2 treated 
cells and untreated cells transfected with the back-door cysteine mutants of Shp2a 
appeared far greater than for cells transfected with wild-type Shp2a, suggesting that 










































































































Fig. 1. back-door cysteine mutants of zebrafish shp2a have reduced catalytic activity. (A) a sche-
matic representation of the Shp2a protein, indicating the SH2 domains (yellow), the catalytic PTP 
domain (blue), and the C-terminal domain (magenta). Mutation of key residues in the PTP domain 
results in abrogated catalytic activity. Mutation of the catalytic cysteine (C460), or the arginine 
assisting in the catalytic process (R466), completely abolishes catalytic activity. Mutation of D61 
in the SH2 domain, associated with Noonan syndrome (NS), results in enhanced catalytic activity, 
whereas mutation of A462 in the PTP domain, associated with Noonan Syndrome with multiple 
lentigines (NSML), results in reduced catalytic activity. C460, R466 and A462 are located in the 
catalytic pocket of Shp2a in the PTP domain, whilst the back-door cysteines C334 and C368 are 
presumed to be positioned outside the catalytic pocket in the PTP domain. (b-d) catalytic activity 
of purified N-terminal GST tagged zebrafish Shp2a mutant fusion proteins in vitro. GST-Shp2a pro-
teins were concentrated following purification, and subsequently diluted to similar levels for use 
in pNPP phosphatase assays. Catalytic PTP activity was measured by cleavage of the chromogenic 
substrate by the purified GST-Shp2a proteins under reducing conditions (in the presence of DTT), 
and was measured by change in absorbance at 405nm. Comparisons of catalytic activities of puri-
fied proteins within the same experiment are depicted. Percent catalytic PTP activity, representa-
tive of mean absorbance of pNPP of at least two technical repeats, is shown, normalized to that of 
wild-type GST-Shp2a (in b) or GST-Shp2a-D61G (in C and d). Error bars represent standard devia-
tion. (e) Purified N-terminal GST tagged zebrafish Shp2a mutant proteins resolved on an SDS-PAGE 
gel. BL-21 E. coli cells were transformed with constructs encoding GST-Shp2a mutant proteins. Pro-
teins were induced with IPTG, and isolated by lysozyme lysis, binding to GST-agarose beads, and 
elution with reduced glutathione. Proteins were purified by dialysis and resolved on an SDS-PAGE 
gel for identification by Coomassie staining. All GST-Shp2a proteins were purified and resolved for 
Coomassie staining on separate occasions.
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Stripping and re-probing the blot revealed the differences in ox-PTP signal were not 
due to differences in Shp2a levels in the immunoprecipitates (Fig. 2). In parallel, we 
included Shp2a immunoprecipitates that were only treated with DTT, to examine chan-
ges in irreversibly oxidized Shp2a. Immunoblotting with the ox-PTP specific antibody 
revealed an increase in ox-PTP signal of Shp2a-C334S, Shp2a-C367S, or Shp2a-2CS fol-
lowing H2O2 treatment, suggesting an increase in irreversibly oxidized Shp2a following 
H2O2 treatment (Fig. 2b). As expected, the H2O2–induced difference in ox-PTP signal 
in wild-type Shp2a was small, suggesting that the majority of wild-type Shp2a was 
reversibly oxidized. Taken together, the results in Fig. 2 suggest that the back-door 
cysteine mutants of Shp2a were more reversibly and irreversibly oxidized in response 
to H2O2 treatment than wild-type Shp2a.
H2O2: - + - + - + - +
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Fig. 2. enhanced oxidation of back-door cysteine mutants of zebrafish shp2a. HEK293T cells were 
transfected with plasmid vector encoding wild-type Shp2a (WT), Shp2a-C334S, Shp2a-C368S, or 
Shp2a-C334S-C368S (2CS). Transfected HEK293T cells were either treated with 1mM H2O2 (+) or 
an equal volume of H2O (-) for 15 minutes prior to cell lysis. Lysis was performed on ice in buffer 
containing 100mM IAA, and cell lysates were immunoprecipitated with an anti-SHP2 antibody. (A) 
Shp2a immunoprecipitates were treated with DTT followed by pervanadate to convert all rever-
sibly oxidized protein to irreversibly oxidized protein for detection (converting SOH to SO3H). (b) 
Shp2a immunoprecipitates were treated with DTT only, to reduce all reversibly oxidized proteins 
and remove them from detection. Immunoblotting was performed using anti-ox-PTP and anti-
SHP2 antibodies. All samples were loaded on the same blot, samples between WT and C334S were 
removed as they were not relevant. Blots are representative results of two repeats.
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back-door cysteine mutants of shp2a rescue caudal fin-fold 
regeneration in shp2 deficient zebrafish embryos
The enhanced oxidation of the back-door cysteine mutants of Shp2a in cells treated 
with H2O2 (Fig. 2) suggests that they are more susceptible to oxidation-mediated inac-
tivation. In Chapter 5 we proposed that after its initial oxidation induced by zebrafish 
caudal fin amputation, Shp2a would be reduced and its activity required for regenera-
tion of the caudal fin-fold. In Chapter 6, we demonstrate that wild-type Shp2a almost 
completely rescued caudal fin-fold regeneration in ptpn11a-/-ptpn11b-/- zebrafish 
embryos, lacking functional Shp2. We hence used the back-door cysteine mutants of 
Shp2a to test whether changes in susceptibility to oxidation affect the ability of Shp2a 
mutants to rescue regeneration in zebrafish embryos lacking functional Shp2.
One-cell stage zebrafish embryos from a ptpn11a+/-ptpn11b-/- in-cross were micro-
injected with synthetic mRNA encoding either Shp2a-C334S, Shp2a-C368S, or Shp2a-
C334S-C368S (2CS). The mRNAs encoding mutant Shp2a proteins also encode eGFP 
linked by a peptide-2a cleavage sequence, resulting in a single polypeptide that is 
cleaved prior to protein folding (Ryan, King, and Thomas 1991). At 2dpf, eGFP-positive 
zebrafish embryos were selected and their caudal fin-folds were amputated immedi-
ately posterior to the notochord. Representative pictures of amputated fin-folds at 3 
days post amputation (dpa, i.e. 5dpf, 3dpa) of ptpn11a-/-ptpn11b-/- zebrafish embryos 
expressing mutant Shp2a protein are depicted (Fig. 3A). Equivalent uncut zebrafish 
embryo caudal fin-folds (i.e. 5dpf, Uncut) are shown in Fig. 4A. Caudal fin-fold lengths 
were determined and are presented as percentage caudal fin-fold growth, normalized 
to non-injected uncut controls of ptpn11a+/+ptpn11b-/- zebrafish embryos (Fig. 3b). In 
contrast to their siblings, ptpn11a-/-ptpn11b-/- zebrafish embryos displayed severely 
impaired caudal fin-fold regeneration, which, surprisingly, was rescued by expression 
of Shp2a-C334S, Shp2a-C368S, or Shp2a-2CS (Fig. 3b). We observed subtle differences 
in rescues between the backdoor cysteine mutants, in that Shp2a-C368S rescued to 
the least extent, Shp2a-C334S had an intermediate effect and Shp2a-2CS rescued 
regeneration of ptpn11a-/-ptpn11b-/- zebrafish embryos almost completely to sibling 
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Fig. 3. impaired caudal fin-fold regeneration in shp2 deficient embryos is rescued by expres-
sion of shp2a-C334s, shp2a-C368s, or the double back-door cysteine mutant shp2a-2Cs, and by 
shp2a-d61g with enhanced catalytic activity or shp2a-A462t with reduced catalytic activity, but 
not by the catalytically inactive shp2a-R466m. (A) Embryos from a ptpn11a+/-ptpn11b-/- in-cross 
were micro-injected at the one-cell stage with synthetic mRNA encoding Shp2a-C334S, Shp2a-
C368S, Shp2a-C334S-C368S (2CS), Shp2a-D61G, Shp2a-A462T, Shp2a-R466M (RM), or were not 
injected (-). At 2dpf the caudal fin-fold was amputated and regeneration was assessed at 3dpa (i.e. 
5dpf, 3dpa). Equivalent uncut controls were included (i.e. 5dpf, uncut) and are shown in Fig. 4. All 
embryos were genotyped. Representative images of caudal fin-folds of non-injected embryos, and 
of embryos injected with Shp2a mutants are shown. (b) The means of caudal fin-fold growth follo-
wing amputation are depicted relative to caudal fin-fold growth of uncut ptpn11a+/+ptpn11b-/- con-
trols. Means of micro-injected amputated ptpn11a-/-ptpn11b-/- embryos were compared to non-
injected amputated ptpn11a-/-ptpn11b-/- embryos using a Mann-Whitney U-test. Significance: *** 
p<0.001; error bars indicate standard error of the mean. Data pooled from multiple experiments. 
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Fig. 4. Normal caudal fin-fold growth in shp2 deficient embryos expressing shp2a-C334s, shp2a-
C368s, the double back-door cysteine mutant shp2a-2Cs, shp2a-d61g with enhanced catalytic 
activity, shp2a-A462t with reduced catalytic activity, or the catalytically inactive shp2a-R466m. 
(A) Embryos from a ptpn11a+/-ptpn11b-/- in-cross were micro-injected at the one-cell stage with 
synthetic mRNA encoding Shp2a-C334S, Shp2a-C368S, Shp2a-C334S-C368S (2CS), Shp2a-D61G, 
Shp2a-A462T, Shp2a-R466M (RM), or were not injected (-). Caudal fin-fold length was assessed 
after 5 days (i.e. 5dpf, uncut). All embryos were genotyped. Representative images of caudal 
fin-folds of non-injected embryos, and of embryos injected with Shp2a mutants are shown. (b) 
The means of uncut caudal fin-fold growth is depicted relative to caudal fin-fold growth of uncut 
ptpn11a+/+ptpn11b-/- controls. Means of micro-injected ptpn11a-/-ptpn11b-/- embryos were compa-
red to non-injected ptpn11a-/-ptpn11b-/- embryos. Significance: *** p<0.001; n.s. not significant; 
error bars indicate standard error of the mean. Data pooled from multiple experiments. Non-
injected and Shp2a-R466M injected data re-used from Chapter 5 and Chapter 6, respectively, for 
comparison.
Expression of the back-door cysteine mutants in ptpn11a-/-ptpn11b-/- zebrafish 
embryos that were not amputated resulted in normal growth of the caudal fin-fold, 
with comparable lengths to non-injected zebrafish embryos and siblings (Fig. 4b). 
Furthermore, expression of Shp2a-C334S, Shp2a-C368S, or Shp2a-2CS in wild-type 
(ptpn11a+/+ptpn11b+/+) zebrafish embryos did not induce any development defects 
(Fig. 5). Due to low expression levels of all mutant Shp2a proteins in zebrafish em-
bryos, it was not possible to monitor protein expression in vivo. However, transfection 
of constructs encoding the back-door cysteine mutant Shp2a proteins in HEK293T cells 
revealed similar expression levels of all mutant Shp2 proteins (Fig. 6). This suggests 
that the differences in ability to rescue caudal fin-fold regeneration are not due to dif-
ferences in expression or protein stability, but rather to differences in Shp2a function. 
Collectively, these results suggest that the enhanced susceptibility to oxidation of the 
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back-door cysteine mutants of Shp2a does not impair their function in vivo during 




















Fig. 5. No observable phenotypes in zebrafish embryos expressing the back-door cysteine mu-
tant C334s, C368s, or C334s and C368s (2Cs) of shp2a. Wild-type (ptpn11a+/+ptpn11b+/+) embryos 
were micro-injected at the one-cell stage with synthetic mRNA encoding Shp2a C334S, Shp2a-
C368S, Shp2a-C334S, C368S (2CS). Representative pictures of embryos at 5dpf are shown. Injec-

















Fig. 6. similar expression levels of shp2a mutants. HEK293T cells were transfected with CMV-
promoter driven expression vectors for mutants of Shp2a; the back-door cysteine mutants C334S, 
C368S, or C334S and C368S (2CS); or the catalytic mutants D61G or A462T of Shp2a. Cell lysates 
were resolved on an SDS-PAGE gel, and immunoblotted with anti-SHP2 and anti-Tubulin antibo-
dies. Detection was achieved through enhanced chemiluminescence. All samples were transfected 
and processed in parallel.
shp2a mutants with increased or reduced catalytic activity rescue 
caudal fin-fold regeneration in shp2 deficient zebrafish embryos
The ability of the back-door cysteine mutants of Shp2a to rescue caudal fin-fold 
regeneration in ptpn11a-/-ptpn11b-/- zebrafish embryos is also surprising considering 
the reduced catalytic activity observed in vitro (Fig. 1b). We hence investigated to 
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what extent the level of catalytic activity of Shp2a influences zebrafish embryo caudal 
fin-fold regeneration using Shp2a-D61G and Shp2a-A462T. We included Shp2a-R466M 
as a negative control, which we have previously shown does not rescue caudal fin-fold 
regeneration in ptpn11a-/-ptpn11b-/- zebrafish embryos (Chapter 6).
One-cell stage zebrafish embryos from a ptpn11a+/-ptpn11b-/- in-cross were micro-
injected with synthetic mRNA encoding Shp2a-D61G, Shp2a-A462T, or Shp2a-R466M. 
At 2dpf, eGFP-positive zebrafish embryos were selected and their caudal fin-folds 
were amputated immediately posterior to the notochord. Representative pictures of 
amputated caudal fin-folds at 3dpa (i.e. 5dpf, 3dpa) of ptpn11a-/-ptpn11b-/- embryos 
expressing mutant Shp2a protein are depicted (Fig. 3A). Equivalent uncut zebrafish 
embryo caudal fin-folds (i.e. 5dpf, Uncut) are shown in Fig. 4A. Caudal fin-fold lengths 
were determined and are presented as percentage caudal fin-fold growth, normalized 
to non-injected uncut controls of ptpn11a+/+ptpn11b-/- zebrafish embryos (Fig. 3b). In 
contrast to their siblings, ptpn11a-/-ptpn11b-/- zebrafish embryos displayed severely 
impaired regeneration, which was rescued by expression of Shp2a-D61G or Shp2a-
A462T, but not the catalytically inactive Shp2a-R466M (Fig. 3b). Interestingly, the 
regenerated caudal-fin-folds of ptpn11a-/-ptpn11b-/- zebrafish embryos expressing 
Shp2a-D61G or Shp2a-A62T appeared to be similar in length, suggesting Shp2a-D61G 
and Shp2a-A462T rescued caudal fin-fold regeneration to a similar extent. 
Expression of Shp2a-D61G, Shp2a-A462T, or Shp2a-R466M in ptpn11a-/-ptpn11b-/- 
zebrafish embryos that were not amputated resulted in normal growth of the caudal 
fin-fold, with comparable lengths to non-injected zebrafish embryos and siblings (Fig. 
4b). Due to low expression levels of all mutant Shp2a proteins in zebrafish embryos, 
it was not possible to monitor protein expression in vivo. However, transfection of 
constructs encoding Shp2a-D61G or Shp2a-A462T proteins in HEK293T cells revealed 
similar expression levels of both Shp2a-D61G and Shp2a-A462T proteins (Fig. 5b). This 
suggests that the similarity in ability to rescue zebrafish embryo caudal fin-fold rege-
neration was not due to differences in expression or protein stability, and, rather, that 
the differences in catalytic activity of Shp2a-D61G and Shp2a-A462T does not affect 
their function in caudal fin-fold regeneration. Together, these results suggest that the 
level of catalytic activity harboured by Shp2a does not affect the extent of zebrafish 




In summary, we created back-door cysteine mutants of Shp2a and demonstrated that 
these proteins have reduced catalytic activity in vitro (Fig. 1b), and enhanced suscepti-
bility to oxidation in mammalian cells exposed to H2O2 (Fig. 2). Expression of the single 
(C334S or C368S) or the double (C334S-C368S, 2CS) back-door cysteine mutant of 
Shp2a rescued caudal fin-fold regeneration in ptpn11a-/-ptpn11b-/- zebrafish embryos 
(Fig. 3). As the back-door cysteine mutants of Shp2a demonstrated reduced catalytic 
activity in vitro, we subsequently used the D61G and A462T mutants of Shp2a, which 
demonstrated enhanced and reduced catalytic activity in vitro (Fig. 1C), respectively, 
to investigate to what extent the level of catalytic activity of Shp2a determines its 
function in zebrafish embryo caudal fin-fold regeneration. To our surprise, expression 
of Shp2a-D61G or Shp2a-A462T rescued caudal fin-fold regeneration in ptpn11a-/-
ptpn11b-/- zebrafish embryos to similar extents (Fig. 3).
Previous research demonstrated that mutation of the back-door cysteines in SHP1, 
which is highly similar to SHP2 (Pao et al. 2007), resulted in irreversible oxidation of 
the catalytic cysteine of SHP1 (Chen et al. 2009). We therefore mutated the back-door 
cysteines C334 and C368 in zebrafish Shp2a with the aim to investigate if this enhan-
ced the susceptibility to irreversible oxidation of Shp2a following zebrafish embryo 
caudal fin-fold amputation. We thus first characterized the catalytic activity of purified 
N-terminally GST-tagged Shp2a-C334S, Shp2a-C368S, and Shp2a-C334S-C368S (2CS) 
proteins in in vitro phosphatase assays under reducing conditions. Mutation of C334 
or C368 reduced catalytic activity of Shp2a, and mutating both back-door cysteines 
compounded the reduction in catalytic activity, compared to wild-type Shp2a (Fig. 
1b). Chen et al. had previously reported that mutation of C333 in SHP2 resulted in 
~90% reduction in catalytic activity compared to wild-type SHP2. Our results confirm 
that mutation of the back-door cysteine of Shp2a reduce catalytic activity, but that 
mutation of C334 results in an ~50% reduction in catalytic activity. The differences in 
our results could be due to our use of full-length Shp2a in in vitro phosphatase assays, 
rather than the isolated catalytic PTP domain of SHP2 tested by Chen et al. (Chen et 
al. 2009).
To account for the reduced activity in the back-door cysteine mutants of Shp2a in 
the caudal fin-fold regeneration assays that follow, we included two mutants of Shp2a 
in our study: Shp2a-D61G and Shp2a-A462T, which have increased and reduced cata-
lytic activity (Fig. 1C), respectively, as expected (Keilhack et al. 2005). In addition, we 
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included Shp2a-R466M as a negative control. By introducing the R466M mutation in 
Shp2a-D61G, we demonstrated that mutation of R466 completely abolishes catalytic 
activity (Fig. 1d), which is consistent with previous results (Stewart et al. 2010). 
The formation of an intramolecular disulphide bond between the two back-door 
cysteines of SHP2 in response to H2O2 presumably protects the catalytic cysteine from 
irreversible oxidation-mediated inhibition, in a similar manner to the back-door cys-
teines of SHP1 (Chen et al. 2009). We therefore investigated if the back-door cysteine 
mutants of Shp2a experienced enhanced oxidation in mammalian cells treated with 
H2O2. Treatment of HEK293T cells over-expressing zebrafish Shp2a-C334S, Shp2a-
C368S, or Shp2a-C334S-C368S (2CS) with H2O2 induced reversible oxidation of the 
back-door cysteine mutants of Shp2a, and this was enhanced compared to wild-type 
Shp2a (Fig. 2A). Assessment of irreversible oxidation of Shp2a following treatment of 
cells with H2O2 indicated that irreversible oxidation of the back-door cysteine mutants 
of Shp2a was mildly enhanced compared to wild-type Shp2a (Fig. 2b). These results 
suggest that the back-door cysteines in Shp2a indeed protect wild-type Shp2a against 
irreversible oxidation. To our knowledge, the back-door cysteine mutants of Shp2a 
represent novel mutants with enhanced overall susceptibility to oxidation-mediated 
inhibition. 
Previously, we demonstrated that a subset of PTPs were oxidized following the 
H2O2 burst produced by zebrafish caudal fin amputation, including Shp2a (Chapter 5). 
We further demonstrated zebrafish embryos deficient for Shp2 do not regenerate their 
caudal fin-folds, and that Shp2a requires its catalytic activity for its function in caudal 
fin-fold regeneration (Chapter 6). These two results present an interesting conundrum 
that Shp2a is oxidized following caudal fin amputation, and therefore inactivated, but 
its activity is required for caudal fin-fold regeneration. We used the back-door cysteine 
mutants of Shp2a to address this. To this end, we expressed Shp2a-C334S, Shp2a-
C368S, or Shp2a-2CS in ptpn11a-/-ptpn11b-/- zebrafish embryos, which normally do 
not regenerate, and stimulated ROS production by amputation of the caudal fin-fold 
at 2dpf. We expected that the back-door cysteine mutants of Shp2a would be irre-
versibly inactivated following the ROS produced by zebrafish embryo caudal fin-fold 
amputation, based on our previous results (Fig. 2), resulting in non-functional Shp2a 
and hence no rescue in caudal fin-fold regeneration. To our surprise, expression of 
the back-door cysteine mutants of Shp2a in ptpn11a-/-ptpn11b-/- zebrafish embryos 
rescued caudal fin-fold regeneration (Fig. 3). The back-door cysteine mutants of Shp2a 
may experience enhanced irreversible oxidation-mediated inhibition in response 
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to ROS (Fig. 2b). Yet, a considerable proportion of Shp2a-C334S, Shp2a-C368S, and 
Shp2a-2CS is reversibly oxidized (Fig. 2A), and apparently, this is sufficient to rescue 
caudal fin-fold regeneration in zebrafish embryos lacking functional Shp2.
Most intracellular proteins remain reduced due to intracellular reducing systems, 
including the glutathione and thioredoxin systems (Lillig, Berndt, and Holmgren 2008; 
Lu and Holmgren 2014). Hence, the ability of the back-door cysteine mutants of Shp2a 
to rescue caudal fin-fold regeneration in zebrafish embryos lacking functional Shp2 
suggests that the endogenous ROS produced following caudal fin-fold amputation 
is limited to reversible oxidation of PTPs in vivo. Manipulation of PTP oxidation is 
notoriously challenging. Resolving the crystal structure of the dual specificity PTP 
phosphatase and tensin homologue (PTEN) suggested that C71 was a back-door cys-
teine, and formed a disulphide bond with the catalytic cysteine C124 under oxidizing 
conditions (Cho et al. 2004; Lee et al. 2002; Leslie et al. 2003). Similar to our Shp2a 
back-door cysteine mutants, the C71S mutant of PTEN also displays reduced catalytic 
activity compared to wild-type PTEN. However, treatment of PTEN-C71S with sodium 
hydrosulfide (NaHS), which oxidizes wild-type PTEN even more rapidly than H2O2, still 
only induces reversible oxidation of the catalytic cysteine C124 (Greiner et al. 2013). 
In addition, treatment of human prostate cancer cells, over-expressing wild-type PTEN 
or the PTEN-C71S mutant, with H2O2, resulted in oxidation of wild-type PTEN, but not 
PTEN-C71S (Shen et al. 2015). Moreover, there was no increase in downstream AKT 
phosphorylation, suggesting the activity of PTEN-C71S remained unaffected, and, 
interestingly, that PTEN-C71S is oxidation resistant. Therefore, whilst C334 and C368 
may form an intramolecular disulphide bond in response to ROS (Chen et al. 2009), 
this may not have any effect on the susceptibility of the catalytic cysteine to oxidation-
mediated inhibition.
We also addressed the level of Shp2a catalytic activity required for its function 
during caudal fin-fold regeneration by expressing Shp2a-D61G and Shp2a-A462T in 
ptpn11a-/-ptpn11b-/- zebrafish embryos, which have increased and reduced catalytic 
activity compared to wild-type Shp2a respectively (Fig. 1C). Surprisingly, expression 
of Shp2a D61G or Shp2a-A462T rescued the caudal fin-fold regeneration of ptpn11a-
/-ptpn11b-/- zebrafish embryos to a similar extent (Fig. 3). These results suggest that 
neither the enhanced catalytic activity of Shp2a-D61G, or the reduced catalytic activity 
of Shp2a-A462T (Fig. 1C) disrupts the function of Shp2a during zebrafish embryo cau-
dal fin-fold regeneration. Furthermore, the rescue of caudal fin-fold regeneration in 
ptpn11a-/-ptpn11b-/- zebrafish embryos by expression of Shp2a-A462T, but not Shp2a-
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R466M, suggests that catalytic activity is required, but that low level Shp2a activity is 
sufficient for its function in caudal fin-fold regeneration.
A requirement for tight regulation of signal transduction has been demonstrated to 
be essential to zebrafish caudal fin regeneration for several signalling pathways (Grotek, 
Wehner, and Weidinger 2013; Nakatani et al. 2008; Shibata et al. 2016). Considering 
this, it is highly surprising that Shp2a-D61G, or Shp2a-A462T rescue the caudal fin-fold 
regeneration of ptpn11a-/-ptpn11b-/- zebrafish embryos to a similar extent, despite ex-
treme differences in catalytic activity. This may be due to the conformation dynamics 
of SHP2. Normally, SHP2 remains in the closed conformation, through interactions 
between the SH2 domains and the PTP domain (Hof et al. 1998). Ligation of the SH2 
domains to phospho-tyrosine residues on other proteins prompts an open conforma-
tion, allowing the PTP domain to dephosphorylate substrates. “Activating” mutations, 
such as D61G in the N-terminal SH2 domain, disrupt the interaction between the SH2 
domains and the PTP domain, and stabilize the open conformation of SHP2 (Darian 
et al. 2011). Recently, it has been hypothesized that whilst the SHP2 A461T mutant 
has reduced catalytic activity, it is also stabilized in an open conformation, allowing 
prolonged association with substrates that compensates for its reduced activity (Yu et 
al. 2013, 2014). This would certainly explain why both Shp2a-D61G and Shp2a-A462T 
rescue zebrafish embryo caudal fin-fold regeneration. A similar explanation may be 
applicable to the back-door cysteine mutants of Shp2a, because formation of an in-
tramolecular disulphide bond, or lack thereof in the back-door cysteine mutants of 
Shp2a, may induce changes in protein conformation.
Collectively, our results suggest that Shp2a function entails a go/no go signal for the 
regenerative outgrowth of zebrafish embryo caudal fin-folds, independent of the level 
of Shp2a activity. Possibly, the conformation of Shp2a, rather than the level of catalytic 
activity has a role in its function in zebrafish embryo caudal fin-fold regeneration. 
mAteRiAls ANd methods
Zebrafish husbandry
All procedures involving experimental animals were approved by the local animal 
experiments committee (Koninklijke Nederlandse Akademie van Weterschappen-Dier-
experimenten commissie) and performed according to local guidelines and policies in 
compliance with national and European law. The ptpn11a+/-ptpn11b-/- zebrafish lines 
195
7
in the Tuebingen Long fin (TL) background were previously created by target-selected 
gene inactivation (TSGI), and both ptpn11ahu3459 and ptpn11bhu5920 alleles result from 
non-sense mutations that lead to a premature stop codon upstream of the catalytic 
cysteine, C460 (Bonetti, Rodriguez-Martinez, et al. 2014). Adult ptpn11a+/-ptpn11b-/- 
zebrafish were in-crossed to generate ptpn11a-/-ptpn11b-/- zebrafish embryos for 
all experiments. Zebrafish were raised and maintained as described by Westerfield 
(Westerfield 2000) under a 14 hours light/ 10 hours dark cycle at 28.5°C.
In vitro protein production and phosphatase assays
Zebrafish ptpn11 mutant genes were cloned into a bacterial expression vector with 
a N-terminal Glutathione-S-transferase (GST) tag. E. coli sub-cloning competent cells 
(#18265-017, Invitrogen) were transformed with the constructs pGEX-ptpn11a (WT), 
pGEX-ptpn11a-C334S, pGEX-ptpn11a-C368S, pGEX-ptpn11a-C334S-C368S (2CS), 
pGEX-ptpn11a-D61G, pGEX-ptpn11a-A462T, or pGEX-ptpn11a-D61G-R466M (RM) 
and protein induction stimulated with 100µM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at 25°C overnight. Proteins were isolated by lysis of the bacterial pellet in 1mg/
ml lysozyme and 10% triton X-100. The resulting supernatant was bound to GST agarose 
beads (#G-4510, Sigma) and washed with phosphate buffered saline (PBS). Isolated 
proteins were eluted from the GST agarose beads using a reduced glutathione buffer 
(50mM Tris, 10% glycerol, 10mM reduced glutathione), and dialyzed in Spectra/Por 
Dialysis membranes (#132665, Spectrum Labs) by incubating 4x 2h in PBS at 4°C. Puri-
fied proteins were concentrated in Amicon® Ultra – 0.5ml spin columns (#UFC503096, 
Merck Millipore). Purified proteins were diluted in 2-(N-morpholino)-ethanesulphonic 
acid (MES) to similar levels for use in in vitro phosphatase assays. Protein samples in 
MES were mixed with equal volume 2x para-nitrophenylphosphate (pNPP) mix (40mM 
MES, 2mM DTT, 2mM EDTA, 300mM NaCl, 20mM pNPP), and in vitro phosphatase 
assays performed as previously described (Lorenz 2011) with the exception that 50µl 
500mM NaOH was used to stop the reaction. 
Cell protein extraction and immunoblotting
Whole cell protein extracts from human embryonic kidney 293 T cells (HEK293T) cells 
transfected with and overexpressing zebrafish Shp2a were prepared by lysis in ice-
cold buffer (25mM HEPES pH 7.4, 150mM NaCl, 0.25% deoxycholate, 1% triton X-100, 
10mM MgCl2, 1mM EDTA and 10% glycerol) containing protease and phosphatase 
inhibitors. Samples were centrifuged at 12,000g for 20mins and the supernatant col-
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lected. Total protein concentration was estimated using a detergent compatible colori-
metric assay according to the manufacturer’s instructions (#5000111, Bio-Rad) and all 
samples diluted to the same concentration. Proteins were resolved in 10% SDS-PAGE 
gels under reducing conditions and transferred to PVDF membranes (#IPVH00010, 
Merck Millipore). Immunoblotting was performed using anti-oxPTP (#MAB2844, R&D 
Systems Europe Ltd.) or anti-SHP2 (SH-PTP2 C-18, #SC-280, Santa Cruz Technology) 
antibodies followed by horseradish peroxidase (HRP)-conjugated anti-rabbit or anti-
mouse antibodies (BD Pharmingen™), respectively. Detection was done by enhanced 
chemiluminescence (#34095, Thermo Fischer Scientific).
Alkylation, immunoprecipitation, and hyperoxidation
HEK293T were cultured in DMEM 10% fetal calf serum (FCS) and 100U/ml penicil-
lin/streptomycin mix (#15140122, Thermo Fischer Scientific) and treated with 1mM 
H2O2 for 15mins prior to lysis in ice-cold buffer (25mM HEPES pH 7.4, 150mM NaCl, 
0.25% deoxycholate, 1% triton X-100, 10mM MgCl2, 1mM EDTA and 10% glycerol), 
containing protease and phosphatase inhibitors, with 100mM iodoacetic acid (IAA) 
to achieve protein alkylation. The supernatant was collected and samples diluted to 
equal concentration as before. Native protein A sepharose beads (#17-0780-01, GE 
Healthcare) were prepared by washing in fresh ice-cold buffer (25mM HEPES pH 7.4, 
150mM NaCl, 0.25% deoxycholate, 1% triton X-100, 10mM MgCl2, 1mM EDTA and 
10% glycerol), containing protease and phosphatase inhibitors, with 100mM IAA. Ly-
sates were pre-cleared by incubation with Protein A beads for 30mins at 4°C. Samples 
were immunoprecipitated by incubating with 0.1µg SHP2 specific antibody (SH-PTP2 
C-18, #SC-280, Santa Cruz Technology)/1µl lysate and 1µl Protein A beads/40µl lysate 
for 2h at 4°C. Samples were rotated during all incubations steps. Protein A beads were 
washed between steps with HNTG (20mM HEPES pH7.5, 150mM NaCl, 10% glycerol, 
0.1% Triton X-100) containing protease and phosphatase inhibitors. Samples were first 
treated with 10mM dithiothreitol (DTT) in fresh buffer (25mM HEPES pH 7.4, 150mM 
NaCl, 0.25% deoxycholate, 1% triton X-100, 10mM MgCl2, 1mM EDTA and 10% glyce-
rol), containing protease and phosphatase inhibitors, for 15mins at room temperature, 
and subsequently treated with 100µM pervanadate (1 mM orthovanadate and 1 mM 
H2O2, mixed and left at room temperature for at least 5 min before use). Protein A be-
ads were re-suspended in 2x laemmli buffer and boiled for 5-10mins. The supernatant 
was then resolved on 10% SDS-PAGE gels and prepared for immunoblotting as before.
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mRNA synthesis and micro-injections
All constructs contain a N-terminal eGFP connected by a peptide-2a cleavage 
sequence (Ryan et al. 1991). The constructs pCS2+-eGFP-2a-ptpn11a-C334S, pCS2+-
eGFP-2a-ptpn11a-C368S, pCS2+-eGFP-2a-ptpn11a-C334S-C368S (2CS), pCS2+-eGFP-
2a-ptpn11a-D61G, and pCS2+-eGFP-2a-ptpn11a-A462T were obtained as described 
(Bonetti, Paardekooper Overman, et al. 2014). Sense messenger RNA (mRNA) synthesis 
and micro-injection into one-cell stage zebrafish embryos was performed as described 
(Stumpf and Den Hertog 2016).
Caudal fin-fold amputation
Zebrafish embryos were amputated as previously described (Hale and den Hertog 
2016), amputations were performed at 2 days post fertilisation (dpf) for all experi-
ments. Regeneration was allowed to proceed until analysis at 3 days post amputation 
(dpa). Whole zebrafish embryos were lysed for genotyping.
genotyping
All zebrafish embryos that were used in these assays were genotyped to establish 
ptpn11a status. To this end, genomic zebrafish DNA was extracted through lysis of 
zebrafish embryos in 100µg/ml proteinase K (Sigma) diluted in SZL buffer (50mM KCl, 
2.5mM MgCl, 10mM Tris pH 8.3, 0.005% NP40, 0.005% Tween-20, and 10% 0.1% Ge-
latine). Lysis was performed by incubating at 60°C for 1 hour, followed by 95°C for 15 
minutes in a thermal cycler (BioRad T100). The ptpn11ahu1864 allele in non-fixed tissue 
was analysed by Kompetitive Allele Specific PCR (KASP): primers of ptpn11a containing 
the non-sense mutations of the ptpn11ahu1864 allele (ptpn11a WT FWD: GAAGGTGAC-
CAAGTTCATGCTACATGGAGCATCATGGAC, ptpn11a KO FWD: GAAGGTCGGAGTCAACG-
GATTACATGGAGCATCATGGAT, ptpn11a REV: AGCTCAATGACGTCTCCGTTTTTCTCTTT). 
Primers were mixed with genomic zebrafish DNA and KASP master mix (LGC Group). 
Amplification was carried out according to the manufacturer’s instructions and the re-
sulting PCR products were analysed in a PHERAstar microplate reader (BMG LABTECH). 
Klustercaller software (LGC Group) was used to identify the mutations. 
statistics
Histograms of whole data sets were examined to determine non-normal distribution 
of the data. Statistical analysis of unequal variances was obtained through a Kruskall-
Wallis test. Differences between different experimental conditions were assessed for 
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significance using a Mann-Whitney U test. Differences were considered significant 
when p<0.001, and if they satisfied a confidence interval of 95% in a Monte Carlo exact 
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Epimorphic regeneration is the complete replacement of lost tissue without scar 
formation. Fundamental research is challenged with understanding the process of 
epimorphic regeneration in organisms, such as zebrafish (Danio rerio), that retain a 
lifelong capacity for this ability. Within the last century, many advances have been 
made in understanding the molecular mechanisms involved in regeneration. The work 
described in this thesis contributes to the understanding of zebrafish caudal fin (called 
the “fin-fold” in zebrafish embryos) regeneration by discovering that differential oxi-
dation of protein-tyrosine phosphatases (PTPs) is induced by caudal fin amputation. In 
addition, we identify that two PTPs are required for zebrafish embryo caudal fin-fold 
regeneration: Phosphatase and Tensin homolog (Pten), and Src homology 2 domain 
containing phosphatase (Shp2). Below we describe the major findings, discerning 
the roles of Pten and Shp2, as well as the steps of zebrafish embryo caudal fin-fold 
regeneration dependent on Pten and Shp2 mediated signalling.
the tumouR suPPRessoR PteN is RequiRed FoR ZebRAFish 
CAudAl FiN RegeNeRAtioN (ChAPteR 4)
The tumour suppressor Phosphatase and Tensin homolog (PTEN) is a dual-specificity 
phosphatase that antagonizes phosphoinositide-3-kinase (PI3K) signalling (1). We 
demonstrated for the first time that loss of Pten results in impaired zebrafish embryo 
caudal fin-fold regeneration, indicating Pten is required for regeneration. The lack of 
caudal fin-fold regeneration in zebrafish embryos lacking functional Pten was associa-
ted with reduced cell proliferation, enhanced apoptosis, and elevated AKT activation 
during regenerative outgrowth. Restoring Pten expression or inhibiting PI3K activity 
during regenerative outgrowth rescued caudal fin-fold regeneration in zebrafish em-
bryos lacking functional Pten protein. For this reason, Pten most likely has a function 
in balancing PI3K signalling. Thus enabling proper coordination of proliferation and 
apoptosis during regenerative outgrowth of the zebrafish embryo caudal fin-fold. 
Loss of PTEN is known to lead to enhanced AKT signalling, promoting cell survival 
and proliferation in tumour cells (2). However, hyper-active AKT has been shown to in-
duce senescence in mouse embryonic- and human-fibroblasts (3, 4), and loss of PTEN 
has also been shown, by enhancing p53 activity, to induce senescence in mouse and 
human tumour cells (4, 5). Possibly, the loss of Pten in zebrafish embryos leads to ar-
rested cell proliferation during caudal fin-fold regeneration due to a similar induction 
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of cellular senescence by 2 days post-amputation (dpa). The persistence of senescent 
cells can have detrimental effects on tissue homeostasis (6). Moreover, inhibition of 
p53 activity in senescent cells has recently been shown to restore tissue homeostasis 
(7), supporting previous results showing that loss of PTEN induces senescence through 
increased p53 activity (4). 
Surprisingly, we observed enhanced apoptosis in pten knock-out zebrafish embryos 
at both 1dpa and 2dpa, which is contradictory to the role AKT signalling has in en-
hancing cell survival (8). Furthermore, the increased apoptosis preceded the arrested 
cell proliferation observed at 2dpa. Apoptosis preceding reduced proliferation was 
also observed in mouse embryos with increased transforming growth factor β (TGFβ) 
signalling (9), suggesting the occurrence may not be uncommon. However, it is unclear 
how loss of Pten affects the order of apoptosis and proliferation, and it will be interes-
ting to identify if the two processes are cell-type specific.
Overall, our results suggest a loss of homeostasis in caudal fin-fold regeneration 
of zebrafish embryos lacking functional Pten between 1dpa and 2dpa, which may 
lead to cellular senescence. Future research should include screening for genes that 
are possibly deregulated in the regenerating caudal fin-folds of zebrafish embryos 
lacking functional Pten. Such screenings could be achieved by performing sequencing 
techniques such as tomo-seq, which involves cryosectioning a zebrafish embryo and 
performing RNA-seq on individual sections (10), on the caudal fin-folds of zebrafish 
embryos lacking functional Pten and their siblings. Furthermore, useful spatial infor-
mation on differences in transcription would be obtained. The identified genes could 
be validated by creating genetic knock-out zebrafish embryos using the new Clustered 
regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 
9 (CAS9) technology, and assessing the caudal fin-fold regeneration of these knock-
out zebrafish embryos. If these genes are implicated in senescence, the senescence 
response could be characterized by performing whole-mount immunohistochemistry 
for senescence markers (11) at 1dp and 2dpa.
diFFeReNtiAl oxidAtioN oF PtPs duRiNg ZebRAFish CAudAl 
FiN RegeNeRAtioN (ChAPteR 5)
We have detected and identified PTPs in adult zebrafish caudal fin tissue, and reversible 
oxidation of a subset of PTPs following caudal fin amputation. A total of 33 PTP active 
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site peptides were efficiently immunoprecipitated from lysates of zebrafish caudal fin 
clips, and identified by liquid chromatography tandem mass spectrometry (LC-MS/MS). 
The 33 PTP active site peptides represent 75% of all theoretically observable PTPs, and 
include 17 non-receptor and 16 receptor type PTPs. Furthermore, we identified the 
oxidation of 8 different zebrafish PTPs following caudal fin amputation: Ptpn1, Ptpn2a, 
Ptpn4b, Ptpn9a, Ptpn11a, Ptpn11b, Rptph, and Rptpεa.
Protein tyrosine phosphorylation regulates many cellular processes, including 
proliferation, differentiation, and migration, and is essential for the development and 
survival of eukaryotic organisms (12). Protein-tyrosine kinases (PTKs) and protein-
tyrosine phosphatases (PTPs) regulate the duration of phospho-tyrosine signalling 
(13). Inhibition of PTPs by reactive oxygen species (ROS), thus results in maintained 
phospho-tyrosine signalling (14), which has consequences on cell behaviour. Yet, the 
study of PTP oxidation in vivo has been hampered by the lack of tools to detect rever-
sibly oxidized PTPs, the complexity of distinguishing reversibly oxidized states from ir-
reversibly oxidized states of PTPs, and the difficulty of measuring the intracellular ROS 
concentration to ascertain if PTPs become oxidized in vivo at endogenous ROS levels. 
Our results demonstrate a method that facilitates the identification of PTP oxidation 
in tissue samples, and directly implicates PTPs in zebrafish caudal fin regeneration by 
demonstrating that ROS produced in response to caudal fin amputation (15) induce 
oxidation of some, but not all, PTPs. Next, CRISPR-CAS9 technology should be used 
to make genetic knock-out zebrafish of the remaining 6 oxidized PTPs and investigate 
their role in zebrafish caudal fin regeneration. Rescue experiments, by micro-injecting 
synthetic mRNA encoding mutant PTP protein, could be performed on knock-out 
zebrafish embryos to investigate the function of each PTP. 
Both inactivating and activating mutations of either PTKs or PTPs have been de-
monstrated to lead to aberrant tyrosine phosphorylation, which results in a plethora 
of developmental defects and diseases (16) and highlights the importance of balanced 
phospho-tyrosine signalling. We hope this method will be used by others to discover 
and validate the oxidation of PTPs in other tissues, including heart and tumours, and 
possibly in other physiological processes, such as wound healing, brain tissue of Alzhei-
mer patients, diabetes mellitus, as well as different stages of embryonic development. 
Conducting such studies may reveal a differential requirement for PTPs in different 
contexts, and perhaps identify some PTPs as new drug targets.
Understanding and targeting PTP oxidation in vivo will be challenging. An example 
from our own findings is that zebrafish embryos lacking Shp2 (Ptpn11), which is 
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oxidized following caudal fin amputation, do not regenerate their caudal fin-folds. In 
comparison, zebrafish embryos lacking Rptpα, which is not oxidized following caudal 
fin amputation, regenerate their caudal fin-folds normally. These results are surprising 
and present a conundrum that Shp2 is inactivated, but also required for zebrafish 
caudal fin regeneration. We propose that Shp2 is reduced after some time following 
oxidation induced by zebrafish caudal fin amputation, but this will have to be valida-
ted. Although PTP oxidation could be followed over time during zebrafish caudal fin 
regeneration using LC-MS/MS, there would have to be some control to account for 
the possibility that the oxidized PTP is degraded and replaced with freshly translated 
reduced PTP. Instead, conformation sensing antibodies specific for reversibly oxidized 
PTPs (17) may illuminate the dynamics of PTP oxidation. These antibodies could be 
fluorescently tagged and conditionally expressed in vivo, or adapted to be used for 
whole-mount immunohistochemistry to allow for detection of oxidized PTPs at dif-
ferent stages of zebrafish caudal fin regeneration, as well as in response to different 
drug treatments. 
the Role oF shP2A duRiNg ZebRAFish embRyo CAudAl FiN-
Fold RegeNeRAtioN (ChAPteRs 6 ANd 7)
SHP2 is a cytoplasmic PTP with two Src homology 2 (SH2) domains, a catalytic PTP 
domain, and a C-terminal domain (18). The PTP domain contains a conserved catalytic 
cysteine that dephosphorylates phospho-tyrosine substrates. The SH2 domains con-
tain essential arginine residues required for ligation to targets. The C-terminal domain 
contains essential tyrosine residues implicated in receptor and substrate binding (19). 
We have demonstrated that loss of Shp2 results in impaired zebrafish embryo 
caudal fin-fold regeneration, and that this is rescued by restoring expression of wild-
type Shp2a, indicating Shp2 is normally required for zebrafish embryo caudal fin-fold 
regeneration. Furthermore, we have identified the aspects of Shp2a required for 
its function in zebrafish embryo caudal fin-fold regeneration. In zebrafish embryos 
lacking functional Shp2, the expression of catalytically inactive Shp2a, or Shp2a with 
the essential arginine residues of the SH2 domains mutated, did not rescue caudal 
fin-fold regeneration. In comparison, expressing Shp2a with the two essential tyrosine 
residues in the C-terminal domain mutated in zebrafish embryos lacking functional 
Shp2 protein did rescue caudal fin-fold regeneration. Hence, the catalytic activity 
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and the SH2 domains of Shp2a, but not the two tyrosine phosphorylation sites in the 
C-terminal domain, are required for the function of Shp2a during zebrafish embryo 
caudal fin-fold regeneration. By using whole-mount immunohistochemistry we revea-
led that the lack of caudal fin-fold regeneration in zebrafish embryos lacking functional 
Shp2 protein was associated with reduced cell proliferation and reduced mitogen ac-
tivated protein kinase (MAPK) activation during regenerative outgrowth of the caudal 
fin-fold. Furthermore, we have shown that inhibition of the upstream MAPK kinase 1 
(MEK1), which activates MAPK, following zebrafish embryo caudal fin-fold amputation, 
reduced cell proliferation in a similar manner. Collectively, our results strongly suggest 
Shp2a mediated MAPK signal transduction is required for the regenerative outgrowth 
of the zebrafish embryo caudal fin-fold (Chapter 6).
Our results of reduced MAPK activation in the caudal fin-folds of zebrafish embryos 
lacking functional Shp2 protein are consistent with previous studies demonstrating 
Shp2 mediated MAPK signalling (20–23). MAPK signalling stimulates cell proliferation, 
and thus zebrafish embryos lacking functional Shp2 protein experienced reduced 
proliferation during regenerative outgrowth of the caudal fin-fold, resulting in a lack 
of caudal fin-fold regeneration. Loss of SHP2 is associated with a poor response to 
injury (24, 25), consistent with MAPK activation following injury being associated with 
a regenerative competence across species (26, 27). Hence, our findings support the 
notion that Shp2-MAPK signalling is required for regeneration. Notably, the reason 
why the loss of SHP2 impairs regeneration is still under debate. For example, the loss 
of SHP2 in the retina of mice is shown to result in increased apoptosis following injury 
(24). However, no increase in apoptosis is observed in the impaired regeneration of 
muscle in mice following loss of SHP2 in satellite cells (25). Instead, loss of SHP2 was 
associated with satellite cell quiescence. In zebrafish caudal fin regeneration, cells 
dedifferentiate to form a blastema that will proliferate and replace the lost tissue (28, 
29), and the fate of the dedifferentiated cells is lineage restricted (30). Hence, it is pos-
sible that following formation of the blastema, the loss of Shp2 induces quiescence in 
dedifferentiated cells. This would certainly be in concordance with our results, where 
we show that regenerative outgrowth was impaired in zebrafish embryos lacking 
functional Shp2, despite normal blastema formation (Chapter 6). Such quiescence 
phenotype may occur in all multipotent progenitors in the blastema, or may be cell-
type specific.
Our findings that Shp2a is oxidized following zebrafish caudal fin amputation (Chap-
ter 5) suggests that Shp2a is inactivated following caudal fin amputation. Furthermore, 
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oxidation-mediated inactivation of Shp2a may be necessary for zebrafish caudal fin 
regeneration, because production of ROS following zebrafish embryo caudal fin-
fold amputation is required for caudal fin-fold regeneration (31). However, we have 
demonstrated that Shp2a activity is required for zebrafish embryo caudal fin-fold 
regeneration (Chapter 6), presenting the following conundrum: how is the catalytic 
activity of Shp2a required for regeneration when it is oxidized, and thus inactivated, 
following caudal fin amputation? We propose that after its initial oxidation, Shp2a is 
reduced to an active state to exert its function for regeneration. To test this hypothesis, 
we made novel back-door cysteine mutants of Shp2a. SHP2 has been proposed to have 
two back-door cysteines that protect the catalytic cysteine from irreversible oxidation-
mediated inactivation through the formation of an intramolecular disulphide bond 
with each other in response to ROS (32). Mutation of these back-door cysteines may 
thus result in a Shp2a mutant that is permanently inactivated following amputation of 
the zebrafish caudal fin. 
We have demonstrated that mutation of the back-door cysteines C334 or C368, 
or both, reduced catalytic activity, and enhanced ROS induced oxidation of Shp2a. 
Surprisingly though, expressing the back-door cysteine mutants of Shp2a in zebrafish 
embryos lacking functional Shp2 protein, rescued their caudal fin-fold regeneration. 
As the back-door cysteine mutants of Shp2a demonstrated reduced catalytic activity, 
we subsequently addressed the level of Shp2a catalytic activity required for its func-
tion in zebrafish embryo caudal fin-fold regeneration by using two mutants of Shp2a 
with increased and reduced catalytic activity. Interestingly, expression of Shp2a with 
increased (D61G) or reduced (A462T) catalytic activity in zebrafish embryos lacking 
functional Shp2 protein, rescued caudal fin-fold regeneration with similar efficiency. 
Collectively, our results suggest that the level of Shp2a catalytic activity does not affect 
the function of Shp2a in the regenerative outgrowth of the caudal fin-fold (Chapter 7).
We aimed to make novel Shp2a mutants with enhanced susceptibility to irrever-
sible oxidation-mediated inactivation by ROS by mutating the back-door cysteines of 
Shp2a. Unfortunately, these back-door cysteine mutants of Shp2a remain functional 
during caudal fin-fold regeneration when expressed in zebrafish embryos lacking 
functional Shp2 (Chapter 7). Hence, we were unable to explain why Shp2a is oxidized 
following zebrafish caudal fin amputation, which should inactivate Shp2a, but the ca-
talytic activity of Shp2a is required for zebrafish embryo caudal fin-fold regeneration. 
Due to the nature of the catalytic cysteine, tying catalytic activity to susceptibility to 
oxidation, and our limited understanding of back-door cysteines of PTPs, the field of 
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PTP biochemistry has limited options to manipulate PTP oxidation. Instead, further 
research should focus on identifying PTP oxidation at different stages of zebrafish 
caudal fin regeneration (as described above).
Based on our results we proposed that the regulation of Shp2a conformation is 
pivotal to its function during zebrafish embryo caudal fin-fold regeneration. This would 
explain why mutants of Shp2a with increased or reduced catalytic activity function 
similarly in zebrafish embryo caudal fin-fold regeneration. The A462T mutant of Shp2a, 
and possibly the back-door cysteine mutants of Shp2a, may be stabilized in an open 
conformation, allowing prolonged association with substrates and compensating for its 
reduced activity (33, 34). In comparison, the D61G mutant of Shp2a is proposed to have 
increased activity due to disruption of the interaction between the SH2 domains and 
the PTP domain, resulting in a permanently open conformation (35, 36). Interestingly, 
the ability of Shp2a mutants with low catalytic activity to remain functional during 
zebrafish embryo caudal fin-fold regeneration aligns with the proposal that a basal 
level of sustained MAPK signalling is required to maintain proliferating cells during 
regeneration (24, 25). The opposite, increased MAPK signalling beyond normal, ap-
pears not to be detrimental, as expression of Shp2a-D61G in zebrafish embryos lacking 
functional Shp2 had no more effect than expressing Shp2a-A462T. Indeed, expression 
of KRasG12D, which greatly increases MAPK activation (promoting increased prolifera-
tion and migration of cells, and often leading to pancreatic neoplasms (37, 38)), in 
Shp2 deficient mice retina is, surprisingly, limited to rescuing retinal degeneration (24). 
Taken together, these results suggest that Shp2 is required in an open conformation to 
stimulate regenerative outgrowth, and that the level of MAPK signalling is regulated 
further downstream, possibly by dual specificity phosphatases (39). 
The importance of balanced phospho-tyrosine signalling is evident by the plethora 
of developmental defects and diseases that result when either PTKs or PTPs are mu-
tated (16). Our finding that inhibition of MAPK signalling inhibits zebrafish embryo 
caudal fin-fold regeneration (Chapter 6) demonstrates that MAPK signalling is re-
quired. However, our results in Chapter 7, showing that Shp2a mutants with opposite 
extremes in catalytic activities stimulate zebrafish embryo caudal fin-fold regeneration 
to a similar extent, suggest that “balanced” Shp2a activity is not crucial for zebrafish 
embryo caudal fin-fold regeneration. A major challenge to fully understanding the 
function of molecules, and hence signalling pathways, in regeneration, is manipulating 
their expression over time. The expression of genes fluctuates through the distinct 
stages of regeneration (40), and it is evident that the signalling required for regene-
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ration is more complex than just upregulating or downregulating signal transduction. 
For example, both inhibition of Notch signalling and over-activation of Notch signalling 
result in impaired caudal fin regeneration (41), demonstrating that the changes in 
signalling are subtle and tightly regulated. Therefore, there is a need for inducible on/
off systems to delineate when and for how long each gene or signalling pathway is 
required during regeneration. An inducible Shp2a system could be used to understand 
the specific moment when Shp2a function is required during zebrafish embryo caudal 
fin-fold regeneration. In addition, if the lack of caudal fin-fold regeneration in zebrafish 
embryos lacking functional Shp2 protein is due to blastema cells becoming quiescent, 
inducible systems could also be used to address whether the activation of Shp2, or 
MAPK, at 1dpa or 2dpa would re-start the regenerative outgrowth of the caudal fin-
fold. Furthermore, if MAPK signalling is limited downstream of Shp2a, inducible MAPK 
systems could address the importance of balanced phospho-tyrosine signalling.
CoNClusioN
Overall, we show that genetic knock-out zebrafish embryos of pten or ptpn11, lacking 
functional Pten or Shp2 respectively, do not regenerate their caudal fins. This is at-
tributed to the aberrant PI3K or MAPK signalling that results in zebrafish embryos 
lacking functional Pten or Shp2, respectively (Chapters 4 and 6). We make evident that 
amputation induces differential oxidation of PTPs in zebrafish caudal fins, and demon-
strate a differential requirement for PTPs during zebrafish embryo caudal fin-fold rege-
neration (Chapter 5). We uncover that 8 PTPs are oxidized following zebrafish caudal 
fin amputation. Shp2a is one of the PTPs that is oxidized in the zebrafish caudal fin, but 
Shp2a is also required for zebrafish embryo caudal fin-fold regeneration. By expressing 
mutant Shp2a proteins in ptpn11 knock-out zebrafish embryos, we investigated the 
role of Shp2a in caudal fin-fold regeneration. We show that Shp2a requires its catalytic 
activity and the function of its SH2 domains for its role in caudal fin-fold regeneration 
(Chapter 6). Shp2a does not need the tyrosine residues in its C-terminal domain, which 
are needed for Shp2a binding to some substrates. Our findings also reveal that the 
level of Shp2a catalytic activity does not determine the efficiency of zebrafish embryo 
caudal fin-fold regeneration (Chapter 7). We sought to make oxidation hypersensitive 
mutants of Shp2a, however these were not inactivated following zebrafish embryo 
caudal fin-fold amputation. Collectively, our results reveal a crucial role for Pten and 
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Shp2 in zebrafish caudal fin regeneration, and allow for further research to understand 
the importance of their dynamics during zebrafish caudal fin regeneration.
FutuRe PeRsPeCtives
We have emphasized the importance of balanced phospho-tyrosine signalling and 
provided numerous examples of the consequences of aberrant PTP activity in the 
first two chapters. Balanced phospho-tyrosine signalling is also important in zebrafish 
embryo caudal fin-fold regeneration, and we show that loss of pten or inhibition of 
PI3K inhibits regeneration. Furthermore, inhibition of PI3K in pten knock-out zebrafish 
embryos restored zebrafish embryo caudal fin-fold regeneration (Chapter 4). However, 
Shp2a mutants with increased and reduced catalytic activity stimulate zebrafish em-
bryo caudal fin-fold regeneration to a similar extent (Chapter 7), suggesting that the 
regulation of phospho-tyrosine signalling occurs at multiple steps in the signalling pa-
thway. Delineating the exact substrates and MAPK signalling pathway Shp2 is involved 
in will address how this “balance” is achieved. Furthermore, this will indicate which 
cellular processes Pten and Shp2 are involved in during the regenerative outgrowth of 
the zebrafish embryo caudal fin-fold.  
Balanced phospho-tyrosine signalling may also regulate the duration of zebrafish 
caudal fin regeneration. During our studies, we always amputated adjacent to the 
notochord, which is the standard practice in the field of zebrafish embryo caudal 
fin-fold regeneration (Chapter 3). However, amputating only the tip of the zebrafish 
embryo caudal fin-fold results in regeneration that progresses over the same dura-
tion (data not shown). This is not unique to zebrafish caudal fin regeneration as the 
regeneration of planarian eyes also has a set duration, independent from injury size, 
injury type, and metabolic rate (42). Thus, regeneration of the lost tissue experiences 
isometric growth, where an organ grows relative to the size of the organism. In adult 
zebrafish caudal fins, inhibition of the serine and threonine phosphatase Calcineurin 
disrupts isometric growth and promotes positive allometric growth, resulting in the 
regenerating caudal fin growing beyond its original size (43). This was attributed to 
increased retinoic acid signalling, which controls the formation of the blastema, and 
the proliferation of the dedifferentiated cells in the blastema (44). Hence, the isome-
tric growth of regenerating tissues may be in part due to the proliferation gradient 
that exists from the proximal blastema, where cells proliferate, to the differentiation 
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zone (45). Taking into consideration the role of PI3K and MAPK signalling in promoting 
proliferation, it is likely that Pten and Shp2 signalling have a role in the proliferation of 
cells in the blastema. Therefore, another area of interest is cell specific activity of Pten 
and Shp2a in different regions of the blastema. However, the molecular mechanism of 
the blastema is an area that requires significant leaps in understanding. For example, 
Notch signalling is not required for blastema formation, but when Notch signalling is 
enhanced the pool of proliferating cells in the blastema expands, reducing the number 
of cells differentiating into the lost tissue (41). Similarly, inhibition of Notch signal-
ling causes the opposite effect. The limitation to better understanding the molecular 
mechanism of the blastema is the lack of the availability of mutants where protein 
expression can be spatio-temporally regulated at the distinct stages of regeneration. 
In addition, for research on the specific role of PTPs in zebrafish regeneration, there is 
a need for specific water-soluble inhibitors that can be applied during regeneration.
Finally, the ultimate question will be whether gains in our understanding of model 
organism regeneration can be translated to human wound healing. PTPs are important 
for the regenerative process of tissues and organs of other vertebrates. PTP1B is a 
negative regulator of insulin signalling (46), and PTP1B knock-out mice are resistant to 
type 2 Diabetes Mellitus (T2DM) and obesity (47). Moreover, PTP1B knock-out mice 
experience enhanced liver regeneration (48). Mouse models of T2DM, ob/ob mice, 
have impaired wound healing, which is restored when PTP1B is inhibited (49). This 
suggests that PTP1B negatively regulates regeneration, and that there is a differential 
requirement for PTPs in regeneration of the liver. This differential requirement may 
span across organs, and perhaps across species. Targeting PTP1B with available in-
hibitors (50) may be one of the steps required to unlock the regenerative capacity in 
human adults. As our understanding of regeneration improves, we will identify more 
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This thesis describes the use of zebrafish (Danio rerio), which have the capacity to 
regenerate lost tissues and organs, to study the role of protein tyrosine phosphatases 
(PTPs) in caudal fin regeneration. In the first three chapters, we introduce the mecha-
nism and function of PTPs, their importance to intracellular signalling and their role 
in ensuring correct embryonic development, and outline the methods used to study 
their role in zebrafish caudal fin regeneration. These chapters provide the background 
for the scientific questions we pursue in the subsequent experimental chapters. Spe-
cifically, we demonstrate that both Pten and Shp2 are required for zebrafish embryo 
caudal fin regeneration, and that differential oxidation of PTPs during zebrafish caudal 
fin regeneration is evident. We also examine the molecular mechanism of Shp2a 
during zebrafish embryo caudal fin regeneration. 
In Chapter 1 we briefly review the structure and function of PTPs in phospho-
tyrosine signalling, and how PTP activity is regulated. We introduce the process of 
regeneration, outlining the steps required for successful zebrafish caudal fin regenera-
tion, and allude to the role PTPs may have in this process.
In Chapter 2 we review the accumulating evidence highlighting the essential role 
PTPs have in maintaining balanced phospho-tyrosine signalling during embryonic 
development. We cover how the activity of one or more PTPs is instrumental in the 
biology of stem cell self-renewal and differentiation, gastrulation and somitogenesis, 
osteogenesis, and angiogenesis. We also provide examples of how PTP dysregulation, 
in the form of increased or reduced activity, has detrimental consequences to these 
processes, and hence embryonic development. The importance of balanced phospho-
tyrosine signalling is evolutionary conserved, which is evident considering the nume-
rous distinct animal models that are dependent on appropriate PTP activity. We also 
briefly discuss some human syndromes and diseases that are associated with aberrant 
PTP activity.
In Chapter 3 we outline some of the experimental procedures used to study the role 
of PTPs during zebrafish caudal fin regeneration. We provide step-by-step protocols 
for micro-injecting synthetic messenger RNA into one-cell stage zebrafish embryos to 
express a protein of interest, amputating the caudal fin under anaesthesia, and lysing 
tissue for analysis of protein expression. We also share tips on each method collected 
from peers experienced in zebrafish handling and experimentation.
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In Chapter 4 we used zebrafish embryos lacking functional phosphatase and 
tensin homologue (Pten) protein, a tumour suppressor that acts as an antagonist of 
phosphoinositide 3-kinase (PI3K)/Akt signalling, to demonstrate the importance of 
PTPs in zebrafish caudal fin regeneration. We show that homozygous ptena-/-ptenb-/- 
embryos, lacking functional Pten protein, do not regenerate their caudal fins follo-
wing amputation. We analysed two essential and distinct steps in the regenerative 
process: blastema formation, and regenerative outgrowth, using in situ hybridization 
and immunohistochemistry, respectively. Although ptena-/-ptenb-/- embryos do form a 
blastema normally, immunohistochemistry revealed arrested proliferation, increased 
apoptosis, and enhanced activation of Akt (activated by PI3K) during regenerative out-
growth compared to sibling embryos with functional Pten protein. Re-expression of 
Pten, but not the catalytically inactive mutant Pten-C124S, in ptena-/-ptenb-/- embryos 
rescued regeneration, as did pharmacological inhibition of PI3K. Collectively, our re-
sults suggest a critical role for Pten by limiting PI3K signalling during the regenerative 
outgrowth phase of zebrafish embryo caudal fin regeneration.
In Chapter 5 we uncovered differential oxidation of PTPs during caudal fin rege-
neration of adult zebrafish. In response to amputation of the caudal fin, a rapid and 
transient increase in hydrogen peroxide (H2O2) levels is observed emanating from the 
wound margin, which is essential for regeneration. We performed two sequential fin 
clips 40 minutes apart to extract the part of the fin that experienced the increase in 
H2O2 levels. Using an antibody specific for oxidized PTPs (ox-PTP) and liquid chroma-
tography-mass spectrometry, we isolated and identified 33 PTPs in adult zebrafish fin 
clips. Of these 33 PTPs, 8 were significantly more oxidized 40 minutes after caudal fin 
amputation. Shp2a was one of the PTPs that was oxidized. We also provide evidence 
that the oxidized PTPs are important for regeneration: embryos deficient for Shp2, ho-
mozygous ptpn11a-/-ptpn11b-/- embryos, did not regenerate their caudal fins; whereas 
embryos deficient for Rptpα, homozygous ptpra-/- embryos, which was not oxidized 
upon caudal fin amputation, regenerated their caudal fins normally. Our results de-
monstrate that PTPs are differentially oxidized in response to caudal fin amputation 
and suggest that there is a differential requirement for PTPs in regeneration.
In Chapter 6 we used zebrafish embryos lacking functional Shp2 protein, a medi-
ator of mitogen activated protein kinase (MAPK) signalling, to delineate the signalling 
role of Shp2a in caudal fin regeneration. Shp2a has multiple functional domains: a 
catalytic PTP domain, and two SH2 domains, and a C-terminal domain, for binding to 
different targets. We show that re-expression of Shp2a, but not the catalytically inac-
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tive mutant Shp2a-R466M or the Shp2a mutant lacking the capacity to bind via its SH2 
domains, rescued regeneration of homozygous ptpn11a-/-ptpn11b-/- embryos following 
caudal fin amputation. We also show that the ability of Shp2a to bind targets through 
its C-terminal domain is likely not required for its function during zebrafish embryo 
caudal fin regeneration. By using in situ hybridization and immunohistochemistry, we 
show that ptpn11a-/-ptpn11b-/- embryos formed a blastema normally, but displayed 
arrested proliferation and reduced activation of MAPK during regenerative outgrowth. 
Pharmacological inhibition of MEK, activator of MAPK, similarly inhibited regeneration 
and arrested proliferation during the regenerative outgrowth of zebrafish embryo 
caudal fins. Our results suggest a critical role for Shp2a by promoting MAPK signalling 
during the regenerative outgrowth phase of zebrafish embryo caudal fin regeneration.
In Chapter 7 we mutated key residues in Shp2a to investigate the oxidation and level 
of catalytic activity of Shp2a required for its function during zebrafish embryo caudal 
fin regeneration. Shp2a is susceptible to reversible oxidation-mediated inactivation, 
and the two “back-door” cysteines of Shp2a are proposed to protect Shp2 from irre-
versible oxidation-mediated inactivation. Shp2a was oxidized following zebrafish em-
bryo caudal fin amputation (Chapter 5), but its activity was also required for zebrafish 
embryo caudal fin regeneration (Chapter 6). By mutating the back-door cysteines C334 
and C368 of Shp2a, we generated novel mutant Shp2a proteins that demonstrated 
reduced catalytic activity and enhanced susceptibility to oxidation by H2O2. However, 
expression of the back-door cysteine mutant proteins of Shp2a, rescued caudal fin 
regeneration in homozygous ptpn11a-/-ptpn11b-/- zebrafish embryos, suggesting the 
back-door cysteine mutant proteins of Shp2a were not irreversibly oxidized by the 
H2O2 normally produced following caudal fin amputation. In addition, the back-door 
cysteine mutants of Shp2a rescued zebrafish embryo caudal fin regeneration despite 
reduced catalytic activity. Interestingly, Shp2a proteins carrying mutations in D61 or 
A462, resulting in increased or reduced catalytic activity, respectively, rescued zebra-
fish embryo caudal fin regeneration to similar extents. Collectively, our results suggest 
that Shp2a catalytic activity is required for regeneration, but that the level of Shp2a 
catalytic activity does not affect the function of Shp2a in zebrafish embryo caudal fin 
regeneration. 
Finally, Chapter 8 provides a summarizing discussion of the work presented in each 







Dit proefschrift beschrijft hoe de zebravis (Danio rerio), welke het vermogen bezit om 
verloren gegane weefsels en organen te regenereren, wordt gebruikt om de rol van 
tyrosine fosfatases (PTP’s) in staartvinregeneratie te bestuderen. In de eerste drie 
hoofdstukken introduceren we het werkingsmechanisme en de functies van PTPs, hun 
belang voor intracellulaire signaaltransductie en hun rol in het tot stand brengen van 
een correcte ontwikkeling van het embryo. Daarnaast beschrijven we de methoden die 
gebruikt zijn om de rol van deze fosfatases in staartvinregeneratie bij zebravissen te 
bestuderen. Deze hoofdstukken geven de achtergrondinformatie voor de daarop vol-
gende experimentele hoofdstukken, met daarin de wetenschappelijke vragen waarop 
we een antwoord hebben geprobeerd te krijgen. We laten in zebravis embryo’s zien 
dat zowel Pten als Shp2 vereist zijn voor staartvinregeneratie en dat er overduidelijk 
sprake is van verschillende oxidatie niveaus van PTPs gedurende staartvinregeneratie 
in zebravissen. We onderzoeken ook de moleculaire werkingsmechanismen van Shp2a 
gedurende staartvinregeneratie in zebravis embyro’s.
In hoofdstuk 1 bespreken we bondig de structuren van PTPs en hun functies in 
fosfo-tyrosine signaaltransductie, alsmede hoe PTP activiteit wordt gereguleerd. We 
introduceren het regeneratieproces, omschrijven de stappen die noodzakelijk zijn 
voor succesvolle staartvinregeneratie en zinspelen op de rol die PTPs zouden kunnen 
hebben in dit proces.
In hoofdstuk 2 behandelen we het zich opstapelende bewijs dat de onmisbare rol 
van PTP’s in het handhaven van een gebalanceerde fosfo-tyrosine signaaltransductie 
gedurende embryonale ontwikkeling benadrukt. We zetten uiteen hoe de activiteit van 
PTP’s bijdraagt aan stamcelhernieuwing en -differentiatie, gastrulatie en het vormen 
van de somieten, botvorming en bloedvatvorming. We geven ook voorbeelden van 
hoe PTP deregulatie in de vorm van verhoogde of verlaagde activiteit zeer schadelijke 
consequenties heeft voor bovengenoemde processen en daarmee voor de embry-
onale ontwikkeling in zijn geheel. Het belang van een gebalanceerde fosfo-tyrosine 
signaaltransductie is evolutionair geconserveerd, wat duidelijk wordt wanneer men 
het groot aantal verschillende diermodellen dat afhankelijk is van juiste PTP activiteit 
in ogenschouw neemt. We bespreken verder ook enige syndromen en ziektes welke bij 
mensen voorkomen en die veroorzaakt worden door afwijkende PTP activiteit.
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In hoofdstuk 3 beschrijven we een aantal van de experimentele procedures die zijn 
gebruikt voor het bestuderen van de rol van PTP’s in staartvinregeneratie in zebravis-
sen. 
In hoofdstuk 4 hebben we, om het belang van PTP’s in staartvinregeneratie in 
zebravissen aan te tonen, zebravis embryo’s gebruikt die geen werkend ‘phosphatase 
and tensin homologue’ (Pten) eiwit bezitten. Pten is een tumorsuppressor die werkt 
als een tegenhanger van fosfo-inositide 3-kinase (PI3K)/Akt signaaltransductie. We 
laten zien dat homozygote ptena-/-ptenb-/- embryo’s, die geen functioneel Pten eiwit 
hebben, na amputatie hun staartvin niet regenereren.  We hebben twee essentiële en 
onmiskenbare stappen in het regeneratieproces geanalyseerd met behulp van in situ 
hybridisatie en immuunhistochemie: blastema formatie, ook wel kiemweefselvorming 
genoemd, en expansie (regeneratieve groei). Hoewel ptena-/-ptenb-/- embryo’s wel een 
normale blastema vormen, liet immuunhistochemie een blokkade in celdeling, een 
toename in celdood, en verhoogde Akt activiteit zien gedurende de expansiefase in 
vergelijking tot embryo’s met functioneel Pten eiwit uit hetzelfde legsel. Het opnieuw 
tot expressie brengen van Pten evenals farmacologische inhibitie van PI3K redden het 
regeneratieproces, echter, expressie van de katalytische inactieve mutant Pten-C124S 
doet dit niet. Samengenomen suggereren onze bevindingen dat Pten een onmisbare 
rol heeft in het beperken van PI3K/Akt signaaltransductie gedurende de expansiefase 
van staartvinregeneratie in zebravis embryo’s.
In hoofdstuk 5 hebben we ontdekt dat er sprake is van differentiële oxidatie 
van PTP’s gedurende staartvinregeneratie in volwassen zebravissen. Als reactie op 
amputatie van de staartvin is er een snelle en voorbijgaande verhoging van het wa-
terstofperoxide (H2O2) niveau bij de wondgrens waar te nemen, welke essentieel is 
voor regeneratie. We voerden, met een interval van 40 minuten, twee opeenvolgende 
vin clips uit, om precies dat deel van de vin te verzamelen dat is blootgesteld aan de 
verhoogde H2O2 niveaus. Door gebruik te maken van een antilichaam dat geoxideerde 
PTP’s (ox-PTP) herkent en vloeistofchromatografie in combinatie met massaspectro-
metrie hebben we 33 PTP’s uit vin clips van volwassen zebravissen geïsoleerd en ge-
identificeerd. Van deze 33 waren er 8 PTP’s 40 minuten na amputatie significant meer 
geoxideerd. Shp2a was één van de PTPs die geoxideerd bleek te zijn. We leveren ook 
bewijs dat de geoxideerde PTP’s belangrijk zijn voor regeneratie: embryo’s die geen 
Shp2 hebben, homozygote ptpn11a-/-ptpn11b-/- embryo’s, regenereren hun staartvin 
niet, terwijl embryo’s die geen Rptpα bezitten, homozygote ptprα-/ - embryo’s, welke 
niet was geoxideerd na staartvinamputatie in volwassen zebravissen, hun staartvin wel 
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regenereren. Onze resultaten laten zien dat PTP’s in verschillende mate geoxideerd 
worden als reactie op staartvinamputatie en suggereren dat er verschillen zijn in de 
onmisbaarheid van verschillende PTP’s voor regeneratie. 
In hoofdstuk 6 hebben we zebravis embyo’s zonder functioneel Shp2 eiwit gebruikt 
om de rol van Shp2a in de signaaltransductie in staartvinregeneratie op te helderen. 
Shp2 is een intermediair in ‘mitogen activated protein kinase’ (MAPK) signaaltransduc-
tie. Shp2a heeft meerdere eiwitdomeinen met diverse functies: een katalytisch fosfa-
tase domein, en twee SH2 domeinen plus een C-terminaal domein voor het binden 
aan diverse factoren. We laten zien dat, wanneer de staartvin wordt geamputeerd, 
het opnieuw tot expressie brengen van Shp2a het regeneratieproces in homozygote 
ptpn11a-/-ptpn11b-/- embryo’s redt. De katalytisch inactieve mutant Shp2a-R466M en 
de Shp2a mutant die niet in staat is tot het binden van factoren met zijn SH2 domeinen 
kunnen het regeneratieproces in embryo’s zonder functioneel Shp2 eiwit niet herstel-
len. We laten ook zien dat de capaciteit van Shp2a om factoren te binden via zijn 
C-terminale domein waarschijnlijk niet noodzakelijk is voor zijn functie tijdens staart-
vinregeneratie in zebravis embryo’s. Door in situ hybridisatie en immuunhistochemie 
te gebruiken laten we zien dat ptpn11a-/-ptpn11b-/- embryo’s een normale blastema 
vormen, maar een blokkade in proliferatie en een verminderede activatie van MAPK 
vertonen gedurende de expansiefase. Farmacologische inhibitie van MEK, het eiwit 
dat MAPK activeert, belet regeneratie op vergelijkbare wijze en zorgt voor een stop 
in proliferatie gedurende de expansiefase. Onze resultaten duiden op een cruciale rol 
van Shp2a tijdens de expansiefase van staartvinregeneratie in zebravis embryo’s, door 
middel van het bevorderen van MAPK signaaltransductie.
In hoofdstuk 7 hebben we belangrijke aminozuren in Shp2a gemuteerd om te 
onderzoeken welke mate van oxidatie en welk peil van katalytische activiteit van 
deze fosfatase vereist zijn voor zijn correcte functie tijdens staartvinregeneratie in 
zebravis embryo’s. Shp2a is gevoelig voor omkeerbare inactivatie door oxidatie en er 
wordt gepostuleerd dat de twee “hulp” cysteïnes van Shp2a het eiwit beschermen 
tegen zogeheten onomkeerbare inactivatie door oxidatie. Shp2a werd geoxideerd na 
staartvinamputatie (Chapter 5), maar zijn activiteit was ook noodzakelijk voor embry-
onale staartvin regeneratie (Chapter 6). Door de hulp cysteïnes C334 en C368 van 
Shp2a te muteren, hebben we geheel nieuwe mutante eiwitten gegenereerd die een 
verminderde katalytische activiteit en een verhoogde gevoeligheid voor oxidatie door 
H2O2 bezitten. Desalniettemin herstelt het tot expressie brengen van de hulp cysteïne 
mutanten van Shp2a staartvin regeneratie in homozygote ptpn11a-/-ptpn11b-/- em-
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bryo’s, wat suggereert dat de hulp cysteïne mutanten van Shp2a niet onomkeerbaar 
geoxideerd werden door de normale en natuurlijke hoeveelheid H2O2 die wordt ge-
produceerd na staartvinamputatie. Bovendien herstellen de hulp cysteine mutanten 
van Shp2a de staartvinregeneratie ondanks hun gereduceerde katalytische activiteit. 
Interessant is dat Shp2a eiwitten met mutaties in de aminozuren D61 en A462, welke 
resulteren in respectievelijk verhoogde en verlaagde katalytische activiteit, staartvin-
regeneratie in zebravis embryo’s in gelijke mate herstellen. Gezamenlijk duiden onze 
resultaten erop dat Shp2a katalytische activiteit vereist is tijdens regeneratie, maar 
dat de mate van katalytische activiteit de functie van Shp2a in staartvinregeneratie in 
zebravis embryo’s niet beïnvloedt.
Tenslotte biedt hoofdstuk 8 een samenvattende discussie van het werk dat ge-
presenteerd is in elk van de voorgaande experimentele hoofdstukken en beschrijft de 
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